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Abstract 
Background: Nutritional intervention program is an integral and essential component of 
diabetes management and care. It aims to optimize diabetes control and to prevent 
complications. People with diabetes are advised to implement healthy diet; dietary changes 
including modifications in food habits and meal patterns for life long. However, a 
significant amount of patients remain with limited control.    
 
Study aim and objectives: The aim of the study was to evaluate the effectiveness of the 
Diabetes Care Program in controlling diabetes among type 2 diabetic patients registered at 
the diabetes care center at Augusta Victoria Hospital. The objectives were to examine the 
effect of nutrition counseling on HbA1c level and  the effect of the program on patients’ 
physical health, body mass index throughout the follow up period and to identify patients 
socio-demographic characteristics in determining her/his response to the  program.  
 
Methodology: This evaluative file based study was conducted on 746 patients’ with type 2 
diabetes who were followed at the Diabetes Care Center of Augusta Victoria Hospital 
between years 2005 to 2009. Four visits were taken for every patient including the first and 
final results, but the period between these visits were not regular and similar for all 
patients. Personal, medical and family history, physical examination and laboratory 
evaluation data were extracted from the patients’ files. 
 
Results: Analysis of patients' data showed that the mean age of the patients was 57 years ± 
9.34(mean ± S.D). Of the study population, 84% were married and 53% were females. 
74% did not work, 15% were illiterate, the mean duration of having diabetes was 10.08 
years and 57.2% had MOH insurance.41% of the patients were given a diet of 1000 
Calories during the study period .82% of the patients were classified as with light physical 
activity in the 1st visit and 76% were in the 4th visit. The mean HbA1c in the 1st visit was 
9.08±2.1 and in the 4th visit 8.46 ±1.7. The mean BMI in the 1st visit was 31.2±5.3 and in 
the 4th visit 31.9 ±5.3.  The study identified factors associated with good glycemic control, 
as measured by HbA1c levels. The percentage of patients with optimal control (HbA1c < 
7%) increased from 19.2% at the first visit to22.1% at the 4th visit. 60.7% of the patients 
had good change in HbA1c between the 1st and 4th visit. The multivariate logistic 
regression model for the study population (n=746) showed that between the first and last 
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recorded visit, being registered in the center was associated with the good change in 
HbA1c but was inversely associated with good change in MAU.  Age, residency, type of 
insurance, smoking, BMI, physical activity, cholesterol level and caloric intake did not 
show any significant associations with good change in HbA1c in this period of study.   
 
Conclusion: This is the first study done in the Diabetes Care Center which identified the 
determinants of the change in HbA1c and evaluate the program which shows that there was 
an irregular follow up period between the visits of the patients, which was shown in the 
results as an important factor in determining the change in HbA1c level. Results 
recommends the need for modification of the dietary program through involving the 
patients in this modification  to increase their adherence to the program  , system of 
appointment for follow up and evaluation of the compliance of patients with the diet, 
physical activity and as well as the  medication.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
V
Table of contents   
 
Page 
Chapter One: Background and Significance  
1.1   Background 1 
1.2   Study problem 3 
1.3   Justification of the study 4 
1.4   Aim of the Study 6 
1.5   Objectives 6 
1.6   Limitation of the Study 6 
1.7   Expected outcome 6 
1.8   Thesis chapters 7 
Chapter 2: Literature review  
2.1   Introduction 8 
2.2   Epidemiology of type 2 Diabetes Mellitus 8 
2.3   Diabetes management 10 
2.3.1 Glycemic control measure to control diabetes: Glycated     
Hemoglobin HbA1c 
10 
2.3.2 Lifestyle Changes and diabetes control 12 
2.3.3 Dietary Control in type 2 diabetes and diabetes management 14 
2.3.4 Diabetes and physical exercise 19 
2.3.5 Diabetes and overweight 21 
2.3.6 Self-care management 22 
2.3.7 Diabetes Self- Management Education (DSME) and its education 
programs 
23 
2.4 Summary of Literature 28 
Chapter 3: Conceptual Framework  
3.1   Introduction 29 
3.2 Definitions 29 
3.2.1 HbA1c 29 
3.2.1.1 Limitations of HbA1c 31 
3.2.2 Overweight and Obesity 32 
  
 
VI
3.2.3Microalbuminuria (MAU):  33 
3.2.4 Lipid profiles 34 
3.2.5 Blood Pressure 35 
3.3 Diabetes complications 36 
3.4 Duration of diabetes 37 
3.5 Gender 38 
3.6 Smoking 38 
3.7 The Management Goal of DM  38 
3.7.1 HbA1c control 39 
3.7.2 Diabetes and balanced diet  41 
3.7.3 Physical exercise 
3.8 Study conceptual framework model                                                         
43 
44 
 
Chapter four: Study methodology  
4.1 Introduction 45 
4.2 Study setting: Description of the diabetes program at Augusta 
Victoria Hospital (AVH) 
45 
4.3 Study population 46 
4.4 Management of the Diabetic patient at the Diabetes Center 46 
4.4.1 Dietary management 49 
4.5.Study design 51 
4.6 Sample frame 51 
4.6.1 Inclusion and exclusioncriteria 51 
4.7 Data collection 52 
4.7.1   Description of patient's file 52 
4.7.1.1 The assessment sheet form 52 
4.7.1.2 The follow up sheet form 53 
4.7.1.3 The educational planning sheet 53 
4.8 The objective testing used 53 
4.9 Dietary assessments and food groupings 55 
4.10 Ethical considerations 55 
4.11 Data Analysis 55 
  
  
 
VII
Chapter five. The results 
5.1 Introduction 57 
5.2 Section 1: Descriptive analysis 57 
5.2.1: Study population socio-demographic characteristic  57 
5.2.2 Health characteristics of study population before registering in the 
diabetes center 
59 
5.2.3 Laboratory testing (HbA1c, cholesterol, Microalbumin) and BMI 
distribution at the four visits used in this study: 
61 
5.2.4 Physical activity 61 
5.2.5 Medical regimen 62 
5.2.5.1 Medical nutrition Therapy (MNT)  62 
5.2.5.2 Medication 62 
5.3 Section two: Univariate analysis 63 
5.3.1  Association between HbA1c levels in the four visits 63 
5.3.2  Associations between HbA1c with the study demographic 
Variables 
66 
5.3.3  Associations between HbA1c with the Period in study, duration of 
diabetes  
67 
5.3.4  Associations between HbA1c and life style behaviors 68 
5.3.5  Univariate analysis for HbA1c after dividing the levels into good 
change (decrease in HbA1c between visits) and bad change (increase of 
HbA1c levels between visits)  
69 
5.3.6 HbA1c change between fourth and first visit (HbA1c 4-1) 70 
5.4 Multivariate analysis 73 
Chapter six.   Discussion and Conclusion  
6.1 Introduction 76 
6.2  Summary of study findings 76 
6.3  HbA1c levels and change before and after intervention 77 
6.4 Change in HbA1c throughout visits 83 
6.5 HbA1c change determinants between visit 1 and 4                                 85 
6.5.1 Association between HbA1c change and various demographic     
variables between 1st and 4th visit 
 
 
85 
  
 
VIII
6.5.2 Lifestyle factors associated with HbA1c change between the 1st and 
4th visit  
 
88 
6.5.2.1 Association between HbA1c and caloric intake 88 
between 1st and 4th visit  
 6.5.2.2 Association between HbA1c change and Body mass index 
(BMI)  
90 
6.5.2.3 Association between HbA1c change and Physical activity 92 
6.5.3 Association between HbA1c change with MAU  93 
6.5.4 Association between HbA1c change with cholesterol level 94 
6.6  Conclusion 95 
6.7 Recommendations 96 
References  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
IX
List of tables 
Table 3.1: HbA1c categories and Mean blood sugar (mg/dl). 
Table 3.2: Classification of Overweight and Obesity According to WHO. 
Table 3.3: Goals of glycemic control according to Palestinian National Authority Ministry 
of Health Diabetes Disorder Protocol 2008. 
Table 4.1: Calculations used for estimation of the energy requirements. 
Table 4.2: Calculations used for estimation of the physical activity requirements. 
Table 5.1: Associations between HbA1c among the 4 visits with demographic variables. 
Table 5.2: Association between HbA1c among the four visits with the Period in study, 
duration of diabetes.  
Table 5.3: Association between HbA1c at the four visits with BMI, physical activity. 
Table 5.4: The distribution of HbA1c 4-1 change with various demographic variables. 
Table 5.5: Distribution of HbA1C 4-1 with various follow up criteria. 
Table 5.6: The distribution of HbA1c 4-1 with lifestyle behaviors. 
Table 5.7: Multivariate analysis. 
 
 
 
 
 
 
 
 
  
 
X
List of figures: 
Figure 3.1: The food guide pyramid 
Figure 3.2: Study conceptual framework 
Figure 4.1: Diabetes center protocol for patient's visits   
Figure 4.2: Inclusion-exclusion criteria of the study sample 
Figure 5.1: Distribution of study population by Duration of diabetes 
Figure 5.2: Distribution of study population by age group 
Figure 5.3: Distribution of study population by marital status 
Figure 5.4: Distribution of study population by gender 
Figure 5.5: Distribution of study population by Job 
Figure 5.6: Distribution of study population by place of residency 
Figure 5.7: Distribution of study population by Educational level 
Figure 5.8: distribution of patients participating in the diabetes program according to 
health provider 
Figure 5.9: Life style behavior of study population before registering in the diabetes center  
Figure 5.10: Distribution of study population by family history of diabetes 
Figure 5.11: Distribution of women by having history of gestational diabetes 
Figure 5.12: Distribution of study population by having health complications 
Figure 5.13: Distribution of study population by physical activity in four visits 
Figure 5.14: Distribution of caloric intake by visit 
Figure 5.15: Distribution of study population by medical regime type 
Figure 5.16: Linear regression for the 4 HbA1c visits  
Figure 5.17:  Distribution of good and bad change between visits 
Figure 6.1: change in HbA1c between visits 
Figure 6.2: change in BMI between visits 
Figure 6.3: change in MAU between visits 
Figure 6.4: change in cholesterol between visits 
  
 
XI
List of Appendices 
Annex (1): Diabetes Medical File 
Annex (2): Diet Programs 
Annex (3): Box Plots 
Annex (4): Descriptive Analysis 
Annex (5): Univariate analysis among the various visits 
Annex (6): Univariate and multivariate analysis for subsample (n=255) 
Annex (7): Repeated measure analysis for the subsample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
XII
List of Abbreviations 
 
ADA                                The American Diabetes Association 
 
AVH                                Augusta Victoria Hospital 
 
BMI                                 Body Mass Index 
 
CDC                                Center of Disease Control 
 
DCCM                             Diabetes Comprehensive Care Model 
 
DCCT                              Diabetes Control and Complication Trial 
 
DM                                  Diabetes Mellitus 
 
DSME                             Diabetes Self Management Education 
 
FBS                                  Fasting Blood Sugar 
 
HbA1c                             Glycosylated hemoglobin 
 
IDF                                  International Diabetes Federation 
 
IGT                                  Impaired Glucose Tolerance 
 
MAU                               Albumin creatinine ratio 
 
MOH                               Ministry of Health 
 
PMRS                              Palestinian Medical Relief Society 
 
PCBs                               Palestinian Central Bureau of Statistics 
  
 
XIII
 
UKPDS                           United Kingdom Prospective Diabetes Study 
 
UNRWA                         United Nation Relief Work Agency 
 
 UHWC                           Union of Health Worker Committees 
 
WHO                              World Health Organization 
 
WDF                              World Diabetes Foundation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
1
 
 
Chapter 1: Background and Significance 
1.1 Background: 
Type 2 diabetes mellitus (DM) is a global health problem and one of the major causes of 
morbidity and mortality (Polikandrioti et al,2009) . The incidence of the disease is high 
worldwide and varies between populations because of differences in genetic susceptibility 
and other modifiable risk factor (Polikandrioti et al, 2009). Diabetes mellitus is a metabolic 
disease, characterized by hyperglycaemia (increased concentration of blood glucose) and 
disturbance of glucose metabolism, as a result of reduced insulin secretion or insulin 
resistance or both (Quaseem et al, 2007; Hjelm et al, 2003) 
The main disorder of diabetes mellitus is the decreased secretion of insulin from pancreas 
that regulates the metabolism of carbohydrates, proteins and fats. There are two types of 
diabetes, type 1 (insulin dependent) and type 2 diabetes (non-insulin dependent) that 
occurs most often in adults over the age of 40 and accounts for up to 95 percent of all 
diabetes cases.  The main difference between the two is that type 1 is characterized by 
complete lack of insulin, while type 2 is a combination of reduced secretion of insulin from 
the pancreas and resistance to insulin action in peripheral tissues (Halimi et al, 2003; 
Lusignan et al, 2005; Harris et al, 2003).  
The major issue of diabetes care is focused on preventing or delaying longstanding 
complications, which is the major drain of health care. However, patients with type 2 DM, 
before developing into chronic complications, remain symptomless for years without 
urgent characteristics (Larme and Pugh, 1998).  Many complications are associated with 
type 2 DM, such as: hypertension, dyslipidemia, and obesity, which are preventable if the 
glycemic control is maintained within its normal range. (Hopkins et al.,1996). 
Various measures are used to assess diabetes control.   Larson et al. (1990) noted the 
importance of monitoring glycosylated hemoglobin (HbA1c) in diabetes management. 
HbA1c measurements assess the amount of hemoglobin that is glycosylated.  Currently 
many organizations, such as the American Diabetic Association (ADA), recommend an 
  
 
2
HbA1c target value for individuals with diabetes to be set at approximately <7.0% (ADA, 
2003). However, new research suggests that complications related to diabetes may still 
occur at this HbA1c level. The American College of Endocrinology supports a lower 
HbA1c level, and has recommended HbA1c levels be <6.5% in individuals with diabetes 
(Cobin et al., 2002). 
Many of the behavioral and lifestyle trends, such as eating foods with high fat and sugar 
and living a sedentary lifestyle, are linked with the obesity epidemic, which has been 
strongly suggested as the major risk factor for developing type 2 diabetes (Haffner, 1998; 
Berger, 2001; Grubb, 2002; Cleator and Wilding, 2003; ADA, 2008a).   Physical inactivity 
and poor diet are potentially modifiable risk factors for chronic diseases (Yusuf et al, 
1994). 
Nutritional intervention is an integral part of diabetes management and self-care education, 
aiming at the attainment and maintenance of optimal metabolic outcomes, the prevention 
and treatment of medical complications, and the improvement of general health by 
addressing individual nutritional needs (Franz et al, 2002). Dietary management entails a 
series of eating behaviour changes regarding meal planning, food selection, food 
preparation, dinning out, portion control, as well as appropriate responses to eating 
challenges (Yannakoulia, 2006). Diabetic people are routinely advised to adopt a healthy 
diet; dietary changes include modifications in food habits and meal patterns on a lifelong 
basis. However, a significant proportion of patients remain poorly controlled (Monnier et 
al, 2004; Harris et al, 2001; Saaddine et al, 2006; Maizlish et al, 2004; Azab et al, 2001). 
Diet, lifestyle behaviour, has been reported as a management domain with very low 
compliance among diabetics (Peyrot et al, 2005; Thanopoulou et al, 2004; Glasgow et al, 
1997). Results from cross-sectional studies indicate low adherence to the dietary 
recommendations for macronutrient intake and fruit and vegetable consumption (Nelson 
KM et al, 2002). 
There are no high quality data on the efficacy of the dietary treatment of type 2 diabetes. 
The data available indicate that the adoption of exercise appears to improve glycated 
haemoglobin (HbA1c) at six and twelve months in people with type 2 diabetes. There is an 
urgent need for well-designed studies which examine a range of interventions, at various 
points during follow-up (Nield, et al, 2007).  
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1.2 Study problem: 
Palestine is in a nutritional transition, which is a state when countries face both the burden 
of under and over nutrition (Popkin, 1998). This double burden causes significant strains 
on health care providers. The health system in Palestine is already facing many challenges 
because of the political situation. There are four main health care providers for Palestinians 
in West Bank and east Jerusalem. The Palestinian Ministry of Health (MOH), United 
Nations Relief Works Agency (UNRWA), private sector, the non-governmental 
organizations (ex. East Jerusalem hospitals) and the Israeli Sick Fund providing care for 
Palestinians living in Jerusalem (Mataria et al, 2009).   
Universal guidelines and consistent care, especially concerning diabetes, are lacking 
because of the fragmented health care system. Sustainability of the Palestinian health care 
system is a concern because much of it is sustained by international donors or costs are 
paid out of pocket by individuals. In addition, accessibility to health care centers is a major 
challenge both because of security restrictions from the Israelis in the West Bank itself and 
closures or restrictions of movement out of the West Bank and Gaza (Mataria et al, 2009).  
In response to above issues and the rising prevalence of diabetes and other risk factors for 
cardiovascular diseases in Palestine, such as obesity and hypertension (Abdul-Rahim et al, 
2001), and in the context of quality of services for diabetes patients, the Augusta Victoria 
Hospital (AVH) in Jerusalem, initiated a project funded by the World Diabetes Foundation 
(WDF) on “Incorporating diabetes prevention and nutrition counseling into medical 
treatment of diabetes patients”. This program aimed “to promote access to prevention and 
quality care for diabetic patients and high risk groups in the West Bank”. Therefore, this 
diabetes program combines diagnostics, medical treatment, nutrition counseling, 
prevention and foot care.   
Since year 2005, a total of 1375 diabetic patients has been assessed by the project team.  
According to the project protocol, each patient must be referred for nutrition consultation.  
Each referred diabetic type 2 patient must go through a dietary assessment and follow a 
group educational program. This dietary assessment falls within the guidelines of the daily 
food guide pyramid.  The details of this program objectives and implementation will be 
explained in the methodology chapter (chapter 4).  However, and since the start of the 
project, with all the bulk of data presented, from year 2005 only an evaluation was done 
concerning the management of the program but not the specific productivity of the dietary 
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program.  The dietary and education programs have gone for five years without evaluation.  
This means that an evaluation study is a necessity to evaluate the dietary program and the 
education programs content and its effectiveness on the patients' diabetes complications 
and control.   Therefore, we aimed in this study to carry out this evaluation for this five 
years period. The outcome of this evaluation will be used to inform the project planners 
and team to modify the program after evaluation if needed.   
1.3    Justification of the study: 
The association between poor nutrition and risk of chronic diseases later in life is more 
complex in Palestine than in other developed countries. The Palestinian society is in the 
stage of nutrition transition that is characterized of low-income countries, where under 
nutrition and over nutrition coexists (Jackson et al, 2002).  
Studies in Palestine identified major risk factors for chronic diseases such as overall and 
central obesity and high triglycerides (Abdul-Rahim et al, 2001)). In late 1990s, it was 
observed that high prevalence of type 2 diabetes and obesity in the urban and rural 
Palestinian areas occurred and the rates are still rising (Abdul-Rahim , 2001; PCBs, 2000).  
In the demographic health survey in year 2004, it was reported that diabetes, hypertension, 
and cardiac diseases among all age groups in the West Bank have increased from 2.1%, 
2.4%, and 0.6% in year 2000 to 2.4%, 3.4%, and 1.4%, respectively, in 2004. The 
prevalence among adults aged 35 years and older was 10.2% for diabetes (PCBS, 2006).  
Cigarette smoking, a key risk factor associated with chronic diseases, was also prevalent in 
the West Bank, reaching 22% among those aged 10 years and older, and rates were much 
higher among men (41%) than among women (3%) (PCBs, 2006).  Death from acute 
myocardial infarction is higher among Palestinian men and women living in Jerusalem 
than among Israeli Jews, this difference is most likely attributable to the high prevalence of 
risk factors such as obesity and diabetes in both populations; and the stress of the complex 
political situation and socioeconomic inequalities (Kark et al, 2006).  
 Abu Rmeileh et al. showed in their analysis of studies on diabetes in Palestine that the 
prevalence of diabetes in the rural areas was 10% in comparison with 12% in the urban 
areas, which is considered high (Abu-Rmeileh et al, 2008).  
Cross-sectional data for adults (age 30-65 years) in two Palestinian communities in the 
West Bank showed high rates of obesity (defined as body-mass index >30 kg/m2) (Abdul-
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Rahim et al, 2003).  Obesity is associated with an increased risk of developing 
hypertension and diabetes. In fact, the prevalence of diagnosed hypertension and diabetes 
has increased significantly from 1988–1994 to 2001–2004 (21.7% versus 26.7% for 
hypertension, 5.4% versus 7.3% for diabetes). In addition, the prevalence of obesity has 
doubled from 25.7% during 1976–1980 to 50.8% during 1999–2004 among people with 
hypertension. Moreover, strong associations between a higher body mass index (BMI) and 
risk of hypertension or diabetes exist even among people within a normal BMI range (Zhao 
et al, 2009).  
According to UNRWA’s reports, they indicate that there is a steady increase in the burden 
of disease because they lack human and financial resources. They also lack institution 
capacity building programs. They are also lacking community participation in reducing the 
burden of disease. There is an average of 98 patients per doctor per day. Good 
documentation processes are also limited for diabetics and diabetes care.   The current 
system does not allow enough time and resources for education, essential testing and 
screening (HbA1c) or diet counseling. 
No published study or report reflects the presence of any structured comprehensive 
program for prevention of diabetes complication in Palestine. Most health education and 
promotion programs are targeting patients either at the institute setups like hospitals or 
clinics or very limited health education programs such as the education campaigns done by 
several charitable organization, example the campaigns of the Union of Health Worker 
Committees (UHWC) and Palestinian Medical Relief Society (PMRS Chronic Disease 
Program). Other international organizations are just providing educational material for 
diabetes but none of them supported such programs at the community level.  
The implementation of the Diabetes Comprehensive Care Model (DCCM) focused and 
structured awareness raising and community programs that could target the wider 
community about healthy lifestyles. The partnership between Augusta Victoria Hospital 
and UNRWA became much more formalized in 2009 with the additional support from the 
Danish Representative Office of the Palestinian National Authority to establish a Diabetes 
center in one of the refugee camps in the West Bank. Due to this project, UNRWA staff 
members have been trained intensively at AVH and in the new center and HbA1c has been 
introduced as a central protocol of the testing of some 20,000 registered Diabetics in the 
West Bank. In addition, this new center provides a foot care service and they have a trained 
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group of professionals who can respond to this urgent need in their center. AVH has also 
helped to build the capacity of the health staff within the UNRWA system to act as 
Dietitians in support of the overall Diabetes work in the clinic.  
 
1.4   Aim of the Study: 
To evaluate the effectiveness of the Diabetes Care Model in controlling diabetes among 
type 2 diabetic patients registered at the Diabetes Care Center at Augusta Victoria Hospital 
between the years 2005-2009. 
1.5   Objectives: 
1. To examine the effect of nutrition counseling on HbA1c level throughout the follow up 
period. 
2. To examine the effect of the Diabetes program on patients’ physical health, body mass 
index, and lipid profiling throughout the follow up period. 
3. To identify patient socio - demographic characteristics determining her/his response to 
the program.  
 
1.6   Limitation of the Study: 
Many diabetic patients living in the West Bank who joined the program had problems in 
accessing the center in Jerusalem due to Israel permission restrictions, and the geographic 
distance which limited the number of patients included in the study. 
Detailed data about some aspects of patient management at baseline were not available in 
this study, such as changes in drug management and compliance of patients with the 
treatment protocol. 
1.7   Expected outcome: 
 The expected outcome of this evaluative study is to provide evidence to improve the 
quality of services provided to diabetic patients including modification of the dietary 
program, for the next phase of the project that will be expanded to cover other areas in the 
West Bank. 
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1.8   Thesis chapters: 
The thesis will consist of six chapters. In chapter one, we present study problem statement, 
study justification, aim and objectives. Chapter two presents the literature review of 
previous studies that are related to research topic. While in chapter three, the theoretical 
and conceptual frame work for the study will be discussed. In chapter four the nature and 
content of the intervention program at the AVH is explained in details.  Study setting, 
study population, type of collected data, method of selecting the patients and extraction of 
data from patients’ files, inclusion and exclusion criteria, ethical consideration, and the 
study statistical analysis of data are presented. While in chapter five, study results will be 
presented and demonstrated in form of tables and figures which is built on the univariate 
and multivariate analysis. While in chapter six, the study findings are discussed and 
compared to the reviewed literature are presented, in addition, study conclusion and 
recommendations are presented. 
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Chapter 2: Literature review: 
2.1 Introduction: 
Diabetes is a chronic condition of abnormalities in the metabolism of fat, protein and 
carbohydrates.  It is found that in type 1 diabetes there is an absolute insulin deficiency and 
in type 2 there is relative insulin deficiency and defects in insulin action (Burant, 2004).  In 
the developed countries type 2 diabetes accounts for 85% to 95% of all diabetes cases, 
while it is even higher in the developing countries (IDF, 2008).  
Complications of diabetes account for much of the social and financial burden of diabetes 
(IDF, 2004).  Its complications are severe and might be leading to serious conditions such 
as kidney failure, blindness, micro and macrovascular complications, cardiovascular 
disease, and amputation (IDF, 2004).   
Type 2diabetes has been shown to have genetic links but is most often caused by lifestyle 
factors such as obesity, smoking, and stress.  Lifestyle intervention programs that combine 
regular exercise, dietary modulation and/or oral blood glucose lowering medication have 
proven to be an effective therapeutic strategy in type 2 diabetes (Mataria et al, 2009).   
Therefore, in this chapter, literature related to type 2 diabetes control, in particular lifestyle 
intervention programs will be presented.  
2.2 Epidemiology of type 2 Diabetes Mellitus: 
The diabetes burden was estimated to be over than 100 million people in the world by the 
International Diabetes Foundation (IDF) (IDF, 2011).  It is expected that the number of 
adults with diabetes worldwide to increase from 150 million in 2000 to 300 million in 2025 
(Day, 2001). The IDF expects the number will reach 430 million by 2030 (Adebayo, 
2011). The spread of type 2 diabetes increases with age and it is estimated to affect nearly 
17% of the people aged 65-74 old in USA (Dunstan et al, 2002).  The World Health 
Organization (WHO) year 2002 report indicates that about 58% of the diabetes worldwide 
can be attributed to body mass index (BMI) above 21 kg/m². Type 2 diabetes and obesity 
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are closely linked with weight gain resulting in insulin resistance (Adebayo, 2007). In the 
United States, a study on 17,306 participants aged 20 year between years 1999 to 2006 
found that the prevalence of diagnosed diabetes was 6.5% from 1999 to 2002 and 7.8% 
from 2003 to 2006 (P <.05) (Cheung, 2009).  
In the Eastern Mediterranean area, it is predicted that the number of diabetics will increase 
from 22 million to 30 million by 2025 (IDF, 2003). This rapid increase is attributed to 
different factors such as westernization, economic development, unhealthy diet, 
urbanization the increase in the number of aging population, obesity and over weight in 
addition to physical inactivity (Husseini et al, 2009). 
In Palestine, according to the WHO estimations, the prevalence of diabetes is increasing.  
In a study conducted in cooperation between Al-Quds University and the Palestinian 
Ministry of Health in year 2000 showed that the prevalence of diabetes in Palestine was 
9% (Abdeen, 2006). The Union of Palestinian Medical Relief Committee screened 2,482 
men and women between the age of 35-65 for obesity, hypertension, diabetes and 
dyslipidemia. The results showed that 77% of the sample was overweight (BMI > 25), 47% 
was obese (BMI > 30), 31% with hypertension, 18% with diabetes, and 49% with 
dyslipidaemia (Abdeen, 2006).  Abdul Rahim et al. investigated the prevalence of diabetes 
and associated factors in a cross-sectional survey of an urban Palestinian population of 492 
men and women aged 30-65 years. Diabetes was found in 12.0% of the survey population, 
including 9.4% previously diagnosed, and impaired glucose tolerance in 5.9%. Logistic 
regression analysis, controlling for age and sex revealed body mass index, waist-to-hip 
ratio and family history of diabetes to be significantly independently associated with 
diabetes (Abdul Rahim et al., 2001). In a study that was conducted in 1996, revealed that, 
clinical services offered to diabetic patients have no or minimal effect in determining the 
health status of population. Low quality of educational services was due to lack of trained 
human resources (Shaar, 1996).  In a master thesis on diabetic patient type 1 in Ramallah 
revealed the prevalence of diabetic complications among type 1 diabetics as follows: 
retinopathy 36.4%, neuropathy 26.2 and nephropathy 7.5%.  The study results showed a 
significant association between retinopathy and neuropathy with HbA1c, disease duration 
and patients’ sex (P<0.05) (Al-Khdoor, 2007). 
In the West Bank, the MOH report for year 2010 showed that diabetes was the six leading 
cause for death and accounts of 5.7% of all deaths and which was higher among females 
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(6.95%) compared to males (4.52%) (MOH report 2010).   This rate varied by age which 
was 1.6% among age group 20-59 years and 13.6% among individuals 60 years and above.  
The report showed that the incidence rate was increasing.  In year 2009 the incidence rate 
was 154 per 100,000 and was 174 per 100,000 populations in year 2010 (MOH report 
2010).  
2.3 Diabetes management: 
In order to prevent diabetes and its complications it is necessary to raise awareness about 
diabetes, make changes in lifestyle and to improve the quality of care (Quinn, 2008).  In 
this section, literature on the various methods of controlling type 2 diabetes is reviewed. 
2.3.1 Glycemic control measure to control diabetes: Glycated hemoglobin HbA1c 
HbA1c mirrors the average glycemia over several months, in addition to its strong value in 
predicting complications (Alcal et al, 2009; Martin et al, 2006). Its quarterly testing shows 
if the treatment targets are being met. It is enough for the people with stable glycemia to do 
the test twice a year. The availability of the results of HbA1c testing when the patient is 
seen had a great influence on the treatment process and leads to better and improved 
glycemic control (Stratton et al, 2000; Miller et al, 2003).  In clinical practice, optimal 
glycemic control is difficult to obtain on a long-term basis because the reasons for poor 
glycemic control in Type 2 diabetes are complex (Wallace , 2000).  Both patient- and 
health care provider related factors may contribute to poor glycemic control (Rhee et al., 
2005; Wallace, 2000).  In Emirates, the mean HbA1c for diabetic patients with type 2 
diabetes in primary health care was 8.3%, and only 38% of patients had good glycemic 
control (HbA1c < 7.0%) (Juma Al-Kaabi et al, 2008). In Amman-Jordan the percentage of 
patients with optimal control (HbA1c ≤ 7%) increased from 25.4% at the first visit to 
27.5% at 12-month follow-up (M. Adham et al , 2010).  In Al-Ain, UAE the mean HbA1c 
declined from 8.5% in 2008 to 7.5% in 2010.(Layla Alhyas et al, 2012) . In Iraq the mean 
HbA1c levels at the start of the study was 9.8 ± 1.9 % and after 3 years it was 8.1 ± 1.6 % 
(Mansour et al, 2011).  In Saudi Arabia 27% of the patients reached target level of 
glycemic control (Akbar, 2001). In Kuwait, only 17.6% of patients had achieved the goal 
of HbA1c < 7% and In Trinidad, 15% of the patients had HbA1c≤ 7% (Ezenwaka & 
Offiah, 2001). Baseline data of newly diagnosed patients enrolled to the Korea National 
Diabetes Program (KNDP) cohort study conducted in Korea showed that mean HbA1c was 
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8.2 ± 2.4%. (Choi et al, 2011). In Sweden a survey revealed that from type 2 diabetes 
patients only 34% had good glycemic control (Holmström IM et al, 2005). In Finland, only 
25% of a study group had HbA1c < 7.3%. (Valle T et al, 1999). The authors suggested that 
the difficulty to obtain optimal glycemic control ( HbA1c <7) is attributed to the rapid 
urbanization, poor lifestyle habits, obesity, physical inactivity and the poor adherence and 
follow up of diabetic patients to structured diabetes care programs.  
Diabetic patients are advised to do the HbA1c testing on a regular basis as part of their 
ongoing treatment.  It was found that lowering HbA1c levels reduces the development of 
diabetes complications. As HbA1c decreases by 1%, micro-vascular complication 
decreases by 37%, as well as macro-vascular complications (Ousman et al, 2011). Micro 
vascular and neuropathic complications of diabetes were reduced when the HbA1c was 
reduced to 7% or below.  It is also accompanied with a long-term reduction in macro 
vascular disease if it was implemented soon after the diagnosis of diabetes (ADA, 2011).   
In Sweden a survey revealed that from type 2 diabetes patients only 34% had good 
metabolic control (Holmström IM et al, 2005).  
Significant decrease in the rates of micro vascular (retinopathy and nephropathy) and 
neuropathic complications resulted from improved glycemic control was shown in two 
important epidemiological studies, i.e. the Diabetes Control and Complication Trial 
(DCCT) and the UK Prospective Diabetes Study (UKPDS) (Ohkubo Y et al, 1995; 
UKPDS, 1998).  As suggested by these studies, analyses of large portion of diabetes 
complications were avoided by moving patients from weak control to good or fair control.  
Furthermore, studies analyses suggest that lowering HbA1c from 7% to 6% is 
accompanied with reduction in the risk of microvascular complications (Gerstein, 2008). 
A cross-sectional, case-control study in Negri Bergamo Laboratories in Italy explored the 
association of proliferative diabetic retinopathy (PDR) with insulin resistance (IR) in type 
2 diabetics. PDR patients (n= 29) had higher IR and low-density lipoprotein cholesterol 
(LDL) and triglyceride levels than Bilateral Diabetic Retinopathy (BDR) patients (n=29), 
but comparable levels of HbA1c. Compared with patients without retinopathy (n = 58), 
those with PDR had higher IR, low-density lipoprotein cholesterol, and albuminuria; those 
with BDR had higher HbA1c, but comparable IR (Parvanova, et al. 2004). 
A study in Saudi Arabia examined the impact of glycemic control on diabetic lipid profile 
and determining that HbA1c as an indirect marker of dyslipidemia. 1011 type 2 diabetes 
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patients were chosen (males, 574; females, 437) mean age was 59.76 years.HbA1c levels, 
FBS and LDL were similar in the case of males and females. Serum cholesterol levels and 
HDL were higher in females and TG levels were lower among females compared to males. 
HbA1c levels and FBS had a strong relationship and both showed strong correlation with 
TG, cholesterol and LDL, and inverse relation with HDL. There was a linear relationship 
between HbA1c and dyslipidemia The levels of serum cholesterol was significantly higher 
among patients with worse glycemic control as compared to patients with good glycemic 
control. The findings of this study clearly indicate that HbA1c is a good predictor of lipid 
profile. (Khan HA et al.,2007) 
In the National Health and Nutrition Examination Survey the trends in HbA1c levels was 
examined for adults with diabetes using three periods: 1999–2000, 2001–2002, and 2003–
2004.  Mean HbA1c levels decreased from 7.82% in 1999–2000 to 7.47% in 2001–2002 
and 7.18% in 2003–2004. Controlled Diabetic patients with HbA1c < 7.0% increased from 
37.0% in 1999–2000 to 49.7% in 2001–2002 and 55.7% in 2003–2004; this indicates 
corresponding betterment over time (Hoerger et al, 2007). 
 
Effective diabetes management programs, assessment of the target population’s needs, 
implementing programs that include screening, surveillance and involvement of patients in 
the programs and evaluation of diabetes programs are all key characteristics of effective 
diabetes management. Glasgow et al studied using a cross over design study that involved 
162 diabetic patients with type 2 diabetes over the age of 60 years using a multidisciplinary 
team that included also a dietitian. Reduction in caloric intake and percentage of calories 
from fat was significant in the intervention group compared to the control group. When 
control group patients crossed over to the intervention group, their HbA1c levels decreased 
from 7.4% to 6.4% (Glasgow et al. 2001)  
2.3.2 Lifestyle Changes and diabetes control: 
There are lots of ways designed to help specialists to control diabetes, from changing 
eating habits to increasing physical activity.   However, the responses to the illnesses of 
some patients are influenced by their beliefs, attitudes, and experiences (Hamlets, 2011). It 
was found that intensive lifestyle intervention make long-term valuable modification in 
diet, physical action, and clinical and biochemical parameters. This helps preventing type 2 
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diabetes and should be implemented as one of the most important health care system 
(Lindstrom et al, 2003).   
It was assured that diet and exercise can postpone the onset of type 2 diabetes in persons at 
risk strongly exists.  In one intervention trial in year 1986, 110,660 men and women from 
33 health care clinics in the city of Da Qing in China where 577 subjects with impaired 
glucose tolerance were randomized to control, diet, and exercise groups. Over a period of 
six years, 67% of the control group but only 41 to 43% of the intervention groups 
developed type 2diabetes, which is around 25% risk reduction (Pan X et al, 1994). 
Prospective cohort study examined associations of lifestyle factors, measured using 
repeated assessments later in life, with incident diabetes mellitus during a 10-year period 
(1989-1998) among 4883 men and women 65 years or older enrolled in the Cardiovascular 
Health Study. Low-risk lifestyle behaviors were defined by physical-activity levels above 
the median and never smoking or smoking <5 pack-y ears or having quit smoking >20 
years ago. Alcohol use in this cohort was rare, with 94% consuming less than two drinks 
daily.  Individuals were also assigned a dietary score based on their intake of dietary fiber, 
low glycemic index foods, lower trans-fats, and a higher polyunsaturated-to-saturated-fat 
ratio. Assessments of adiposity were also performed, with a low-risk body-mass index 
(BMI) defined as not being overweight, or a BMI <25, while a low-risk waist 
circumference for men was <92 cm and <88 cm for women (Mozaffarian et al, 2009). 
917 type 2 diabetic patients were randomly selected for the study for a period of 6 months 
in 2008. The objective of this study is to evaluate and determine the factors associated with 
poor glycemic control among Jordanian type 2 diabetics. Weight, height and waist 
circumference were measured for the sample in addition to the last HbA1c, fasting blood 
sugar and lipids. “Poor glycemic control was defined as HbA1c ≥ 7. 65.1% among the 
patients studied appeared to be within the poor glycemic control% had HbA1c ≥7%. In the 
multivariate analysis, increased duration of diabetes (N>7 years vs. ≤7years) (OR=1.99, 
P≤.0005), not following eating plan as recommended by dietitians (OR=2.98, P≤.0005), 
negative attitude towards diabetes, and increased barriers to adherence scale scores were 
significantly associated with increased odds of poor glycemic control. The authors 
concluded that Educational programs, raising awareness, campaigns and lifestyle 
modifications will bring benefit in glycemic control among diabetics. (Khattab et al.,2008) 
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Zgibor et al conduct a survey to identify patient behavior change goals and diabetes 
educator responses including 954 diabetics with type 1 and 2 diabetes.74% and 54% of 
diabetics identified that healthy eating and being active respectively as the most common 
behavior-change goal (Zgibor et al, 2007). 
In a systematic review and Meta analysis research to study the association between active 
smoking and incidence of type 2 diabetes. The research composed of 25 cohort studies (N= 
1.2 million participants), reported that 45,844 incident cases of diabetes during a follow up 
period ranging from 5 – 30 years.  In this study, participant selection was based on having 
impairment in fasting glucose; those with impaired glucose tolerance; or type 2 diabetic 
patients with having their smoking status at baseline. While excluded if they were diabetic 
at baseline. Results showed that "the risk of diabetes was greater for heavy smokers (more 
than 20 cigarettes/ day; RR, 1.61; 95% CI, 1.43-1.80) than for lighter smokers (RR, 1.29; 
95% CI, 1.13-1.48) and lower for former smokers (RR, 1.23; 95% CI, 1.14-1.33) compared 
with active smokers". As a conclusion, active smoking is coupled with an increase risk of 
type 2 diabetes (Willi et al, 2007). 
 
2.3.3 Dietary Control in type 2 diabetes and diabetes management: 
Nutritional intervention is an essential element of diabetes prevention, management, and 
self-care education. It is important at all levels of diabetes prevention, in addition to its role 
in preventing and controlling diabetes (Bantle et al, 2008).  People with diabetes are 
normally advised to implement a healthy diet; dietary changes include modifications in 
food habits and meal patterns for lifelong. However, a significant amount of patients 
remain with limited control (Yannakoulia, 2006). In a study that took place in Iran with a 
goal of examining the association of glycemic control with the demographic, 
anthropometric, clinical and other data among Iranian diabetic females. The percentage of 
patients with poor glycemic control was 56.3%. Controlled and uncontrolled patients’ 
glycemic control did not differ with respect to age, education, marital status, smoking, 
duration of disease, medication, blood pressure, duration of disease, waist circumference 
and presence of dislipidemia. (Ghazanfari et al., 2010) 
 The treatment of type 2 diabetes through dietary control has been found effective and it is 
known with the name Medical Nutrition Therapy (MNT). This kind of therapy depends on 
diagnosing, treatment and counseling. It must be provided by a nutrition specialist or 
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dietitian. The steps of MNT include assessment of individuals and follow up. The nutrition 
specialist designs or plans the meals for the patient. Routine visits to the nutrition specialist 
are vital in order to adapt and improve the treatment (Campbell et al, 2009).   
It was obviously noticed that MNT proved to be helpful for diabetics. Sustained 
improvements in HbA1c at 12 months and longer was seen among those consulting with 
registered dietitian that provided follow-up visits ranging from monthly to three sessions 
per year. HbA1c have decreased by 1% in type 1 diabetes and by 1-2% in type 2 diabetes. 
Improvements were clear after 3 to 6 months of starting MNT. Studies have shown a 
decrease in HbA1c during the same period by 0.25% to 2.9%. Reductions were higher for 
type 2 diabetes in a shorter period of time (ADA, 2008).  Furthermore, studies on non-
diabetic people showed that MNT reduces LDL cholesterol by 15–25 mg/dl up to 16% and 
play a role for lifestyle modification in treating hypertension (Franz et al, 1995; Van Horn, 
2008). Success in nutrition therapy lies in the food choices that are made. Research 
evidence proved that nutrition advice in the form of guidelines for healthy food choices is 
equally effective in producing changes in glycemic control as the traditional exchange-
based dietary regime (Ziemet et al, 2003). 
A case study showed that abiding to moderate lifestyle of light supper with morning 
swimming for 40 minutes decreased HbA1c level from 6.7 to 6.0 in six months and to keep 
this level for the following six months. The results also indicate that the recovery time of 
the postprandial blood glucose level can be adjusted to 4 hours (Hsin-i Wu, 2005).  Also, a 
high intake of total fat increases the risk of developing impaired glucose tolerance. 
Substituting saturated by unsaturated fatty acids improve glucose tolerance and increase 
insulin sensitivity (Parker DR et al, 1993). 
The potential role for dietary fiber in diabetes was first promoted more than 30 years ago 
by Trowell on the basis of his experience in East Africa where he noted a virtual absence 
of what is now known as type 2 diabetes in association with the consumption of traditional 
diets which were extremely high in `lightly processed' cereal foods. Uncontrolled clinical 
studies from Anderson's group in Kentucky demonstrated that introduction of a high 
carbohydrate high fiber diet was associated with a dramatic improvement in glycemic 
control and reduction in insulin dose for a small number of insulin-treated patients (Mann, 
2001) 
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The low glycemic index (low-GI) diets were proved to improve insulin sensitivity, HbA1c 
level, blood lipid concentrations and increase blood HDL cholesterol concentrations. In a 
trial to compare the effects of low-GI diet with the high cereal fiber diet, it was shown that 
HbA1c was decreased by 0.5% in the low-GI diet and by 0.18% in the high cereal fiber 
diet. Another study showed a reduction by 0.43% in HbA1c in the low-GI diets. The 
experts from the WHO and FAO encourages the low-GI diets (Adebayo, 2007).   
Three self-assessed daily blood glucose profiles over a 1-week period, including 18 
glucose readings before and 2 hours after meals, were obtained from 3,284 unselected 
outpatients (men 51%; age 63±10 years) with non-insulin-treated type 2 diabetes mellitus 
attending 500 different diabetes clinics operating throughout Italy. More than 84% of 
people with type 2 diabetes experience significantly elevated post-meal blood glucose 
(Bonora et al, 2006). This is a main worry due to the link between elevated post-meal 
glucose and diabetes complications (Ceriello, 2005). 
The nutritional advice for people with diabetes was recognized as major issue in treatment 
of the disease. The aim of dietary recommendations is to prevent and treat diabetes through 
improving glycemic control and lipid profile and optimizing the blood pressure, as high 
risk of microvascular abnormalities and cardiovascular diseases in diabetic subjects is 
linked to increased postprandial glucose response (ADA, 2011). 
 In a cross‐sectional study conducted in the regional diabetes clinic at the Prince of Wales 
Hospital (PWH) of Hong Kong. This study investigated a total of 562 consecutive 
newly‐referred to type 2 diabetic patients (57% women) during a 12‐month period. All 
patients underwent a structured assessment with documentation of clinical and biochemical 
characteristics. At the time of referral, 70.5% (n=396) were on drug therapy (9% on insulin 
and 62.8% on oral agents), 20.6% (n=116) were on diet and 9% (n=50) had not received 
any form of treatment. HbA1c was lower in patients who had seen a dietitian (7.9% vs. 
8.7%, p<0.001) or diabetes nurse (7.8% vs. 8.7%, p<0.001) or who performed self blood 
glucose monitoring (7.9% vs. 8.6%, p=0.001) and higher among smokers (8.9% vs. 8.2%, 
p=0.003) (Chan, 2000). 
To describe diet and exercise practices from a nationally representative sample of U.S. 
adults with type 2 diabetes, Karin et al analyzed data from 1,480 adults older than 17 years 
with a self-reported diagnosis of type 2 diabetes in (NHANES III). Fruits and vegetables 
consumption was obtained from a food frequency questionnaire.  The percentages of total 
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calories from fat and saturated fat were obtained from a 24-h food recall. Physical activity 
was based on self report during the month before the survey. Results of individuals with 
type 2 diabetes show that 31% reported no regular physical activity and another 38% 
reported less than recommended levels of physical activity. Sixty-two percent of 
respondents ate fewer than five servings of fruits and vegetables per day. Almost two 
thirds of the respondents consumed >30% of their daily calories from fat and >10% of total 
calories from saturated fat. Lower income and increasing age were associated with 
physical inactivity. Thirty-six percent of the sample was overweight and another 46% were 
obese. Mexican Americans and individuals over the age of 65 years ate a higher number of 
fruits and vegetables and a lower percentage of total calories from fat (Karin et. al, 2002).  
Anderson et al examined in one meta analysis of eight studies the effects of very low and 
low calorie diets in 219 obese subjects with type 2 diabetes. The eight studies concluded 
that 11.1% of their initial weight and fasting plasma glucose decreased by 14.7% at 48 
weeks (Anderson et al, 2003). 
 
Another meta-analysis examined eleven randomized controlled trials including 402 
participants to study the efficacy of low glycemic index diets in people with type 1 and 
type 2diabetes. Data for six trials measuring HbA1c showed a mean reduction of 0.5% for 
patients on low glycemic index diets compared to patients with higher glycemic index diets 
(Thomas et al, 2009).  
In a study, 102 of patients with type 2 diabetes were randomly divided into two groups to 
receive group education and individual dietary advice for six months. One of the groups 
received a diet with 13% of carbohydrates of their daily energy intake and the other group 
received 33% of carbohydrates from their daily energy intake. In patients who adhere to a 
low carbohydrate diet a reduction in weight was greater than the other group (Daly et al, 
2006). 
A randomized crossover study examined the beneficial effects of high dietary fiber intake 
in patients with type 2 diabetes mellitus. Thirteen patients with type 2 diabetes were 
recruited to follow two different diets for six weeks. One of the diets contains moderate 
amounts of fiber as the ADA recommends and the other is a high-fiber diet. During the 
sixth week, the high-fiber diet, as compared with the sixth week of the ADA diet. Mean 
daily pre-prandial plasma glucose concentrations was 13 mg/dl lower, and also reduced 
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plasma total cholesterol concentrations by 6.7 percent, triglyceride concentrations by 10.2 
percent, and very-low-density lipoprotein cholesterol concentrations by 12.5 percent 
(Chandalia et al, 2000). Also, in a study that investigated the effect of a low–glycemic 
index diet versus a high–cereal fiber diet on glycemic control and cardiovascular risk 
showed that HbA1c decreased by 0.50 percent in the low–glycemic index diet compared 
with 0.18 percent in the high–cereal fiber diet (David et. al, 2008).  
In a prospective randomized trial, in USA, that used two levels of MNT on metabolic 
control in persons newly diagnosed with or currently under treatment for non insulin 
dependent diabetes, showed that “with more intensive nutrition intervention, changes in 
lifestyle can lead to significant improvements in glucose control.  The fasting plasma 
glucose level decreased by 50–100 mg/dl and the HbA1c dropped by 1–2%. The average 
duration of diabetes for all subjects was 4 years and the decrease in HbA1c was 0.9% 
(from 8.3 to 7.4%). In the subgroup of subjects with duration of diabetes _1 year, the 
decrease in HbA1c was 1.9% (Franz et al, 1995). 
In a randomized trial study in a teaching hospital in Naples-Italy, showed greater benefit 
from a low-carbohydrate, Mediterranean-style diet compared with a low-fat diet in patients 
with newly diagnosed type 2 diabetes mellitus. This trial included 215 overweight patients 
with newly diagnosed type 2 diabetes mellitus who had never been treated with 
antihyperglycemic drugs and whose HbA1c levels were less than 11% were assigned to 
either a Mediterranean-style diet (< 50% of daily calories from carbohydrates) ) (n = 108)  
or a low-fat diet (<30% of daily calories from fat) (n = 107). After 4 years results showed 
that the participants assigned to the Mediterranean-style diet had lost more weight and had 
more improvement in some measures of glycemic control and coronary risk than had 
participants consuming the low-fat diet. About 44% of patients in the group adhering to the 
Mediterranean diet required anti hyperglycemic drug therapy, compared with 70% of those 
in the low-fat diet group (Esposito et al, 2009). 
A study examined the association between the magnitude of weight loss and changes in 
CVD risk factors at 1 year showed that weight loss was strongly associated with 
improvements in glycemia, blood pressure, triglycerides, and HDL cholesterol. Also when 
compared with weight-stable participants, those who lost 5 kilograms or less than 10% of 
their body weight had increased odds of achieving a 0.5% point reduction in HbA1c (Wing 
et. al, 2011).  
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2.3.4 Diabetes and physical exercise:  
Exercise is an important element of diabetes management. People with diabetes should be 
advised to perform at least 150 min/week of moderate-intensity aerobic physical action. 
Standard exercise proved to improve blood glucose control, reduce cardiovascular risk 
factors, improve well-being, and contribute to weight loss (ADA, 2004). 
Trials have provided strong evidence for the HbA1c-lowering value of resistance training 
in older adults with type 2 diabetes and for an additive benefit of combined aerobic and 
resistance exercise in adults with type 2 diabetes.  It was shown that designed physical 
exercises of at least 8 weeks are helpful in lowering HbA1c by an average of 0.66% in type 
2 diabetic people. The improvements in HbA1c are better if the exercises were higher in 
levels (ADA, 2011). Also, t was shown that continuous endurance–type exercise lowers 
blood HbA1c, increase insulin sensitivity, increase the risk profile for cardiovascular 
disease and reduce adipose-tissue mass in patients with type 2diabetes (Hansen, 2009). 
In a randomized controlled trial to study the effect of high-intensity progressive resistance 
training combined with moderate weight loss on glycemic control and body composition in 
sedentary, overweight (BMI > 27 and < or equal to 40) in 36 men and women aged 60–80 
years with non insulin treated diabetes who were diagnosed with for more than 6 months 
and had HbA1c of 7-10%. HbA1c decreased significantly more in resistance training and 
weight loss than in weight loss alone at 3 months and 6 months.  When compared with 
moderate weight loss, resistance training was more effective for improving HbA1c than 
moderate weight loss without resistance training. The author recommended this form of 
exercise in the management of glycemic control of adult patients with type 2 diabetes.  
(Dunstan et al, 2002) 
A randomized controlled trial was performed in a population of Latino older adults with 
poor glycemic control and no personal history of regular exercise adults with type 2 
diabetes ( n=62)  to determine the ability of high intensity, low-volume progressive 
resistance training (PRT) to improve glycemic control and other metabolic abnormalities. 
Glycemic control, metabolic syndrome abnormalities, body composition, and muscle 
glycogen stores were determined before and after the intervention. Sixteen weeks of PRT 
(three times per week) resulted in reduced HbA1c levels (from 8.7 to 7.6), and reduced the 
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dose of prescribed diabetes medication in 72% of exercisers compared with the control 
group, P = 0.004–0.05. Control subjects showed no change in HbA1c, and a 42% increase 
in diabetes medications. PRT subjects versus control subjects also reduced systolic blood 
pressure (–9.7 vs. +7.7 mmHg). Author concluded that supervised high intensity resistance 
training proved both feasible and effective among high-risk older adults with type 2 
diabetes, resulting in improved glycemic and metabolic control (Castaneda et al 2002). 
A meta-analysis of randomized, controlled clinical trials of at least 12 weeks duration 
evaluated the ability of structured exercise training or physical activity advice to lower 
HbA1c levels as compared with a control group in patients with type 2 diabetes. A total of 
47 RCTs studies (n=8538 patients) were included. Overall, structured exercise training in 
23 studies was associated with a decrease in HbA1c level (−0.67%, to −0.49%) compared 
with control participants. In addition, structured aerobic exercise, structured resistance 
training, and both combined were each associated with declines in HbA1c levels compared 
with control participants. Further analysis indicated that interventions which included 
structured exercise durations of more than 150 minutes per week were associated with 
HbA1c reductions of 0.89%, while structured exercise durations of 150 minutes or less per 
week were associated with HbA1c reductions of 0.36%. In 24 studies interventions of 
physical activity advice were associated with lower HbA1c levels compared with control 
participants. Combined physical activity advice and dietary advice was associated with 
decreased HbA1c (−0.58% to −0.43%) as compared with control participants. Physical 
activity advice alone was not associated with HbA1c changes (Umpierre, 2011). 
A Meta analysis study evaluated the effect of exercise interventions (duration ≤ 8 weeks) 
in adults with type 2 diabetes (11 randomized and 3 non-randomized) using controlled 
trials. The mean HbA1c post physical exercise intervention was lower in the exercise 
groups compared with the control groups (7.65% versus 8.31).  The authors concluded that 
exercise training reduces HbA1c by an amount that should prevent the risk of suffering 
diabetic complications, but no significantly greater change in body mass was found when 
exercise groups were compared with control groups (Boule et. al, 2001). 
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 2.3.5 Diabetes and overweight: 
Obesity is the main reason behind the onset of diabetes. Estimations say that 60 to 90% of 
type 2 diabetes is attributed to obesity. An increase in the prevalence of obesity in several 
populations has been noticed after transition from traditional diets to western diets 
(Adebayo, 2007). 
Controlling body weight is of great importance in reducing risks related to diabetes. Due to 
the effects of obesity on insulin resistance, weight loss is an important therapeutic 
objective for individuals with pre-diabetes or diabetes (ADA, 2008). Moderate weight loss 
(5% of body weight) in people with type 2diabetes is associated with decreased insulin 
resistance, improved measures of glycemia and lipemia, and reduced blood pressure as 
proved by short-term studies.  Moreover, weight gain, the degree of obesity and its 
duration, all separately predict the commencement of type 2 diabetes. It was calculated that 
nearly 65 to 75% of diabetes cases could be avoided in white people if the BMI of the 
population did not exceed 25 kg/m² (Seidell, 2000).   Also, it was noted that an increasing 
amount of planned weight loss was accompanied with a linear decrease in diabetes 
occurrence among obese adults; active weight loss is a valuable way to the treatment of 
diabetic people (Colditz et al, 1995; Will et al, 2002). 
In the United States, a study on 17,306 participants aged 20 year between years 1999 to 
2006 found that the prevalence of diagnosed diabetes increased significantly in women, 
non-Hispanic whites, and obese people (Cheung, 2009).  Another study in which type 2 
diabetic patients were treated in a behavioral weight control program and followed up for 
one year showed that weight loss was significantly correlated with improvements in 
HbA1c. Patients who lost more than 6.9 kg or had more than 5% reduction in body weight 
had significant improvements in HbA1c values at one year (Wing, 1987).  
 In 2004 a meta-analysis assessed the effectiveness of lifestyle and behavioral weight loss 
and weight control interventions in adults with type 2 diabetes. A total of 22 studies were 
included. In this analysis, persons who adhere a physical activity and very low calorie diet 
lost 3 kilogram more than those who adhered to a very low-calorie diet alone. Persons who 
underwent a more intense physical activity intervention lost 3.9 kg more than those who 
received a less intense or no physical activity intervention with adhering to the same 
dietary and behavioral intervention. Several studies reviewed in this meta-analysis reported 
a significant reduction in HbA1c of 1.0% to 2.6% with lifestyle intervention corresponding 
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to weight loss (Norris et al, 2004). In the UKPDS, the degree of weight loss required to 
normalize the fasting blood glucose was 10 kg (16% of initial body weight) if the initial 
value was 6-8mmol/L versus 22 kg (35%) if the initial value was 12-14 mmol/L (NHS, 
2008).  
In a randomized control trial weight loss of 8.5% through an intensive education and 
support program decreased HbA1c by 0.64% (6.99mmol/mol) and decreased fasting blood 
glucose by 1.19mmol/l. The use of glucose-lowering medication was reduced from 86.5% 
to 78.6% (Pi-Sunyer, 2007).  
The prevalence of obesity was found to be high at 41% among the Palestinian urban 
population (49% among women and 30% among men). This was indicated in a study to 
show the relations between the prevalence of obesity and central obesity and selected co-
morbidities, including diabetes, hypertension and dyslipidaemia in the Palestinian urban 
society (Abdul-Rahim, 2001).  A significant relation was found between obesity and 
diabetes, low HDL cholesterol and elevated triglycerides. Furthermore; a substantial link 
between hypertension and central obesity was found. The prevalence of central obesity in 
men was more than in women (59% compared to 25% in women) (Abdul-Rahim, 2001).   
2.3.6 Self care management:   
Self management is very essential for preventing further diabetes complications. 
Adherence and self care are two of the biggest challenges in managing diabetes. Self 
management in practice is complex and difficult since it should include meal planning, 
being physically active, skin care, taking medicines, foot care, avoiding smoking and 
tobacco, and other health monitoring tasks (Ahmed, 2006).   
Studies showed that one-in-four (28%) were poor adherers to their diabetes (Gatt, 2008)) 
and as many as 50% do not take their medication regularly (WHO and IDF, 2004). Factors 
such as stress, eating certain foods, or being physically inactive can dramatically change 
blood glucose readings (Ahmed, 2006).  
Research has shown that various factors influence patients adherence to diabetes 
management some of these include their personal beliefs, perceptions of the health system, 
trust of doctors, emotional and psychological status; and outside support (Ahmed ,2006; 
Donnan, 2002; Collins, 2009). Adherence is particularly difficult for the elderly and for 
patients receiving long term care (Donnan, 2002).  
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The role of Self management was shown in several studies to affect the control of HbA1c.  
It has been found that there is not always time for primary health care providers to conduct 
diabetes specific assessments or discuss self care management with patients. Yet improved 
status of the Glycated hemoglobin (HbA1c) and other diabetes indicators has been found 
when sustained health care is provided (Quinn et al, 2008).  
In a cross-sectional survey in U.S in 2004 for adults with type 2 diabetes who had HbA1c 
checked in the past 6 months (n=686).  66% reported that they did not know their last 
HbA1c value and only 25% accurately reported that value.  Participants who knew their 
HbA1c values reported better diabetes care understanding and assessment of their 
glycemic control than those who did not. It was concluded that knowledge of HbA1c level 
alone was not sufficient to increase better understanding of diabetes care necessary to 
improve patients’ diabetes self-management. (Heisler et. al, 2005) 
From 2003 to 2005, a telephone survey of adults with type 2 diabetes was performed to 
examine self-management behaviors and glycemic control. Analyses compared patient 
characteristics and self-management behaviors to recent HbA1c levels.  Of 139 patients 
contacted, (74%) completed the study. Mean HbA1c was 7.7%, and the average duration 
of diabetes was 2.0 years. More than 80% of patients reported ≥ 75% medication 
compliance, and 59% monitored blood glucose > 2 times daily > 70% of patients reported 
exercising ≥ 2 times a week, but 68% reported watching ≥ 2 hours of television daily. 
Although patients reported good medication and monitoring adherence, they also reported 
poor diet and exercise habits and multiple barriers. Non white race were significantly 
associated with higher HbA1c. As authors concluded this may be related to difference in 
lifestyle behaviors and that additional studies are needed for further assessment of self-
management behaviors and potential racial disparities in adults with type 2 diabetes 
(Russell et al, 2008). 
2.3.7 Diabetes Self-Management Education (DSME) and its education programs: 
Diabetes Self Management Education DSME is the process of teaching individuals with 
diabetes to manage their disease and is an integral component of the treatment plan (CDC, 
2003). 
 
Patients must receive accurate diabetes education from the healthcare team in order to be 
able to self-manage their disease. This team includes the primary physician, nurse, certified 
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diabetes educator, registered dietician, pharmacist, podiatrist, ophthalmologist and the 
patient (Carney, 2010). 
When diabetes is diagnosed; it is recommended that the patient should receive diabetes self 
management education by a qualified health care provider according to the National 
Standards of Diabetes Self Management Education (DSME). The diabetes health care 
educator should be skilled, experienced and with up to date knowledge and skills in 
diabetes, educational principles and behaviour change strategies (AADE,1999) (Gigina, 
2007). 
A meta-analysis of randomized and controlled trials of diabetes patient education 
published from 1990–2000 and evaluated educational interventions in adult outpatients 
with diabetes, and reported on HbA1c concentrations before and after the intervention and 
at ≥12 weeks after the intervention was conducted. This study included 21 articles, with 28 
educational interventions (n=2439). It was noted that the net glycemic change was 0.32% 
lower in the intervention group than in the control group. Further analysis indicated that 
interventions which included face to face delivery, cognitive reframing teaching method, 
and exercise content were more likely to improve glycemic control. The authors concluded 
that current patient education interventions modestly improve glycemic control in adults 
with diabetes (Ellis et al, 2004). 
Several studies have shown that DSME is associated with improved diabetes knowledge 
and improved self-care behavior, improved clinical outcomes such as lower HbA1c, lower 
self-reported weight, improved quality of life, healthy coping, and lower costs (Norris, 
2001).  
The results were better when the DSME interventions lasted for longer periods and 
included follow-up. Patients who participate in diabetes education are more likely to 
follow the best treatment recommendations. Both individual and group approaches have 
been proved helpful (ADA, 2011).  
In a small study, confirmed in a similar group of patients that an intensive educational 
program, including dietary instruction, had the potential to improve glycemic control to the 
extent that delaying the introduction of insulin was considered appropriate (Coppell et al, 
2011). 
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A meta analysis of 31 studies showed that self management education (DSME) decreased 
HbA1c by 0.76%.  HbA1c decreased more with additional contact time between 
participant and educator; a decrease of 1% was noted for every additional 23.6 hour of 
contact. The authors concluded that the meta-analysis provides evidence of the efficacy of 
DSME for patients with type 2 diabetes for glycemic control and that further research is 
needed to develop interventions effective in maintaining long-term glycemic control 
(Norris et al.,2002). 
A Cochrane systematic randomized controlled and controlled clinical trials evaluated 
group-based education programs for adults with type 2 diabetes compared with routine 
treatment, waiting list control or no intervention. The review included only studies that 
assessed outcome measures six months or more from baseline. The results of this meta-
analyses that favoured group-based diabetes education programs included: reduced HbA1c 
at four to six months, 12–14 months and two years; reduced fasting blood glucose levels at 
12 months; reduced body weight at 12–14 months; improved diabetes knowledge at 12–14 
months; and reduced systolic blood pressure at four to six months. The authors concluded 
that group-based training for self-management strategies in people with type 2 diabetes 
positively impacts health outcomes by improving fasting blood glucose levels, HbA1c and 
diabetes knowledge and reducing systolic blood pressure levels, body weight and the 
requirement for diabetes medication (Deakin et al.,2005). 
A randomized, controlled study to determine the effects of a diabetes self-management 
program on glycemic control, coronary heart disease (CHD) risk, and quality of life was 
conducted on 147 type 2 diabetic patients. The patients were randomized into two groups 
for a six months period. The experimental group received the diabetes self-management 
program and the control group received the usual nursing care. The results indicated that 
the experimental group had statistically significant lower HbA1c than the control group at 
24 weeks. 12% patients in the experimental group reached the HbA1c level recommended 
by ADA (HbA1c <7%) compared to 1.39% in the control group. The experimental group 
was noted to have a decrease in the CHD risk factors, including total cholesterol, 
triglycerides, LDL cholesterol, diastolic blood pressure and body mass index (BMI) and a 
greater increase in HDL cholesterol levels as compared to the control group. The authors 
concluded that the diabetes self-management program was effective for improving 
metabolic control and quality of life for individuals with diabetes and that further studies 
should be replicated using larger groups over a longer time frame. (Wattana et al, 2007). 
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A study was done in a sample from the Old American Nutrition Program OANP, where 
105 was the number of participants, with a mean age of 73 years, and 70% among them 
were women. The study tested the hypothesis that A1C knowledge is positively correlated 
to demographic and health characteristics, and that an education intervention would 
increase HbA1c knowledge and decrease HbA1c blood levels. In regression analyses, 
higher HbA1c knowledge at baseline was negatively associated with age (P < 0.0001) and 
HbA1c blood levels (P < 0.07). In the subset of participants that completed the 
intervention, the percent of participants who scored 40% or higher on HbA1c knowledge 
increased from 48% to 82% (n = 99).  After the intervention, blood HbA1c decreased 
0.66% in participants with initial HbA1c > 6.5% (n = 43) (Burnett, 2003). 
 
A randomized study investigated 170 subjects with type 2 diabetes, who were assigned to 
two different groups either group (n = 87) or individual (n = 83) educational settings over a 
period of 6 months. Outcomes included “changes in knowledge, self management 
behaviors, weight, BMI, HbA1c, health related quality of life, patient attitude and 
medication regimen. Education material included information on carbohydrate counting, 
portion control, meal spacing, self-monitoring of blood glucose, physical activity, heart-
healthy eating, foot care, sick day management, monitoring for diabetes complications, 
self-management problem solving, and information regarding the progression of type 
2diabetes. They found that knowledge scores increased significantly in both treatment 
groups. In addition, “HbA1c decreased in both groups. However, the individuals receiving 
group education had an HbA1c reduction of 2.5% compared to the 1.7% reduction seen in 
the individuals receiving individual treatment. Therefore, the authors concluded that group 
diabetes education was as effective as individual diabetes education (Rickheim et al, 2002). 
Foods like bread, pasta, rice, cereal, milk, fruit and starchy vegetables such as corn and 
peas are considered carbohydrate foods and consumed daily by the majority of the people. 
All these foods cause higher levels of blood sugar. As indicated by many studies; the 
intake of nutrients plays a major part in Diabetes Self Management Education (DSME) 
programs. Teaching people how to distribute their consumption of carbohydrates during 
the day is vital to the nutrition management of diabetes and allows diabetic people to 
control what they eat by choosing the most suitable carbohydrate and non-carbohydrate 
foods (Carney, 2010). 
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The patients are taught through DSME programs to plan their meals according to the 
recommended amounts of carbohydrates they should consume during the day (Carney, 
2010). 
The major areas of DSME programs are: Nutrients in food and their effect on blood 
glucose levels, carbohydrate exchanges, the plate method and portion control, food labels, 
and sweeteners (Carney, 2010). 
An intervention study aimed to determine the benefits of diabetes education and dietician 
counseling in New York city, allocated patients into two groups, a treatment group 
(include patients referred to a diabetes educator and dietician for counseling by their 
primary care physician, n=150), and a  control group (those not referred to a diabetes 
educator or dietician, n=150). Weight and HbA1c levels were compared before the study 
and six months after study initiation. Mean HbA1c was significantly reduced by 1.02% 
among patients who had contact with a diabetes educator and dietician compared with a 
0.59% decrease among patients who did not.  Weight decreased by 2 lb among patients in 
the treatment group (P<0.05) compared with 0.71 pounds among patients in the control 
group (P=0.36). Researchers recommend that physicians should refer as many patients as 
possible with type 2 diabetes to diabetes educators as it is essential for good glycemic 
control (Hildegarde, 2009). 
In a study conducted to identify  how selected factors influence patient use of diet 
regimens for diabetes and to determine the effect of demographic characteristics reported 
that personal motivation, social support, continuity of care and the understanding of meal 
plans and diet positively affects the diabetes self management. On the other hand, 
emotional factors, busy schedules and holidays negatively affect patient’s self care and 
diabetes management. Travis used 75 item questionnaire designed to collect responses 
from non insulin dependent diabetic patients. Five factors were assessed during the study, 
which are: age and emotions, age and schedule, gender and emotions, diet plan control and 
follow up visits. The study elaborated that increased education promoted increased 
adherence to dietary recommendations (Travis, 1997). 
In a randomized controlled trial of medical nutrition therapy at the UK Prospective 
Diabetes Study involved 30,444 newly diagnosed diabetic patients (type 2) at 15 centers. 
All groups received nutrition counseling from dieticians for three months. During the 
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study, when the nutrition counseling was the primary intervention, “the mean HbA1c 
decreased by 1.9% fasting plasma glucose was reduced by 46 mg/dl, and there were 
average weight losses of 5 kg after 3 months (Pastors et al, 2002). 
 
2.4 Summary of Literature 
In summary, studies conducted on Diabetes Management show the following results:  
- It has been demonstrated that a structured care approach improves outcomes. The 
conclusion is that structured care saves lives and reduces morbidity. (CDA, 2003) 
- In order to prevent diabetes and its complications it is necessary to raise awareness about 
diabetes, make changes in lifestyle and to improve the quality of care (Quinn, 2008).  
- There are lots of ways designed to control diabetes, from changing eating habits to 
increasing physical activity.   Intensive lifestyle intervention make long-term valuable 
modification in diet, physical action, and clinical and biochemical parameters and should 
be implemented as one of the most important health care system (Lindstrom et al, 2003).  
- Intensive educational and support programs, raising awareness, campaigns and lifestyle 
modifications including dietary instructions improve HbA1c control. (Khattab et al.,2008; 
Zgibor et al, 2007; NHS, 2008; Ellis et al, 2004; Rickheim et al, 2002;  Coppell et al, 
2011). 
- Optimal glycemic control is difficult to obtain because various factors influence patients 
adherence to diabetes management and the responses to the illnesses of some patients are 
influenced by their beliefs, attitudes, and experiences  beliefs, perceptions of the health 
system, trust of doctors, emotional and psychological status; and outside support (Ahmed 
,2006; Donnan, 2002; Collins, 2009; Hamlets, 2011). 
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Chapter 3: Study Conceptual Frame Work 
3.1   Introduction: 
In this chapter we will discuss variables and definitions related to type two diabetes 
mellitus control. In addition, an overview of the study conceptual model used will also be 
presented. 
 
3.2 Definitions: 
 
3.2.1 HbA1c:  
Various definitions of HbA1c are used. The American Diabetes Association (ADA) 
defines HbA1c as” a test that measures a person's average blood glucose level over the past 
2 to 3 months”. Hemoglobin is the part of a red blood cell that carries oxygen to the cells 
and sometimes joins with the glucose in the bloodstream. Also called hemoglobin A1C or 
glycosylated hemoglobin, the test shows the amount of glucose that sticks to the red blood 
cell, which is proportional to the amount of glucose in the blood (ADA, 2012).According 
to the WHO HbA1c reveals the average plasma glucose over the previous eight to twelve 
weeks, which requires no specific conditions to be performed such as fasting and could be 
done during any time of the day (WHO, 2011). HbA1c reflects average plasma glucose 
over the previous 2–3 months in a single measure which can be performed at any time of 
the day and does not require any special preparation such as fasting. These properties have 
made it the gold standard for assessing glycemic control in people with diabetes and have 
resulted in its consideration as an option for assessing glucose tolerance in people without 
diagnosed diabetes (WHO, 2006). 
HbA1c is an indicator of the average blood glucose concentrations over the preceding 2–3 
months and is currently considered the best index of metabolic control in individuals with 
diabetes (Viswanathan et al, 2010). According to the International Diabetes Foundation 
(IDF), HbA1c is defined as a measure used by health care providers in relating blood 
glucose control to the possible risk of diabetes complications (IDF, 2007).  
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Hemoglobin A1C indicates how well the diabetic patient blood sugar has been controlled 
over the last 2-3 months, thus giving an indication of long-term blood glucose control. 
HbA1c is formed when the glucose in the blood binds irreversibly with Hemoglobin to 
form a stable glycated Hemoglobin complex. Since the normal life span of red blood cells 
is 90-120 days, the HbA1c will only be eliminated when the red cells are replaced; HbA1c 
values are directly proportional to the concentration of glucose in the blood over the full 
life span of the red blood cells. The American Diabetes Association recommends HbA1c 
as the best test to find out if the patient blood Sugar is under control over time and that 
patients with type 2 diabetes do the test twice per year (ADA, 2010). Since blood glucose 
levels can fluctuate significantly, self-monitoring may not accurately reflect the long-term 
effectiveness of a person’s blood glucose control. The HbA1c test is a valuable measure of 
the overall effectiveness of blood glucose control over a period of time (Diabetes care, 
2007).The range for HbA1c for people without diabetes is between 4.0% and 5.9 %. In 
people with poorly controlled diabetes, it is 7.0% or above; in people with good blood 
glucose control, it is less than 7.0% (ADA, 2007). Consistently high HbA1c levels increase 
the risk for long-term disabling and potentially life-threatening complications, including 
cardiovascular disease, stroke, kidney disease, eye damage and nerve damage. IDF 
recommends HbA1c values below 6.5% in most people with type 2 diabetes but individual 
targets are set in some groups (e.g. the elderly). (Diabetes care, 2007). ADA and the 
American Association of Clinical Chemists have determined that the correlation (r = 0.92) 
is strong enough to justify reporting both an HbA1c result and an estimated average 
glucose (EAG) result when a clinician orders the Hb A1c test (ADA,2012).  The 
correlation between A1C levels and mean plasma glucose levels is shown in table 3.1. 
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Table (3.1): HbA1c categories and Mean blood sugar (mg/dl): 
HbA1c % Estimated Average Glucose ( EAG in  mg/dl) 
6 126 
6.5 140 
7 154 
7.5 169 
8 183 
8.5 197 
9 212 
9.5 226 
10 240 
 
Source: adapted from The American Diabetes Association, 2012 
3.2.1.1 Limitations of HbA1c: 
HbA1c has several advantages to the fasting plasma glucose, including greater 
convenience, since fasting is not required, evidence to suggest greater preanalytical 
stability, and less day-to-day perturbations during periods of stress and illness. These 
advantages must be balanced by greater cost, the limited availability of HbA1c testing in 
certain regions of the developing world, and the incomplete correlation between HbA1c 
and average glucose in certain individuals. The HbA1c can be misleading in patients with 
certain forms of anemia and hemoglobinopathies. Analyses of NHANES data indicate that, 
assuming universal screening of the undiagnosed, the  HbA1c cut point of ≥6.5% identifies 
one-third fewer cases of undiagnosed diabetes than a fasting glucose cut point of ≥126 
mg/dl. A large portion of the population with type 2 diabetes remains unaware of their 
condition.  (ADA, 2011) (WHO, 2006). 
Because HbA1c is based on hemoglobin, quantities or qualitative variations in hemoglobin 
can affect the HbA1c value and interpreting of results (Bloomgarden, 2008). These 
Variations include the case of reduced total Hb or turnover of red blood cells that cause 
reduced level of HbA1c even in the presence of high ambient plasma glucose (Tran et al., 
2004) Generally, abnormal results of HbA1c test may get with sickle-cell disease, glucose-
6-phospahte dehydrogenase deficiency, B12 or folate deficiency, alcoholism, chronic renal 
or liver disease, splenectomy or splenomegaly, chronic opiate use, large doses of aspirin, 
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vitamin C and vitamin E supplements, creatine and drugs such as dapsone, ribavirine and 
so forth (Gallagher et al., 2009; Tran et al., 2004). Other conditions or treatments that 
might interfere with the measurement of HbA1c such as diseases that might require steroid 
therapy or that might interfere with the putative relationship between HbA1c and average 
glucose values, including anemia, high erythrocyte turnover as evidenced by 
reticulocytosis, blood loss and/or transfusions, or high-dose erythropoietin treatment 
(ADA, 2008).  
Genetic variants and chemically modified derivatives of hemoglobin (carbamylated Hb in 
patients with renal failure, HbS trait and HbC trait) all can impact the reading of the 
HbA1c. Any condition that shortens erythrocyte survival will falsely lower HbA1c test 
results regardless of the test method (recovery from acute blood loss, hemolytic anemia). 
Vitamins C and E are believed to falsely lower test results by inhibiting glycation of 
hemoglobin. Iron deficiency anemia will increase results, hypertriglyceridemia, 
hyperbilirubinemia, uremia, chronic alcoholism, chronic ingestion of salicylates, and 
opiate addiction are reported to falsely increasing results (NGSP, 2010).  
So HbA1c by itself is not enough to assess the type 2 diabetic patients, although it is a 
good indicator; it has to be accompanied by other tests such as Hb. 
 
3.2.2 Overweight and Obesity: 
Overweight and obesity are defined as abnormal or excessive fat accumulation that may 
impair health. Body mass index (BMI) is a simple index of weight-for-height that is 
commonly used to classify overweight and obesity in adults. It is defined as a person's 
weight in kilograms divided by the square of his/her height in meters (kg/m2). A BMI 
greater than or equal to 25 is overweight and a BMI greater than or equal to 30 is obesity.  
BMI provides the most useful population-level measure of overweight and obesity as it is 
the same for both sexes and for all ages of adults. However, it should be considered a 
rough guide because it may not correspond to the same degree of fatness in different 
individuals Overweight and obesity are the fifth leading risk for global deaths (WHO, 
2011). 
According to the Center for Disease Control and Prevention, overweight and obesity are 
both labels for ranges of weight that are greater than what is generally considered healthy 
for a given height. The terms also identify ranges of weight that have been shown to 
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increase the likelihood of certain diseases and other health problems. For adults, 
overweight and obesity ranges are determined by using weight and height to calculate a 
BMI. BMI is used because, for most people, it correlates with their amount of body fat 
(CDC, 2010). 
Unhealthy eating habits together with sedentary lifestyle are considered major factors 
responsible for obesity. As body fat increases in the body, the secretion of a number of 
toxic substances also increases and thus leads to less insulin action.  (Arora, 2007)  
High BMI is directly related to CVD and retinopathy. As BMI rises above 30 kg/m²a 
significant relationship with CVD appears. (Latika et al., 2006) In another study, the time 
needed to develop retinopathy among young diabetic adults was related to high BMI and 
hyperglycemia (Henricsson et al., 2003) 
Being overweight or obese make controlling blood sugar more difficult, so to assess if the 
patients are overweight, the body mass index (BMI) = ( kg/m2)  is measured and classified 
according to World Health Organization’s criteria as can be seen in table 3.2  (WHO 1995, 
2000 and 2004)   
 
 Table 3.2:  Classification of Overweight and Obesity According to WHO: 
                        BMI: weight (kg) / height* height (m) 
 
 
 
 
 
 
3.2.3Microalbuminuria (MAU):  
Microalbuminuria (MAU) measures the functioning level of the kidney cells in the initial 
stages of renal damage and it is a powerful detector of future cardiovascular and kidney 
  Obesity Class BMI (kg/m2)  
Underweight   <18.5  
Normal    18.5 - 24.9  
Overweight    25.0 - 29.9  
Obesity  I  30.0 - 34.9  
Obesity II  35.0 - 39.9  
Obesity III  40  
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disease (IDF & ISN, 2003) below 30mg/g is considered normal, where as 30-300mg/g is 
considered microalbuminuria and 300mg/g and above is classified as macroalbuminuria 
the presence of small amounts of albumin, a protein, in the urine.(IDF, 2005) 
Microalbuminuria is an early sign of kidney damage, or nephropathy, a common and 
serious complication of diabetes. The ADA recommends that people diagnosed with type 2 
diabetes be tested for microalbuminuria at the time they are diagnosed and every year 
thereafter; Microalbuminuria is usually managed by improving blood glucose control, 
reducing blood pressure, and modifying the diet. (ADA, 2012) 
Microalbuminuria refers to an abnormally increased excretion rate of albumin in the urine 
in the range of 30-299 mg/g creatinine. It is a marker of endothelial dysfunction and 
increased risk for cardiovascular morbidity and mortality especially, but not exclusively, in 
high-risk populations such as diabetics and hypertensive. Physicians should screen all 
diabetics for albuminuria and strongly consider screening for hypertension to identify those 
at higher risk for cardiovascular disease. Appropriate intervention, including use of drugs 
that block the renin-angiotensin-aldosterone system, may be appropriate in such cases as 
suggested by the American Diabetes Association and the Seventh Report of Joint National 
Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood 
Pressure (Hypertens, 2004). 
3.2.4 Lipid profiles: 
Lipid profile test is a blood test that measures total cholesterol, triglycerides, HDL and 
LDL cholesterol.  ADA recommends that total cholesterol should be below than 
200mg/dL; HDL above 40mg/dL for men and above 50 mg/dl for women; LDL cholesterol 
below 100 and triglyceride below than 150mg/dl. (ADA, 2004) 
The lipid profile and body fat play a major role in metabolic disturbances, these include 
dyslipidaemia, hypertension, diabetes and cardiovascular diseases. Changes in the level of 
lipids in the body make the people more prone to develop those diseases. The body fat and 
lipid profiles are main reasons for developing diabetes as was revealed by the research 
findings. (Arora, 2007) 
Increase amount of triglycerides and LDL-C increase the risk of heart diseases and have 
been reported to predict diabetic retinopathy and diabetic nephropathy (Orchard et al., 
1998). 
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Despite the association between hyperlipidemia and cardiovascular events decline with 
age, a significant association has been shown to continue into the eighth decade of life 
(Corti et al.,1997). Further, primary prevention trials with older adults up to age 73 years 
and secondary prevention trials involving adults up to age 75 years clearly manifested that 
lowering cholesterol levels can significantly reduce cardiovascular event rates in older 
adults with and without diabetes (Downs et al., 1998; Sacks et al., 1996; Pyorala et al., 
1997). 
 
3.2.5 Blood Pressure: 
Blood pressure is measured through systolic and diastolic, cutoffs if below 140/90 is 
normal and above should be considered for treatment (bhsoc, 2009) 
Lowering blood pressure in patients with type 2 diabetes has been associated with 
decreased cardiovascular events and mortality. The UKPDS was among the first studies 
demonstrating a reduction in macro vascular disease with treatment of hypertension in type 
2 diabetes (Fowler, 2008). 
Although blood pressure may not be important in the initiation of diabetic retinopathy, a 
higher diastolic BP, even within the normal range, may increase the risk of progression of 
retinal lesions (Lloyd et al, 1995) 
Controlling the high blood pressure in type 2 diabetic patients plays a major role in 
reducing the rates of cardiovascular diseases and mortality. This was demonstrated firstly 
by the U.K. Prospective Diabetes Study. Increased systolic and diastolic blood pressure is a 
strong indicator of micro vascular complications as was proved by numerous studies. 
(klein et al., 1995) Baseline blood pressure data from recent trials indicate that in diabetic 
patients there is nearly a fourfold excess in systolic pressure over diastolic pressure with 
respect to the recommended systolic/diastolic target pressure of <130/80 mmHg. Diabetic 
hypertensive individuals showed 2–3 mmHg higher systolic pressure and 1–3 mmHg lower 
diastolic pressure when compared to non diabetic individuals which adds ∼4 mmHg to 
pulse pressure and also to the difference between the excess systolic and excess diastolic 
pressure. (Etty et al., 2008) 
The U.K. Prospective Diabetes Study may have been the first to discover the unique 
advantage offered to diabetic subjects by effective antihypertensive treatment, the rate of 
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diabetic related death and stroke was lower in diabetics with reduced blood pressure 
(144/82 mmHg) in comparison with patients with higher blood pressure (154/87 mmHg), 
this was proved firstly by the U.K. Prospective Diabetes Study. The Hypertension Optimal 
Treatment (HOT) proved that the diastolic pressure should be lowered to below 80 mmHg 
as the lowest rate  of major cardiovascular events were observed at patients with treated 
hypertensive diabetic patients with that diastolic pressure rate. (Osher et al., 2008). 
 
Spread of hypertension in type 2 diabetic patients rises from 40% at age 45 to 60% by age 
75, a factor that contributes significantly to both macro- and micro vascular disease 
complications (Vijan et al.; UKPDS 38, 1998). Therefore, screening for and aggressive 
treatment of hypertension are critical components of diabetes care. In most cases, therapy 
should be instituted if blood pressure (BP) exceeds 140/90 mmHg, and expert opinion 
suggests a treatment goal of BP <130/85 for patients with type 2 diabetes (JNCDETHBP, 
fifth Report, 1993). 
Measuring BP to diagnose hypertension and monitor therapy is problematic. Clinic BP 
measurements have great variability, which can affect accurate classification of patients. 
Reliable clinic measurements require adequate rest period prior to measurement, observer 
training, adjustment of the cuff size to the arm circumference, and slow deflation of the 
cuff.  Clinic BP measurements have several limitations.  BP measurements may not 
represent the usual BP outside of the clinic setting or the burden of BP throughout a day. 
BP may rise in the clinic in response to the medical environment may be normal in the 
clinic but not outside of the clinic. Additional problems with clinic BP measurement 
include terminal digit bias and variability in a small number of readings. (Ghuman N et al., 
2009) 
3.3 Diabetes complications: 
The risk of experiencing diabetic complications is dependent on the degree of glycemic 
control in patients with diabetes. Clinical trials such as the Diabetes Control and 
Complications Trial (DCCT) and Kumamoto study have demonstrated that tight glycemic 
control achieved with intensive insulin regimens can reduce the risk of developing or 
progressing retinopathy, nephropathy or neuropathy in patients with type I or II diabetes. 
The EDIC trial, a follow-up to the DCCT, has shown that the previous degree and duration 
of glycemic exposure are also important determinants of risk of developing micro vascular 
  
 
37
diabetic complications (Bretzel, 2004). The progression of diabetic retinopathy in patients 
with high HbA1c and long duration of diabetes was twice comparing to patients without 
these risk factors ( Bonney et. al, 1995)  
Several factors have been suggested to be of importance for the development of long term 
complications in diabetes. Some associations have asserted that the duration of diabetes 
and metabolic control are well established risk factors, while others have been more 
controversial with partly contradictory findings in different studies. The causal relationship 
between these factors and the development of complications is unclear and a better term 
would be risk markers. The importance of different risk factors also differs in patients with 
short or long diabetes duration (Karamanos B, et al 2000).   
 Chronic complications of diabetes include micro vascular and macro vascular 
complications. Micro vascular complications include retinopathy, nephropathy and 
neuropathy (ADA, 2004). These complications are influenced by several factors such as 
glycemic control, hypertension and hyperlipidemia (Bate and Jerums, 2003).  
3.4 Duration of Diabetes: 
Many complications are related to diabetes, and these can be prevented through healthy life 
style, medication, follow-up and self management (ADA, 2009).  
 Macro vascular complications and micro vascular complications are caused by 
hyperglycemia. The most common micro vascular complication of diabetes is diabetic 
retinopathy; which cause around 10,000 new cases of blindness annually in the U.S 
(Fowler, 2008). 
 The risk of developing micro vascular complications of diabetes depends on both the 
duration and the severity of hyperglycemia. The U.K. Prospective Diabetes Study 
(UKPDS) found that development of diabetic retinopathy in patients with type 2 diabetes is 
related to both severity of hyperglycemia and presence of hypertension. (UKPDS 33, 2007)   
Prevalence of retinopathy increases with increasing duration of diabetes, since one third of 
patients with duration between 10 and 12 years have retinopathy. (Kernell et al., 1997) 
Patients with shorter diabetes duration were more concerned about the management of 
their diabetes than were patients with a long duration. The fear of chronic complications 
increased with diabetes duration. 
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3.5 Gender: 
Females with Type II diabetes appear more likely than males to experience symptoms and 
vascular complications related to diabetes (Summerson et al, 1999 ). The incidence rate of 
coronary heart disease was slightly higher in males, while lower- extremity arterial disease 
incidence rate was slightly higher in females (Forrest et al., 2000). The risk of ESRD did 
not significantly differ between sexes (Finne, 2005) 
Men seemed to underestimate problems related to diabetes more than women. They 
worried less about long-term complications and hypoglycemia, but were more troubled by 
the limitation of personal freedom caused by their diabetes (Gåfvels et al, 1993). 
 3.6 Smoking: 
It is proven now that smoking is an independent risk factor for diabetes, and amongst 
diabetes patients it increases the risk of complications. Diabetes complications include 
heart disease, stroke and circulation problems and smoking adds to the risk of developing 
these complications. In some cases, smoking may double the likelihood of these problems, 
as well as double the chances of suffering from kidney problems and erectile dysfunction . 
Many studies have found significant association between cigarette smoking and advanced 
stages of diabetic nephropathy ( Muhlhauuser et al., 1996). Significant association between 
the development of microalbuminuria and smoking was reported in few studies 
(Chaturvedi et al., 1995) 
Smoking is also related to the premature development of micro vascular complications of 
diabetes and may even have a role in the development of type 2 diabetes. Several 
randomized clinical trials have demonstrated the efficacy and cost-effectiveness of certain 
forms of behavioral counseling in changing smoking behavior of primary care and 
hospitalized patients. This work, combined with the more limited studies specific to 
individuals with diabetes, suggests that smoking cessation counseling is effective in 
reducing tobacco use in this high-risk group (ADA, 2004).  
  3.7 The Management Goal of DM:  
The goal of effective DM management is to prevent macrovascular complications such as 
hypertension, stroke, and heart disease, as well as debilitating acute and chronic 
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microvascular complications, including nephropathy, neuropathy, and retinopathy. Other 
possible complications of diabetes include birth defects and spontaneous abortion, immune 
system dysfunction, and periodontal disease. 
Individuals with type 2 diabetes should receive medical care and supervision from a team 
that may include, among others, physicians, physician assistants, nurses, nurse 
practitioners, dieticians, pharmacists, lab technicians and psychosocial professionals with 
expertise in treating individuals with diabetes (standard of care, 2012) 
In addition, however, individuals with type 2 diabetes must take an active role in self-care. 
Self-care includes self-monitoring of blood glucose, adhering to an appropriate diet, 
exercising regularly, and managing behavioral and psychological issues as they arise. 
Such care requires the followings:  
1. Appropriate glycemic control goal setting and achievement. 
2. Regular monitoring for complications 
3. Dietary management 
4. Life style modifications (physical activity, smoking cessation, weight management, 
salt reduction…). 
5. Medications as needed 
6. Appropriate self-monitoring of blood glucose (SMBG) testing. 
 
3.7.1 HbA1c control: 
When starting treatment of diabetic patients, the aim is to achieve treatment goals for 
glycemic control according to the following table (3.3): 
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Table (3.3) Goals of glycemic control according to the Palestinian National Authority 
Ministry of Health Diabetes Disorder Protocol 2008 
Parameters Targets of control 
Glycemic control 
Fasting or pre-prandial plasma glucose 
Post prandial plasma glucose ( 1-2 hrs after the beginning of the meal) 
Bedtime glucose 
HbA1c 
 
90-130 mg/dl 
140-180 mg/dl 
110-150 mg/dl 
<7% 
Lipids 
HDL-Cholesterol 
LDL-Cholesterol 
≥ 40 mg/dl men 
≥ 50 mg/dl women 
< 100 mg/dl 
Triglycerides < 150 mg/dl 
Blood pressure < 130/80 mmHg 
 
EMRO stated in the guidelines for the prevention, management and care of diabetes 
mellitus that the treatment plan for diabetes may include diabetes education, meal planning 
and nutritional recommendations, exercise, anti-diabetic agents, insulin and management 
of associated conditions and complications.(WHO, 2006) 
Healthy life style behaviors play an important role in the prevention of chronic diseases 
such as elevated blood pressure and diabetes. (Sabbah et. al, 2007)Most Arab Middle East 
countries suffer from chronic diseases that are mainly attributed to unhealthy 
diet.(Abudayya et. al ,2009) 
The Palestinians have been subjected to a number of dynamic factors in the last century, 
which inflicted big changes on their lifestyle and health conditions. Some of these changes 
were attributed to imported factors such as the undergoing regional and global transition in 
dietary care and living standards. Food consumption patterns have changed to a more 
'Westernized' diet with high intake of foods rich in fat and cholesterol, while being low in 
dietary fiber. Other nutritional changes that have occurred are attributed to the uniqueness 
of the Palestinian political situation presented in border closures, town besieges, road 
blocks, imprisonment of family bread winners, house demolitions, farms and orchards 
uprooting, enforcing high taxes, denial/withdrawal of residency/citizenship and 
construction of the apartheid wall. The brutal Israeli measures against the Palestinians over 
the long decades of occupation have certainly affected the households' economical status 
and their ability to purchase healthy food. The first chapter of the “change” story started 
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when millions of Palestinian refugees lost access to their traditional food bases in 1948, 
which were characterized by high-fiber and low-fat/cholesterol contents. More chapters 
were added to the story as the years of occupation and oppression continued; the mating of 
the Israeli and Palestinian economy, the close attachment to the global market, and the 
flow of donations to the refugees are important elements for these dietary changes 
(Abudayya et. al ,2009). 
3.7.2 Diabetes and balanced diet:  
Obesity and diet are risk factors in type 2 diabetes mellitus, not only for determining the 
disease onset but also dictating its progression (WHO study group, 1994). According to 
Russell-Jones and Khan over 80% of diabetics are obese (Joshi & Joshi 2009; Russell-
Jones & Khan 2007). Studies have also shown that increased dietary intake of saturated 
fats and decreased intake of dietary fibre can result in decreased insulin sensitivity and 
abnormal glucose tolerance (Zimmet, 1992). A realistic weight loss goal of between 5-10% 
of body weight has been proposed because it is associated with significant improvement in 
glycaemic control and there is no need in getting people to ideal body weight (Joshi & 
Joshi 2009). Therefore, attention should be paid to patient education and compliance. 
Diet alone has varying degrees of success. Elderly patients with diabetes are able to 
improve diabetes control with diet and weight loss. However, they may find it difficult to 
adhere to a strict dietary regimen and maintain weight loss. (Kenneth L, 2002). 
 A diabetic diet is relatively high in carbohydrates (50%-60% of total calories), low in fat 
(30% of total calories from fat, with 10% saturated fat, 10% polyunsaturated fat, and 10% 
monosaturated fat), and moderate in protein (~20% of total calories). (Kenneth L, 2002) 
In 2005 the United States Department of Agriculture (USDA) released a new food 
guidance system (figure 3.1) replacing the former Food Guide Pyramid.  The new system, 
called "My Pyramid," provides a set of tools based on caloric requirements to help 
individual make healthy food choices. The Diabetes Food Pyramid divides food into six 
groups.  These groups or sections on the pyramid vary in size.  The largest group: grains, 
beans, and starchy vegetables, is at the bottom.  The smallest group fats, sweets, and 
alcohol are at the top of the pyramid. (American Diabetes Association, 2009). 
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Figure 3.1: The food guide pyramid1 
In human intervention studies, replacement of saturated by unsaturated fatty acids leads to 
improved glucose tolerance and enhanced insulin sensitivity. A high intake of total fat has 
been shown to predict development of impaired glucose tolerance (Vessby et al, 2001). 
In many controlled experimental studies, high intakes of dietary fiber have been shown to 
result in reduced blood glucose and insulin levels in people with type 2 diabetes and 
impaired glucose tolerance (Mann J, 2001). A randomized controlled trial showed that an 
increased intake of wholegrain cereals, vegetables and fruit was a feature of the diet 
associated with a reduced risk of progression of impaired glucose tolerance to type 2 
diabetes. (Tuomilehto J et al, 2002). 
Generally, the emphasis should be on a low fat diet and a more complex high fibre 
carbohydrate diet, including foods with soluble fibre such as leafy vegetables, fruits, 
cereals, roots and pulses. Brown bread or whole grains should be the main part of meals. 
Saturated fats should be restricted and monosaturated fats (such as Olive oil) should be the 
replacement.  Salt intake should be limited to <6gm/day and even less if the patient is 
hypertensive(WHO, 1994; Joshi & Joshi 2009). 
Foods with high glycemic index (GI) are said to cause a higher peak in post-prandial blood 
glucose and a greater overall blood glucose response in the first 2hours after consumption 
than foods with a low GI (Powell, Miller, 2002).  
                                                            
1  Source: https://stage.diabetes.org/nutrition-and-recipes/nutrition/foodpyramid.jsp 
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There are studies which have provided evidence showing that low-GI diets are associated 
with improvement in insulin sensitivity and blood lipid concentrations (Frost et al, 1998). 
3.7.3 Physical exercise: 
The goal for physical activity focuses on maintaining healthy body weight. The 
recommendation is for a total of one hour per day on most days of the week of moderate-
intensity activity, such as walking. This level of physical activity is needed to maintain a 
healthy body weight, particularly for people with sedentary occupations. The recommendation 
is based on calculations of energy balance and on an analysis of the extensive literature on the 
relationships between body weight and physical activity.  (Lyon, 2002) 
Exercise is important in the management of diabetes because of its effect on blood glucose and 
free fatty acids. Exercise burns calories and helps to control weight, eases stress and tension, and 
maintains a feeling of well-being. In addition, regular exercise improves the body’s response to 
insulin and may make oral anti-diabetic drugs and insulin more effective. It also promotes 
circulation, and lowers cholesterol and triglyceride levels, thus reducing the risk of 
cardiovascular disease. Persons with diabetes should be encouraged to lead a normal life and 
participate in sports and exercise programs. The main risk when exercising is hypoglycemia, 
therefore blood glucose should be checked before, and if appropriate, medication dosage may 
need to be reduced before exercise, or the individual may need to take an extra carbohydrate 
snack. Before starting any exercise programme, the health provider should do a thorough 
physical examination to find out whether or not it is safe for the patient to exercise.(WHO, 
2003)(Pan X et al, 1997) 
Current guidelines recommend that patients with type 2 diabetes should perform at least 
150 minutes per week of moderate-intensity aerobic exercise and should perform 
resistance exercise 3 times per week. (ADA, 2011) 
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3.8 Study conceptual framework 
 
According to the literature review and study objectives, we developed this study 
conceptual framework.  Several definitions and factors affecting diabetes as summarized in 
figure 3.2 were defined and discussed and will be discussed later to be of importance for 
the management and control of HbA1c.  
 
 
 
Figure 3.2 Study conceptual framework 
 
 
Demographic 
Variables 
(Age, Sex, Marital 
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level, Working 
status )
Lifestyle factors: 
Obesity, Smoking, 
Physical activity, 
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Diabetes history 
 Duration of 
diabetes 
  diabetes      
Complications 
Physical 
examination 
Lipid profile, 
MAU,Blood 
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Type 2 diabetes 
Control 
HbA1c 
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Chapter four: Study methodology 
4.1 Introduction: 
This study focuses on the control of type 2 diabetic patients’ attending the Diabetes Care 
Center at Augusta Victoria Hospital / East Jerusalem. In this chapter the research’s 
methodology will be presented. The study setting, study population, study design, study 
tools, and the sampling method are described. 
4.2 Study setting: Description of the diabetes program at Augusta Victoria Hospital 
(AVH).  
Augusta Victoria Hospital established a Diabetes Center. The Diabetes Center addresses 
diabetes holistically, considering both the clinical and social factors that influence the 
diagnosis as well as the quality of care. Also the behavioural patterns that increase the risk 
of either acquiring diabetes or worsening an already existing diabetic condition are 
considered by this approach.  The center follows three strategies involving treatment, 
prevention and capacity building; addressing people with diabetes, high risk groups care 
and the general public.  
In 2003, with the support from the World Diabetes Foundation, Dan Church Aid, the 
Augusta Victoria Hospital initiated a diabetes project with the purpose of establishing a 
diabetes center at the Augusta Victoria Hospital. The aim was to create a center of 
excellence for the introduction of a holistic approach to diabetes care and prevention, thus 
challenging the biomedical approach that has dominated the diabetes care in the Palestinian 
areas for decades (WDF report 2010).  
As a first step in this center, a diabetes program was initiated. This program aimed to 
promote access to prevention and quality care for diabetes patients and high risk groups in 
the West Bank. Therefore, this diabetes program combines diagnostics, medical treatment, 
nutrition counseling, prevention, eye care and foot care.  
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4.3 Source of Diabetes center patients:  (participants) 
1.AVH patients in outpatient and inpatient clinics:  
Patients admitted to AVH departments or those coming to have consultation at the 
outpatients clinics in the hospital were recruited through the daily rounds conducted by the 
Center team.  In those rounds, team members visited outpatient and inpatient clinics daily 
to identify self-reported persons with diabetes and to inform them about the services 
available at the Center.  The staffs of those inpatient and outpatient clinics have also been 
acquainted with the Center’s services, and they may advise persons with diabetes to visit it.   
2.Patients from outside AVH: those include patients identified through outreach activities 
as well as patients referred by other health providers that cooperate with the Center, such 
as UNRWA and MoH. 
3. Self-recruited patients: those are patients who have heard about the Center and its 
services through friends and/or family or have read the advertisements posted around the 
hospital.  
 
4.4 Management of the Diabetic patient at the Diabetes Center: 
The center targets persons with diabetes and involves providing services which include 
regular monitoring through clinical and laboratory investigations as well as individualized 
counseling and general health education. Patients with type 2 diabetes receive medical care 
and supervision from a team that  include physicians, nurses, foot care specialists, 
dieticians, lab technicians and psychosocial professionals with expertise in treating 
individuals with diabetes. 
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Since the program was initiated a total of 1375 diabetic patients has been assessed and 
evaluated by the team.  All services are done according to diabetes protocol shown in 
figure 4.1. 
 
Figure 4.1: Diabetes center protocol for patient's visits   
Patient registered at the Center
First Visit 
 Filling Patient Record 
 Individual Nutrition Counseling 
 Foot screening 
Second Visit within one week 
 Laboratory testing 
 Group education 
 Diabetologist 
Appointment every 3months: 
 Lab tests: HbA1c, Urine analysis       
                         and MAU if more than 30. 
 Group education 
 Diabetologist Counseling 
Annually 
 Foot screening (if no ulcer) 
 Eye screening 
 Individual Nutrition counseling 
 MAU if < 30 
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As a first step, each patient is assessed by a team of health professionals that include a 
diabetologist who prescribe the proper treatment according to patient’s condition and level 
of control, a dietitian for individual nutrition assessment and counseling, and specialized 
diabetes care nurses. Healthy lifestyle strategies are discussed with all diabetics and their 
families. Group education sessions for topics related to diabetes self management, 
complications, treatment and control are regularly done. Also, all necessary laboratory tests 
mainly HbA1c and creatinine albumin ratio are done to all diabetics.  Feet-exam and 
retinopathy screening are done regularly for all diabetics. 
Each patient goes through the following: 
1- Medical care: Diabetes patients attending the Center for the first time are registered and 
a file is opened which contains demographic data, subjective data (e.g. education, 
occupation, social support system, information about reported diagnosis and treatment), 
and objective data (e.g. weight, height, and blood pressure).   
2- Each patient has to do baseline laboratory investigations include blood glucose (either 
random or fasting, urine analysis, lipid profile, HbA1c, and albumin creatinine ratio 
(ACR).   
3- In addition to the clinical examination and laboratory testing: each patient has to be seen 
by the diabetes specialist 
4- Each patient receive a host of other services, including individual nutritional counseling, 
group health education sessions and materials, counseling with a social worker, referral to 
other specialized clinics at AVH when needed, and ophthalmic examination.   
5- Self care training: In addition the diabetic patients at the diabetes center are taught to 
take an active role in self-care. Self-care includes self-monitoring of blood glucose, 
adhering to an appropriate diet, exercising regularly, and managing behavioural and 
psychological issues as they arise.  
6- Follow up: Patients are provided with follow-up cards, and they are given an 
appointment after 3 months, unless otherwise requested by the doctor. 
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4.4.1 Dietary management: 
Diet plan used at the Diabetes center in Augusta Victoria Hospital 
The diet of the diabetics is planned using the ADA exchange lists. The plan falls within the 
guidelines of the daily food guide pyramid. 
 Each patient is assessed by the dietician that performs the following tasks: 
- Monitors the patient medical condition, psychosocial and economic status, physical 
activity and lifestyle. 
-  Learns about the patients’ usual eating habits. 
-  Determines a reasonable bodyweight and the energy intake necessary to maintain this 
body weight. 
- Teaches patients how to tailor the diet to meet their own preferences (food from starch, 
fruit, milk lists contain similar amounts of energy and CHO and can be substituted from 
one another from time to time). In order to have an idea about the amount of food items 
usually consumed by the participants, examples of portion sizes were provided as 
demonstration, using cups, plates and spoons. 
 Teaches the patient to eat regularly at the right times to balance the effects of any tablets 
or insulin. 
 Monitors regularly the patient through clinical and laboratory investigations as well as 
individualized counseling and general health education. 
Diet Forms with different calorie content ranging from 1000 Cal to 2400 Calories (See 
annex 2) are used following the below criteria: 
 Determine the daily energy requirements based on the equations shown in table 4.1 and 
4.2. 
 Determine the recommended grams of  protein, CHO, and fat based on the Calories ( 
CHO: 45-60% , Protein: 10-20%, Fat<= 30% ) 
 Use the exchange list, the number of servings from each group is determined. 
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 Then translation of the diet prescription into meal plan. First the dietician plan servings 
of food that contain carbohydrates (Starch, Dairy, fruit, Vegetables) then protein (meat and 
products) and then fat. 
 Food is distributed into meals that fit the patients usual eating pattern. 
 Modification on the diets is done for special cases when needed. 
 The patient is regularly seen by dietician upon every scheduled visit to the diabetes 
center.  
Table 4.1:  Calculations used for estimation of the energy requirements: (David H. et 
al, 2008) 
 Male calculation equations: 
Age Total calorie 
10-18 ((17.5* IBW) + 651) * activity level 
18-30 ((15.3* IBW) + 679) * activity level 
30-60 ((11.6* IBW) + 879) * activity level 
>60 ((13.5* IBW) + 487) * activity level 
Female calculation equations: 
Age Total calorie 
10-18 ((12.2* IBW) + 746) * activity level 
18-30 ((14.7* IBW) + 496) * activity level 
30-60 ((8.7* IBW) + 829) * activity level 
>60 ((10.5* IBW) + 596) * activity level 
Table 4.2:  Calculations used for estimation of the physical activity requirements: 
(David H. et al, 2008) 
Activity level Male Female 
Very light 1.3 1.3 
Light  1.6 1.5 
Moderate 1.7 1.6 
Heavy 2.1 1.9 
Very heavy 2.4 2.2 
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4.5 Study design 
The study design was an evaluative file based study 
4.6 Sample frame: 
A total number of 1,375 diabetic patients are registered at the Diabetes Care Center at 
Augusta Victoria Hospital (AVH). The sample results were taken from all the patients who 
were followed up in the center and had at least two visits with HbA1c test done from year 
2005 to 2009.  
4.6.1 Inclusion and exclusion criteria: 
All registered patients with type 2 diabetes attending AVH between years 2005 – 2009 and 
had at least two visits since the beginning of 2006 were included in this study. We 
excluded type one diabetes patients, women with gestational diabetes, type two diabetes 
patients who are on dialysis or patients who are long staying in geriatric department 
because the management and control status and tool for these patients differ than that for 
the included type two diabetes patients. The inclusion-exclusion criteria is shown in figure 
4.2. 
 
Figure 4.2: Inclusion-exclusion criteria of the study sample 
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4.7 Data collection  
Data was collected from June 2009 to February 2010. The researcher is a dietician at the 
Diabetes Center since 2005 and trained a research assistant who is also a qualified dietician 
and work at Augusta Victoria Hospital since 2003. The file of the patient was used as the 
sole instrument of data collection for this study. The information collected from file was 
taken from five sections (see Annex 1 patient file).  
4.7.1 Description of patient’s file: 
The system of following up the patients from the day they are included in the center, 
consist of 3 forms; the assessment sheet, follow up sheet, the educational Planning Sheet 
(see Annex 1 patient file).    
4.7.1.1 The assessment Sheet form 
This form is filled out when the patient first comes to the Center.  It gives the team an idea 
of the patient’s medical condition, life style and living conditions, which could be very 
useful in personalizing counseling and health education. The form is usually filled out once 
at the beginning of the patient’s visits to the Center. A clinical assessment is performed and 
documented for every patient with diabetes; immediately upon registering in the center. 
The assessment covers the following: 
A. Personal, Medical and Family history 
1.Patient Identification and demographic information (Name, ID, Residency…..) 
2.Age at onset  
3.Review of previous treatment  
4.History of diabetes-related complications. 
5.Eating patterns, physical activity habits, nutritional status, smoking and weight history 
6.Family history of type 2 diabetes 
7.Others: psychosocial problems, oral disease  
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8.Current treatment of diabetes, including medications, meal plan, physical activity 
patterns, and results of glucose-self monitoring 
B. Physical Examination 
1.Height, weight, to calculate BMI.  
2.Blood Pressure  
3.Comprehensive foot examination 
C. Laboratory Evaluation 
1.HbA1c, within the past 3 months  
2. fasting lipid profile, including total, LDL- and HDL-cholesterol and triglycerides 
3.Test for urine albumin excretion with spot urine albumin/creatinine ratio 
4.7.1.2 The follow-up Sheet form contains Data on date, weight, BMI, activity level, and 
dilated eye exam, in addition to lab tests and results.  
4.7.1.3 The educational Planning Sheet form lists the topics that are discussed with the 
patient in counseling sessions.    
4.8   The objective testing used: 
The patients at the diabetes center underwent certain laboratory investigation at their first 
visit such as HbA1c, MAU, lipid profile, Body mass index (BMI), and blood pressure. In 
addition patients undergo testing for HbA1c, MAU (if > 30 mg/dl), and blood pressure 
every three months. The lipid profile and MAU (if < 30mg/dl) is repeated annually.  
a- Biochemical blood testing:  
A blood sample (fasting or random) is taken by vein puncture, this sample is divided into 
two tubes. One tube has an EDTA anti coagulant used for measurement of HbA1c, the 
second tube is a plane tube used for measurement of glucose and lipid profile.   
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- Glycolcylated Hemoglobin A1c:  
HbA1c determination was done by High Performance Liquid Chromatography HPLC 
method using Hi-Tech produced by Tosoh company. 
- Microalbuminuria: 
MAU determination was done by Cytochemistry, impedance, absorbance and flow 
cytometry method produced by DYN Company. 
- Fasting / Random blood testing: 
Glucose determination was done by glucose oxidase method using thermo kit produced by 
Konelab company. 
- Lipid profile: 
Cholesterol determination was done by cholesterol esterase method using thermo kit 
produced by Konelab Company. 
- Urine analysis  
Urine analysis examines sugar, protein, ketone, blood, PH, specific gravity, nitrate, 
leukocyte using Siemens multi-stix 10 SG. 
b- Blood pressure measurement 
Trained nurses made resting blood pressure under standardized conditions using the 
WelchAllyn blood pressure machine. 
c- Body mass index  
Calculated by using the equation: BMI = weight in Kg/ Height in m².  
d- Foot care (Screening and treatment for foot abnormalities): 
Trained and specialized nurses are responsible for foot care screening and treatment for 
foot abnormalities according to the IDF consensus. 
e- Ophthalmic examination: Every month nurses from Saint John Eye Hospital do 
screening for diabetic patients at the diabetes care center at AVH. Every patient registering 
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in the center is given an appointment of eye screening annually. If the patient has any 
complications, they will be referred to St. John Eye Hospital for  
4.9 Dietary assessments and food groupings.  
Dietary intake was assessed using the special diets that the dietician in the diabetes center 
gives to patient. The food grouping scheme was based on Nutrition exchange list in order 
to divide the amount of food items given to the patient (see annex 2 examples of diet). 
Participant were given their diets according to their requirements and follow-up with the 
dietician every visit 
4.10 Ethical considerations 
The study was approved by AL Quds University, school of Public Health-graduate study 
committee and the university graduate study accepted the study proposal.  The study was 
also approved by the director of the Diabetes center at Augusta Victoria Hospital. 
The study was conducted in accordance with the ethical guidelines of Augusta Victoria 
Hospital. According to these guidelines, participants were informed upon registration that 
data from their own file will be used for research purposes. Anonymity and confidentiality 
of the participants were maintained throughout the study by using file numbers.  
4.11 Data Analysis: 
The collected data was entered and analyzed by using the statistical package for the social 
science (SPSS version 17.0). Missing Values were replaced using the strategy last 
observation carried forward (LOCF) .First stage includes descriptive frequencies of all 
variables. Second stage a univariate analysis was done to study the associations between 
HbA1c change with all other variables (Demographic, follow up tests, lifestyle factors) 
using person chi-square test of significance at 5% significance level. Third stage included 
multivariate analysis, six logistic regression models for each HbA1c visits was performed. 
Variables that showed a significant difference at the univariate analysis were included in 
the multivariate analysis. Our Main focus was the HbA1c change between the first and 
fourth visit. But we did univariate and multivariate analysis of HbA1c among the other 
visits to see the change in HbA1c through them ( see  Annex 5  ) 
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Since the period of the study was long and the period between the four visits was irregular 
we couldn’t use repeated measure analysis. We analyzed a subsample that included 255 
patient from the original main sample (n=746) that had their four visits within two years 
and with regular periods between the visits (3-6 months) using repeats measures , 
univariate and multivariate analysis (see Annex 6). 
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Chapter Five: The Results 
5.1 Introduction 
In this chapter, results will be presented in three sections.  Section one presents the 
descriptive data from the patients’ files; section two describes the univariate analysis while 
section three represents the multivariate analysis.   
5.2 Section 1: Descriptive analysis 
5.2.1: Socio-demographic characteristics  
Among those who met the study’s inclusion-exclusion criteria, 746 patients’ files with 
diabetes type 2 were included in this analysis. The mean duration of having diabetes was 
10 years (SD 6.51) (see figure 5.1). The mean age of the group was 57 years (SD 9.34) (see 
figure 5.2).  Of the study population, 84% were married (see figure 5.3) and 53% were 
females (see figure 5.4).  Three quarter did not work (see figure 5.5), 44 % lived in the 
middle region of the West Bank (see figure 5.6), 15% were illiterate (see figure 5.7), 96% 
lived within a family, and 57.2% had MOH insurance (see figure 5.8). 
28.30%
30.60%
21.40%
12.50%
7.20%
≤ 5 Years 6‐10 Years 11‐15 Years 16‐ 20 Years ≥21 Years
Duration of Diabetes
 
Figure 5.1 Distribution of study population by Duration of diabetes 
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Figure 5.2: Distribution of study 
population by age group 
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Figure 5.3: Distribution of study population 
by marital status 
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Figure 5.4: Distribution of study 
population by gender 
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Figure 5.5: Distribution of study population 
by Occupation Status 
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Figure 5.6: Distribution of study 
population by place of residency 
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Figure 5.7: Distribution of study population 
by Educational level 
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Figure 5.8: Distribution of patients participating in the diabetes program according 
to health provider 
 
5.2.2 Health characteristics of study population before registering in the diabetes 
center 
Of the sample, 67% were non smokers (see figure 5.9) and 80% had a family history of 
diabetes (see figure 5.10).  Of the women, 14.1% reported having gestational diabetes (see 
figure 5.11). Of the study sample, 53.1% had peripheral neuropathy followed by 
hypertension and dyslipidemia (see figure 5.12). 
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Figure 5.9: Life style behavior of study population before registering in the diabetes 
center  
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Figure 5.10: Distribution of study population by family history of diabetes 
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Figure 5.11: Distribution of women by having history of gestational diabetes 
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Figure 5.12: Distribution of study population by having health complications 
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5.2.3 Laboratory testing (HbA1c, cholesterol, Microalbumin) and BMI distribution at 
the four visits used in this study: 
HbA1c average change by visit decreased from 9.1% (SD 2.1) in the first visit to 8.5% (SD 
1.7) in the fourth visit.  The mean cholesterol in the first visit decreased from 208 mg/dl 
(SD 90) to 195 mg/dl (SD 88.8) in the fourth visit. The mean Microalbuminuria (albumin/ 
creatinine ratio) in the fourth visit increased compared to the first visit.  The distributions 
by visit are presented in Annex 4.   
According to WHO classification of obesity, less than 10% of the sample had normal 
weight throughout the study period and 10% were obese 3. The mean systolic and diastolic 
pressure didn’t change in the four visits.  The distributions by visit are presented in Annex 
2.   
5.2.4 Physical activity 
In figure 5.13, the activity level of the patients was shown as light in 82 % in the first visit 
and 76% in the fourth visit and moderate level increase by following up those patients 
from 16% in the first visit to 20.8% in the fourth visit.   
2%
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3.20%
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20.80%
0%
10%
20%
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40%
50%
60%
70%
80%
90%
Very Light Light Moderate
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2 Figure 5.13: Distribution of study population by physical activity in four visits 
  
                                                            
2 Note: Very light physical activity: Extremely inactive, light: Sedentary and getting little or no exercise; 
moderately active: walking or exercising 150 minute per week (3 times a week). 
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5.2.5 Medical regimen 
5.2.5.1 Medical nutrition Therapy (MNT)  
The distribution of caloric intake for the patients was the same in the four visits .The 
majority of the study population (n=307) were given a diabetic diet with 1000 calories to 
control diabetes and reduce body mass index (see figure 5.14).   
 
Figure 5.14: Distribution of caloric intake  
5.2.5.2 Medication 
The history of medication of the patients show that 70.5% were treated by oral medication 
, 7.5% were treated by insulin, 9.7% were treated by insulin and tablets and 1.6 was treated 
by diet and oral medication together, but only 4.3 %managed their diabetes by diet regime 
only (see figure 5.15).  
4.30%
70.50%
7.50% 9.70%
1.60%
6.40%
Diet Oral Tablet Insulin Mixed Diet and oral 
tablet
Others
 
Figure 5.15: Distribution of study population by medical regime type  
  
 
63
Section two: Univariate analysis 
5.3.1 Association between HbA1c levels in the four visits 
Figure 5.16 shows that the strongest association is between the third and fourth visit 
(r²=0.63), and the weakest is between the first and fourth visit (r²=0.37). 
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Note r²:  1st-2nd =0.58, 2nd-3rd   =0.62, 3rd-4th =0.63, 1st-4th =0.37 
Figure 5.16: Linear regression for the 4 HbA1c visits 
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5.3.2   Associations between HbA1c with the study demographic variables 
Table 5.1 presents data for the relationship between changes in mean HbA1c of the 746 
patients with the socio demographic variables in the various visits. Age and type of 
profession showed no significant association with HbA1c (p>0.05). Male patients had 
better HbA1c compared to female patients in the 3rd and 4th visit (p<0.05). Highly educated 
patients had better HbA1c compared to illiterate patients among the four visits (p<0.05). 
Patients with MoH insurance had higher mean of HbA1c than patients insured with other 
insurance (private and Israeli sick fund) (p<0.05) in the four visits. Patients who were 
employed had lower HbA1c than unemployed patients among the four visits (p<0.05). 
Patients who were Single had better HbA1c than patients who were widowed among the 
visits (p<0.05). (see table5.1) 
 
Table 5.1: Associations between HbA1c among the 4 visits with demographic 
variables 
Variable  HbA1c 
1st visit 
HbA1c 
2nd  visit 
HbA1c 
3rd visit 
HbA1c 
4th  visit 
Mean ±SD T.sig. Mean 
±SD 
T.sig. Mean  T.sig. Mean ±SD T.sig. 
Age ≤40  8.7±2.3 0.77 7.9±1.9 0.14 7.9±2.0 0.14 7.8±1.8 0.07 
41-50 9.1±2.2 8.7±2.0 8.6±1.8 8.6±1.7 
51-60  9.1±2.1 8.7±1.8 8.5±1.7 8.5±1.6 
> 60  9.1±2.0 8.7±1.9 8.7±1.9 8.4±1.7  
Gender Male 9.08±2.1 0.87 8.56±1.86 0.21 8.42±1.76 0.04 8.29±1.61 0.01 
Female 9.1±2.07 8.73±1.9 8.7±1.87 8.61±1.73 
Residency South 9.1±2.1 0.91 8.6±2.0 0.74 8.6±1.9 0.92 8.5±1.8 0.98 
North 9.0±2.1 8.8±1.9 8.6±1.8 8.5±1.6 
Middle 9.1±2.1 8.6±1.8 8.5±1.8 8.5±1.6 
Education 
level 
Illiterate 9.5±2.1 0.03 9.1±1.9 0.01 9.0±2.0 0.00 8.7±1.7 0.02 
School 9.1±2.2 8.7±1.9 8.7±1.9 8.6±1.8 
High school 8.9±1.9 8.5±1.9 8.4±1.7 8.3±1.6 
University  8.7±2.0 8.3±1.6 8.1±1.5 8.2±1.4 
Insurance MOH 9.3±2.1 0.00 8.8±1.9 0.00 8.6±1.8 0.00 8.5±1.6 0.00 
UNRWA 9.1±2.0  8.8±1.9 8.8±2.0 8.8±1.8 
Others 8.5±2.0  8.1±1.9 8.1±1.7 8.1±1.7 
Profession worker 9.0±2.1 0.09 8.6±2.0 0.11 8.4±1.8 0.10 8.3±1.6 0.07 
Highly 
educated 
8.5±1.7 7.9±1.4 7.8±1.3 7.7±1.3 
health sector 8.0±1.9 8.0±2.2 8.2±2.3 7.9±1.4 
Employment Yes 8.8±2.1 0.04 8.4±2.0 0.01 8.2±1.8 0.00 8.1±1.6 0.00 
No 9.2±2.1 8.8±1.8 8.7±1.8 8.6±1.7 
Marital 
status 
Single 9.25±2.19 0.03 8.18±1.54 0.01 7.86±1.96 0.04 8.12±1.52 0.18 
Married 9.02±2.07 8.61±1.86 8.52±1.8 8.42±1.64 
Divorced 10.59±2.12 10.32±2.1 9.33±1.98 8.99±1.85 
Widow 9.37±2.08 8.81±1.93 8.95±1.95 8.76±1.92 
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5.3.3 Association between HbA1c with the Period in study and duration of diabetes 
Table 5.2 shows that patients who were registered in the center for ≤6 months had higher 
HbA1c in the 1st visit compared to patients who had been registered in the study for >36 
months(p<0.05).There was no significant association between period being registered in 
the center and HbA1c in the other visits (p>0.05). Patients who were diagnosed with 
diabetes for ≤5 years had much better HbA1c than patients who were diagnosed for >20 
years (p<0.05). (See table 5.2)  
 
Table 5.2: Association between HbA1c among the four visits with the Period in study, 
duration of diabetes.  
Variable HbA1c 
1st visit 
HbA1c 
2nd  visit 
HbA1c 
3rd visit 
HbA1c 
4th  visit 
Mean  T. sig. Mean  T. sig. Mean  T. sig. Mean  T. sig. 
Period in study ≤6  9.1±1.9 0.03 8.6±1.9 0.93 8.6±1.9 0.7 8.3±1.9 0.29 
7-12  9.5±2.1 8.9±1.8 8.7±1.7 8.8±1.8 
13- 18  9.1±2.5 8.6±2.2 8.4±2.0 8.1±1.8 
19- 24 9.1±2.1 8.6±1.9 8.3±1.6 8.3±1.6 
25- 30  9.5±2.3± 8.8±2.1 8.6±1.9 8.6±1.9 
31- 36  9.2±2.0 8.6±1.8 8.6±1.9 8.5±1.7 
> 36  8.7±1.9 8.6±1.9 8.6±1.9 8.4±1.5 
Duration of 
diabetes 
≤5  8.1±2.0 0.00 7.6±1.8 0.00 7.6±1.6 0.00 7.6±1.5 0.00 
6-10  8.8±1.9 8.4±1.7 8.5±1.6 8.4±1.5 
11-15 9.8±2.0 9.4±1.7 9.2±1.7 9.0±1.5 
16-20  10.3±1.8 9.5±1.7 9.4±1.6 9.4±1.7 
> 20  9.7±1.7 9.8±1.8 9.7±2.0 9.3±1.8 
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5.3.4   Association between HbA1c and life style factor: 
Table 5.3 presents data for the relationship between mean HbA1c with lifestyle factors in 
the four visits. Calorie intake showed no significant association with mean HbA1c in the 
four visits (p>0.05). Patients who had normal BMI had higher  mean HbA1c compared to 
patients who were classified as obese 3 in the 1st visit (p<0.05), no association was found 
among the other visits (p>0.05).Patients who were with very light physical activity had 
higher mean HbA1c than patients who were moderately active among the four visits 
(p<0.05).Patients who were non smokers had lower mean HbA1c compared to patients 
who were past smokers in the first visit (p<0.05), no association was found among the 
other visits(p>0.05). 
Table 5.3: Associations between HbA1c at the four visits with BMI, physical activity 
and smoking 
Variable HbA1c 
1st visit 
HbA1c 
2nd  visit 
HbA1c 
3rd visit 
HbA1c 
4th  visit 
Mean  T. sig. Mean  T. sig. Mean  T. sig. Mean  T. 
sig. 
BMI  Underweight ----------- 0.00 ---------- 0.07 ---- 0.65 ------- 0.1 
 Normal weight 10± 2.49 9.1± 1.94 8.8± 2.04 8.4±1.82 
 Overweight 9.1± 1.85 8.6 ± 1.87 8.5± 1.8 8.3±1.62 
 Obese 1 8.9± 2.18 8.7±1.93 8.5± 1.79 8.5±1.62 
 Obese 2 8.9± 1.95 8.4± 1.73 8.6± 1.75 8.6±1.76 
 Obese3 8.7±1.86 8.8± 1.89 8.8± 2.08 8.9±1.75 
Physical 
Activity 
Very Light 10.5±2.0 0.01 10.2±2.1 0.00 9.3±2.1 0.05 9.6±1.7 0.00
Light 9.1±2.1 8.7±1.9 8.6±1.8 8.5±1.7 
Moderate 8.7±2.1 8.3±1.8 8.2±1.7 8.0±1.6 
Smoking Yes 9.1±2.0 0.01 8.7±1.9 0.14 8.5±1.9 0.32 8.4±1.8 0.31
No 9.0±2.0 8.6±1.9 8.5±1.8 8.4±1.7 
Past Smoker 9.6±2.2 8.9±1.8 8.8±1.8 8.7±1.7 
Calories 
intake 
1000 9.0±2.1 0.06 8.7±1.9 0.86 8.6±1.9 0.83 8.6±1.7 0.13
1200 9.3±2.0 9.0±2.2 8.8±1.9 8.6±1.5 
1400 9.3±2.0 8.7±1.8 8.8±1.8 8.8±1.8 
1600 8.9±2.1 8.5±2.0 8.4±1.7 8.1±1.5 
1800 8.8±1.8 8.5±1.8 8.4±1.8 8.3±1.7 
2000 9.3±2.1 8.7±1.8 8.5±1.8 8.3±1.4 
2200 9.7±2.2 9.0±2.0 8.6±1.7 8.6±1.9 
2400 10.3±3.3 8.4±2.2 8.4±1.9 8.5±1.8 
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5.3.5 Univariate analysis for HbA1c after dividing the levels into good change 
(decrease in HbA1c between visits) and bad change (increase of HbA1c levels between 
visits)  
Since there were no fixed periods between patients’ visits to the clinics, we decided to 
determine the good change (decrease in HbA1c) and bad change (increase in HbA1c) 
among the four visits.  
As shown in figure 5.17 the best change in HbA1c was seen between the first and fourth 
visit were 60.7% of the patients had developed good change in their HbA1c.  
 
 
Figure 5.17 Distribution of good and bad change between visits 
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5.3.6 HbA1c change between fourth and first visit (HbA1c 4-1): 
A- HbA1c 4-1 and demographic variables 
 A significant association was found between HbA1c 4-1with the age category (41-50) 
years and period in study of (7 -12 months), (13-18 months) and (31-36 months) and in 
teaching and highly educated profession job category and MoH  insurance (P <0.05), but 
no association was found between HbA1c 4-1 and sex, duration of diabetes, educational 
level, place of residency and employment (P >0.05, see table 5.4). 
 
Table 5.4: Distribution of HbA1c 4-1 change with various demographic variables 
 
Continues in the next page 
 
 Variable  Total 
N=746(%) 
Bad HbA1c 
N= 293 (%) 
Good HbA1c 
N= 453 (%)  
P 
value 
Odds ratio(CI) 
Age ≤40  35 (4.69) 13 (37.1) 22 (62.9) 1 1 (0.48- 2.07) 
41-50 143 (19.2) 68 (47.6) 75 (52.4) 0.04 0.65 (0.43- 0.98) 
51-60  296 (40) 111(37.5) 185(62.5) 0.93 0.98 (0.7-1.38) 
> 60  272(36.46) 101(37.1) 171(62.9)  1 
Sex Male 349(46.78) 124(35.5) 225(64.5) 0.05 0.74 (0.55- 1) 
Female 397(53.21) 169(42.6) 228(57.4) 
Period in study 
( months) 
≤6  40 (5.3) 14 (35) 26 (65) 0.13 1.71 (0.85- 3.45) 
7-12  91 (12.19) 29 (31.9) 62 (68.1) 0.01 1.97 (1.18- 3.29) 
13- 18  50 (6.7) 15 (30) 35 (70) 0.02 2.15 (1.11- 4.16) 
19- 24 107 (14.3) 44 (41.1) 63 (58.9) 0.25 1.32 (0.83- 2.12) 
25- 30  74 (9.91) 26 (35.1) 48 (64.9) 0.06 1.7 (0.99- 2.94) 
31- 36  165 (22.1) 60 (36.4) 105(63.6) 0.02 1.61 (1.07- 2.44) 
> 36  219(29.35) 105(47.9) 114(52.1)  1 
Duration of 
Diabetes 
(years) 
≤5  211(28.28) 100(47.4) 111(52.6) 0.07 0.56 (0.3- 1.04) 
6-10  228(30.56) 95 (41.7) 133(58.3) 0.26 0.7 (0.38- 1.31) 
11-15 160 (21.4) 53 (33.1) 107(66.9) 0.98 1.01 (0.53- 1.94) 
16-20  93 (12.46) 27 (29) 66 (71) 0.59 1.22 (0.59- 2.52) 
> 20  54 (7.23) 18 (33.3) 36 (66.7)  1 
Place of 
residency 
Middle  332(31.09) 140(42.2) 192(57.8) 0.15 0.79 (0.57- 1.09) 
North 131(17.56) 50 (38.2) 81 (61.8) 0.73 0.93 (0.6- 1.42) 
South 283(37.93) 103(36.4) 180(63.6)  1 
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B- HbA1c 4-1 with various follow up criteria  
A significant association was found between good change in HbA1c 4-1 and good change 
in diastolic blood pressure 4-1(p<0.05). No association was found between change in 
HbA1c 4-1 and change in MAU 4-1 and cholesterol 4-1 (P >0.05, see table 5.5) 
  
Table 5.5:  Distribution of HbA1c 4-1 change with various follow up criteria 
*reference category bad  
 Variable  Total 
N=746 
Bad HbA1c 
N= 293    
Good HbA1c  
N= 453   
P 
value 
Odds ratio(CI) 
Education 
level 
Illiterate 109(14.61) 36 (33) 73 (67) 0.19 1.44 (0.84- 2.5) 
School 385 (51.6) 156(40.5) 229(59.5) 0.84 1.05 (0.68- 1.6) 
High school 139(18.63) 54 (38.8) 85 (61.2) 0.66 1.12 (0.68- 1.86) 
University  113(15.14) 47 (41.6) 66 (58.4)  1 
Profession 
Total N=203 
Worker 138(67.98) 51 (37) 87 (63) 0.05 3.98 (0.99- 16.08) 
Highly 
educated 
55 (27.09) 18 (32.7) 37 (67.3) 0.04 4.8 (1.11- 20.76) 
Health  
sector 
10 (4.92) 7 (70) 3 (30)  1 
Employed Yes 195(26.13) 76 (39) 119 (61) 0.92 0.98 (0.7- 1.37) 
No 551(73.85) 217(39.4) 334(60.6) 
Smoking 
Yes 119(15.95) 48 (40.3) 71 (59.7) 0.21 0.71 (0.42- 1.2) 
No 501(67.15) 204(40.7) 297(59.3) 0.09 0.7 (0.47- 1.06) 
Past 
smoker 
126(16.89) 41 (32.5) 85 (67.5)  1 
Insurance  
MOH 427 (57.2) 148(34.7) 279(65.3) 0.03 1.55 (1.06- 2.28) 
UNRWA 175 (23.45 80 (45.7) 95 (54.3) 0.92 0.98 (0.63- 1.52) 
Others 144 (19.3) 65 (45.1) 79 (54.9)  1 
Marital 
Status 
Singe 14 (1.87) 4 (28.6) 10 (71.4) 0.35 1.8 (0.52- 6.2) 
Married 633(84.85) 250(39.5) 383(60.5) 0.67 1.1 (0.7- 1.74) 
Divorced 13 (1.74) 3 (23.1) 10 (76.9) 0.21 2.4 (0.62- 9.35) 
Widow 86 (11.52) 36 (41.9) 50 (58.1)  1 
Variable  Total 
N=746(%) 
Bad HbA1c 
N= 293(%) 
Good HbA1c 
N= 453(%) 
P 
value 
Odds ratio (CI) 
Good MAU* 346 (46.38) 132 (38.2) 214 (61.8) 0.56 1.09 (0.81- 1.47) 
Good Cholesterol 
(mg/dl) 
404 (54.15) 159 (39.4) 245 (60.6) 0.96 0.99 (0.74- 1.33) 
Good Systolic 
(mmHg)* 
350 (46.9) 144 (41.1) 206 (58.9) 0.33 0.86 (0.64-1.16) 
Good Diastolic 
(mmHg)* 
401 (53.7) 142 (35.4) 259 (64.6) 0.02 1.42 (1.06- 1.91) 
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 C- HbA1c 4-1 and Lifestyle behavior  
 No significant association was found between HbA1c 4-1 change with BMI, calorie intake 
and physical activity (P >0.05) (see table 5.6). 
 
Table 5.6: Distribution of HbA1c 4-1 with lifestyle behaviors 
Variable  Total 
N=746(%) 
Bad HbA1c
N= 421(%) 
Good HbA1c 
N= 325(%) 
P 
value 
Odds ratio (CI) 
Good BMI* 249 (33.37) 105 (42.2) 144 (57.8) 0.25 0.83 (0.612- 1.138) 
Calories 1000 306 (41.01) 133 (43.5) 173 (56.5) 0.2 0.5 (0.174- 1.438) 
1200 29 (3.88) 11 (37.9) 18 (62.1) 0.48 0.629 (0.176- 2.253) 
1400 67 (8.98) 32 (47.8) 35 (52.2) 0.14 0.421 (0.135- 1.312) 
1600 104 (13.94) 39 (37.5) 65 (62.5) 0.43 0.641 (0.212- 1.936) 
1800 100 (13.4) 35 (35) 65 (65) 0.55 0.714 (0.235- 2.168) 
2000 93 (12.46) 32 (34.4) 61 (65.6) 0.59 0.733 (0.24- 2.239) 
2200 29 (3.88) 6 (20.7) 23 (79.3) 0.58 1.474 (0.375- 5.79) 
2400 18 (2.41) 5 (27.8) 13 (72.2)  1 
Activity 
level 
Very light 14 (1.87) 5 (35.7) 9 (64.3) 0.98 1.018 (0.321- 3.234) 
Light 613 (82.17) 245 (40) 368 (60) 0.43 0.85 (0.565- 1.277) 
Moderate 119 (15.9) 43 (36.1) 76 (63.9)  1 
*reference category bad  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
73
5.4 Multivariate analysis 
 
Table 5.7 shows the Multivariate analysis for HbA1c change with the different variables 
among the four visits. 
Between the  1st  and 2nd   visit HbA1c was significantly determined by period being 
registered in the center , patients who had their visits within(7-12) months had 4 times 
better change in HbA1c compared with patients who had their  four visits within >36 
months. HbA1c between this visit was inversely associated with good change in diastolic 
blood pressure (AOR= 0.7(CI=0.5-0.9)) and good change in MAU (AOR= 0.6(CI=0.4 -
0.9)). 
Between the 2nd  and 3rd visit  HbA1c change was significantly associated with period 
being registered in the center ,  patients who were registered in the center for 31-36 month 
had 1.5 times better change in HbA1c compared to patients who had their four visits >36 
month. 
Between the 1st and 4th visit HbA1c change was significantly associated with period being 
registered in the center, patients  having their 4 visits within 7-12 months 
(AOR=1.94(CI=1.10-3.44)) or 13-18 months (AOR=2.33(CI=1.13-4.79) showed a better 
change in their HbA1c by 2 folds when compared to those spending longer time (>36 
months).  HbA1c change was inversely associated by change in diastolic blood pressure.  
 Between the 2nd and 4th visit HbA1c change was inversely associated with duration of 
diabetes <5 years (AOR=0.35(CI=0.18-0.69). 
Between the 3rd and 4th visit HbA1c change was inversely associated with Systolic blood 
pressure (AOR= 0.71(CI=0.51-0.98)).  
Between the 1st and 3rd HbA1c change was inversely associated with change in MAU 
(AOR=0.62(CI=0.44-0.87)).  
No significant association was found between HbA1c change with  age, gender , 
employment, marital status , smoking , BMI, insurance , cholesterol level, residency and 
caloric intake among the four visits in the study. 
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Table 5.7: Multivariate analysis for HbA1c change with the different variables among the four visits. 
Continue in the next page 
 HbA1c 2-1 HbA1c 3-2 HbA1c 4-1 HbA1c 4-2 HbA1c 4-3 HbA1c 3-1 
Variable AOR (CI) AOR (CI) AOR (CI) AOR (CI) AOR (CI) AOR (CI) 
Age ≤40  1.5(0.7-3.5) 1.2(0.5-3.0) 1.1(0.5-2.6) 1.2(0.6-2.8) 1.7(0.7-3.7) 0.9(0.4-2.1) 
41-50 0.8(0.5-1.3) 0.7(0.4-1.1) 0.7(0.4-1.1) 0.9(0.6-1.4) 0.95(0.6-1.5) 0.8(0.5-1.2) 
51-60  1.4(0.9-2.0) 0.9(0.6-1.3) 1(0.7-1.5) 0.9(0.6-1.4) 0.96(0.7-1.4) 0.9(0.6-1.3) 
> 60  1 1 1 1 1 1 
Period in 
study 
(months) 
7-12  4.0 (2.2-7.3) 1.5(0.9-2.7) 1.9(1.1-3.4) 0.9(0.5-1.6) 0.9(0.5-1.5) 4.8(2.6-8.8) 
13- 18  2.9(1.4-5.9) 1.3(0.6-2.5) 2.3(1.1-4.8) 1.5(0.8-2.9) 1.0(0.5-1.97) 4.2(1.96-8.9) 
19- 24 1.7(1.-2.9) 1.7(0.98-2.8) 1.3(0.8-2.2) 1.1(0.7-1.8) 0.6(0.4-1.1) 2.7(1.6-4.7) 
25- 30  2.5(1.4-4.6) 1.1(0.6-1.95) 1.9(1.0-3.4) 1.1(0.6-1.97) 0.7(0.4-1.3) 3.3(1.8-6.0) 
31- 36  1.9(1.3-3.0) 1.6(1.0-2.5) 1.7(1.1-2.7) 1.1(0.7-1.7) 0.7(0.4-1.0) 2.3(1.5-3.5) 
> 36  1 1 1 1 1 1 
Duration of 
 Diabetes 
(years) 
≤5  1.3(0.7-2.5) 0.6(0.3-1.2) 0.5(0.3-1.0) 0.3(0.2-0.6) 0.4 (0.2-0.7) 0.70(0.4-1.4) 
6-10  1.6(0.8-3) 0.7(0.4-1.3) 0.8(0.4-1.5) 0.5(0.3-0.9) 0.7(0.34-1.2) 1.0(0.5-1.95) 
11-15 1.5(0.8-2.8) 1.2(0.6-2.4) 1.0(0.5-1.99) 0.8(0.4-1.6) 0.6(0.3-1.2) 1.4(0.7-2.8) 
16-20  1.9( 0.9-4.0) 1.2(0.6-2.6) 1.2(0.6-2.5) 0.5(0.2-1.0) 0.5(0.3-1.1) 1.97(0.9-4.2) 
> 20  1 1 1 1 1 1 
Sex *** - 1.1(0.5- 2.3) 0.9 (0.4-2.1) 0.9(0.4-2.0) 0.5 (0.2-1.0) 0.8 (0.4-1.6) 0.8(0.4-1.7) 
Work**  1.1(0.7-1.7) 1.7(1.1-2.7) 0.9(0.6-1.4) 0.9(0.6-1.3) 0.7(0.5-1.1) 1.2(0.7-1.8) 
Marital 
status 
Single 2.3(0.6-8.6) 4.3(1.2-15.0) 2.4(0.7-9.1) 1.8(0.5-5.8) 0.4(0.1-1.3) 3.96(1.1-14.7)
Married 1.0(0.6-1.7) 1.5(0.8-2.5) 1.1(0.7-1.9) 1.2(0.7-2.1) 0.8(0.5-1.3) 1.8(1.1-3.1) 
Divorced 0.5 (0.2-1.9) 4.1(1.2-14.8) 2.97(0.7-12.5) 5.1(1.2-21.4) 0.96(0.3-3.4) 3.2(0.8-12.4) 
Widow 1 1 1 1 1 1 
Smoking Yes 1.2(0.7-2.1) 0.84(0.5-1.5) 0.8(0.5-1.4) 0.7(0.4-1.2) 0.9(0.54-1.6) 1.3(0.7-2.2) 
No 1.2(0.7-1.9) 0.8(0.5-1.2) 0.98(0.6-1.6) 0.6 (0.4-1.0) 0.9(0.5-1.4) 1.2(0.7-1.96) 
Past smoker 1 1 1 1 1 1 
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*reference category bad; ** reference category No;***Reference category males 
                        
 
                                                            
3 AOR: Adjusted Odds Ratio 
 HbA1c 2-1 HbA1c 3-2 HbA1c 4-1 HbA1c 4-2 HbA1c 4-3 HbA1c 3-1 
Variable AOR 3(CI) AOR (CI) AOR (CI) AOR (CI) AOR (CI) AOR (CI) 
Insurance 
 
MoH 1.1(0.7-1.6) 1.2(0.8-1.8) 1.4(0.9-2.1) 0.99(0.7-1.5) 0.95(0.6-1.4) 1.1(0.7-1.7) 
UNRWA 0.8(0.5-1.4) 1.3(0.8-2.2) 0.8(0.5-1.3) 0.7(0.4-1.1) 0.7(0.4-1.2) 0.8(0.5-1.4) 
Others 1 1 1 1 1 1 
Cholesterol 
(mg/dl)* 
 0.99(0.7-1.4) 1.0(0.7-1.5) 1.0(0.7-1.4) 1(0.7-1.4) 0.8(0.6-1.1) 0.7(0.5-1.0) 
MAU (* - 0.6(0.4-0.9) 0.5(0.3-0.7) 0.8(0.6-1.1) 0.9(0.6-1.2) 0.95(0.7-1.3) 0.6(0.4-0.9) 
Systolic 
(mmHg)* 
- 1.1(0.8-1.6) 1.2(0.9-1.7) 1.4(0.98-1.9) 0.8(0.6-1.1) 0.7(0.5-0.98) 1.2(0.8-1.6) 
Diastolic 
(mmHg) * 
- 0.7(0.5-0.9) 0.5(0.4-0.7) 0.7(0.5-0.9) 0.9(0.6-1.2) 0.98(0.7-1.4) 0.8(0.5-1.1) 
Residency Middle 1.0 (0.7-1.5) 0.9(0.6-1.3) 0.8(0.5-1.1) 0.7(0.5-1.0) 1.2(0.9-1.7) 0.8(0.5-1.1) 
North 0.7(0.4-1.1) 1.0(0.7-1.7) 0.9(0.6-1.4) 1.1(0.7-1.8) 1.3(0.9-2.1) 0.9(0.5-1.4) 
South 1 1 1 1 1 1 
BMI * - 1.0(0.7-1.4) 0.8(0.6-1.2) 1.1(0.8-1.5) 0.8(0.6-1.0) 0.8(0.6-1.0) 1.0(0.7-1.5) 
Calorie Intake 1000 0.6(0.2-2.5) 2.0(0.6-7.4) 0.5 (0.1-1.8) 1.1(0.3-4.2) 0.5(0.1-1.6) 0.3(0.1-1.3) 
1200 0.8(0.2-3.8) 1.4(0.3-6.4) 0.5(0.1-2.3) 0.7(0.2-3.3) 0.5(0.1-2.2) 0.3(0.1-1.8) 
1400 0.6(0.2-2.5) 1.1(0.3-3.96) 0.4(0.1-1.4) 0.7(0.2-2.6) 0.6(0.2-1.8) 0.2(0.1-1.1) 
1600 0.5(0.2-1.9) 1.7(0.5-5.2) 0.7(0.2-2.2) 2.6(0.8-7.97) 0.7(0.3-2.1) 0.4(0.1-1.4) 
1800 0.5(0.2-1.8) 1.4(0.5-4.4) 0.7(0.2-2.4) 1.98(0.7-6.0) 0.8(0.3-2.2) 0.3(0.1-1.3) 
2000 0.8(0.2-2.7) 1.3(0.4-3.97) 0.8(0.2-2.4) 2.5(0.8-7.6) 0.98(0.4-2.8) 0.5(0.1-1.8) 
2200 0.6(0.2-2.6) 1.2(0.3-4.5) 1.4(0.3-5.9) 2.4(0.7-8.8) 0.8(0.2-2.6) 0.5(0.1-2.3) 
2400 1 1 1 1 1 1 
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Discussion and Conclusion 
 
6.1 Introduction 
In this chapter, major study results are summarized and compared to other studies results 
worldwide.  Also, these results will be discussed and interpreted.   In the final part of the 
chapter study conclusions and recommendations are presented.   
6.2 Summary of study findings 
The distinguishing feature of this study is that it is the first to evaluate the diabetes 
and dietary program held at the Diabetes Care Center at Augusta Victoria Hospital 
since year 2005. Also this study provides a baseline for further studies to improve 
dietary programs and comprehensive services in diabetes care. 
 
The major study finding showed that, as reported in the medical files and upon patient 
registration in the center, 53.1% of the patients had peripheral neuropathy, 38.1% had 
hypertension, 20.8% with heart problems, 31% had dyslipidemia, and 70.5% were 
treated for diabetes by oral hypoglycemic agents. 
 
Multivariate analysis was carried out on 746 patients who had their four visits within 
4 years with irregular period between each visit (page 74 & 75). 
Only 34% (n=255) of the sample had their four visits in two year, with at most 6 
months between each 2 successive visits .Multivariate analysis was done on this 
subsample to see if the regular short  period between visits shows different results and 
associations with the same variables included in the study ( see annex 6 ).  
 
The results for the multivariate analysis for HbA1c change  in table 5.7, showed that 
between visits, age, residency, type of insurance, smoking, good change in BMI, good 
change in cholesterol level and diet program did not show any significant associations 
with good change in HbA1c among the four visits.  The models for change in HbA1c 
each between two visits were as follows 
- Between the 1st and 2nd visit, the only variable associated with good change of 
HbA1c was numbers of years (period) visiting the clinic, but was inversely 
associated with good change in diastolic blood pressure and good change in 
MAU. 
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- Between the 2nd and 3rd visit, being single or married, and being employed 
determined the good change in HbA1c, but was inversely associated with good 
change in diastolic blood pressure and good change in MAU.   
- Between the 1st and 3rd visit, numbers of years (period) visiting the clinic and 
being married or single were associated with good change in HbA1c, but was 
inversely associated with good change in MAU.   
- Between 3rd visit and 4th visit having diabetes for ≤ 5 years was associated 
with good change in HbA1c, but was inversely associated with good change in 
systolic blood pressure.  
- Between 2nd and 4th visit, being divorced was associated with good change in 
HbA1c, but was inversely associated with having diabetes for less than 10 
years. 
- Between the 1st and 4th visit the only variable associated with good change was 
numbers of years (period) visiting the clinic, but was inversely associated with 
good change in diastolic blood pressure and good change in MAU.   
 
6.3 HbA1c levels and change before and after intervention 
 
In this study, the mean HbA1c (n=746) in the 1st visit was 9.1% (SD± 2.1) and in the 
4th visit was 8.5% (SD± 1.7). In the 1st visit percent of our patients with controlled 
HbA1c (≤ 7) was 19.2% (n=143) and increased in the 4th visit to 22.1% (n= 164). We 
carried another analysis on the 34% patients (n=255) of the total sample (n=746) who 
had their four visits done regularly within 2 years (Annex 6 &7). The repeated 
measures analysis showed that in this subsample (n=255 patients) the mean HbA1c 
for the 1st visit was 9.31 (SD=2.22) and the mean HbA1c for the 4th visit was 8.53 
(SD=1.79). Also, there was good change in HbA1c levels between the 1st and 4th visit 
as the mean difference was 0.78 (p=0.00) (see Annex7).   Comparing the findings 
with studies carried out in developed countries at various levels of healthcare, our 
results were consistent with a number of their findings. In Emirates, mean HbA1c for 
diabetic patients with type 2 diabetes in primary health care was 8.3%, but only 38% 
of patients had good glycemic control (HbA1c< 7.0%) (Juma Al-Kaabi et al, 2008). 
In Amman-Jordan the percentage of patients with optimal control (HbA1c ≤ 7%) 
increased from 25.4% at the first visit to 27.5% at 12-month follow-up (M. Adham et 
al , 2010).  In Al-Ain, UAE the mean HbA1c declined from 8.5% 2008 to 7.5% in 
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2010.(Layla Alhyas et al, 2012) . In Iraq the mean HbA1c levels at the start of the 
study was 9.8 ± 1.9 % and after 3 years it was 8.1 ± 1.6 % (Mansour et al, 2011).  In 
Saudi Arabia 27% of the patients reached target level of glycemic control (Akbar, 
2001). In Kuwait, only 17.6% of patients had achieved the goal of HbA1c < 7% In 
Trinidad, 15% had HbA1c≤ 7% (Ezenwaka & Offiah, 2001). Baseline data of newly 
diagnosed patients enrolled to the Korea National Diabetes Program (KNDP) cohort 
study conducted in Korea showed that mean HbA1c was 8.2 ± 2.4%. ( Choi et al, 
2011) In Sweden a survey revealed that from type 2 diabetes patients only 34% had 
good glycemic control (Holmström IM et al, 2005). In Finland, only 25% of a study 
group had HbA1c < 7.3%. (Valle T et al., 1999). The Authors concluded that it’s 
difficult to obtain optimal glycemic control (HbA1c  7) due to the effects of rapid 
modernization, increased food consumption and obesity, and concomitant adoption of 
sedentary lifestyle. 
This shows that our study population has much higher mean of HbA1c before using 
this intervention program compared to other Arab populations. Diabetic patients 
attending the educational sessions at the Diabetes Care Center Contribute this high 
mean to many factors regarding lifestyle, eating pattern, financial issues, political 
situation, social and psychosocial factors, and unavailability of medications, poor 
eating habits, poor compliance with medication and the use of inappropriate herbal 
medicines. In our study, comparing the reduction in the HbA1c level in the 4th visit 
with the baseline data from the 1st visit, a substantial improvement was found (9.1% 
dropped to 8.5%).  For HbA1c control, as seen only 22.1% of the total number of 
participants reached the required target control level at the 4th visit, compared with 
19.2% at the 1st visit. But compared to any other populations this is similar to many 
countries and many intervention programs. A meta-analysis that evaluated educational 
interventions in adult outpatients with diabetes  before and after the intervention and 
at ≥12 weeks after the intervention showed that the net glycemic change was 0.32% 
lower in the intervention group than in the control group.  (Ellis et al, 2004). In 
clinical practice, optimal glycemic control is difficult to obtain on a long-term basis 
because the reasons for poor glycemic control in Type 2 diabetes are complex 
(Wallace , 2000). Both patient- and health care provider related factors may contribute 
to poor glycemic control (Rhee et al., 2005; Wallace, 2000).  The U.S. Department of 
Veterans Affairs and the U.S. Department of Defense (2010) stratify glycemic goals 
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based on co morbidity and life expectancy4 (VA/DoD, 2010).   This shows that the 
target level for HbA1c depends on the case of the patients.   Therefore, in our 
nutrition program in AVH we aimed to lower the HbA1c level of the patients through 
the consultations and the diet program the patients receive throughout their visits. 
  
Determinants for HbA1c levels: 
 
Patients’ gender and HbA1c 
In our study we carried out a test of significance (T-test) to assess the difference in 
means between the four clinic visits during the follow-up intervals. Our findings 
showed that males had significantly lower mean HbA1c levels than females in the 3rd 
and 4th visit. This could be related to the social norms of women in some conservative 
villages which limit their ability to take up exercise outside the home, another reason 
is that females usually report during the educational session that they don’t have 
enough time during the day to care for themselves due to their huge household 
responsibilities, and that they usually miss their appointment or clinic because of their 
children who they can't leave alone at home. Similar findings were reported from 
Saudi Arabia (Akbar DH, 2001), Jordan (Adham et al., 2010) and Finland (Valle T et 
al., 1999). Other study revealed that there was no significant relationships between the 
level of HbA1c with gender (p=0.655) (Ismail et al., 2011). 
 
 
 
                                                            
4 The guidelines have three categories: (VA/DoD, 2010).    
1) The patient with either none or very mild micro vascular complications of diabetes, who is free of 
major concurrent illnesses and who has a life expectancy of at least 10–15 years, should have HbA1c 
target of ,7%, if it can be achieved without risk. 
2)  The patient with longer-duration diabetes (more than 10 years) or with co morbid conditions and 
who requires a combination medication regimen including insulin should have an HbA1c target of 8%. 
3)  The patient with advanced micro vascular complications and/or major co morbid illness and/or a 
life expectancy of less than 5 years is unlikely to benefit from aggressive glucose-lowering 
management and should have an HbA1c target of 8–9%.  
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Patients' educational level and HbA1c 
Patients with higher educational degree had better mean HbA1c among all the four 
visits compared to illiterate patients (p≤0.05). In the 1st visit patients who were 
illiterate had mean HbA1c 9.5 ±2.1 , and patients who had less than high school 
degree  had mean HbA1c 9.1 ± 2.2  compared to mean HbA1c 8.7± 2 for patients who 
had university degree. In the fourth visits the illiterate patients had mean HbA1c 
8.7±1.7 and the patients with less than high school degree had mean HbA1c of 
8.6±1.8 compared to mean HbA1c 8.2±1.4 for patients with university degree 
(p≤0.05). People with lower educational level have in general a lower satisfaction 
with life and are less satisfied with diabetes treatment, as well as having worse 
metabolic control (Biderman A. Et al, 2009). 
Findings from a cohort study demonstrate that having less than a high school 
education was associated with a twofold higher mortality from diabetes compared 
with adults with a college degree or higher education level. (Saydah et al., 2009). 
Lower educational level was independently associated with poor levels of HbA1c 
(Alex N et al., 2003). But a study from Malysia revealed that, there was no significant 
relationships between the level of HbA1c with education levels (p=0.087) (Ismail et 
al., 2011). Self-management in practice is complex and difficult since it should 
include meal planning, being physically active, skin care, taking medicines, foot care, 
avoiding smoking and tobacco, and other health monitoring tasks (Ahmed, 2006). 
Knowledge about diabetes and understanding treatment aims contribute to patients’ 
active participation in the treatment and it will help the team responsible for the 
diabetes management programs to teach the patients ways of controlling diabetes such 
as the carbohydrate counting with insulin and medication which needs special 
calculations.  
Traditional patient education relies heavily on written material about disease 
processes, medical management, and self-care instructions. Despite the availability of 
extensive health education materials with relatively consistent content, many are 
written at too high a level for low-literate patients to comprehend essential points 
(Davis, 1990). Thus, patients with inadequate literacy may not benefit from such 
educational efforts. This may explain why some patient education programs have 
been unsuccessful (Mulrow et al, 1987). The results of some studies confirm that the 
low-literate patient cannot fully comprehend medical advice using standard patient 
education methods.Direct involvement of patients in developing educational materials 
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may empower them to improve their health while ensuring that the content effectively 
educates them (Rudd, 1994). 
 
Employment and HbA1c 
Patients who were employed had significantly lower mean HbA1c than patients who 
were not. Patients who were employed had mean HbA1c in the first visit 8.8±2.1 and 
improved to be 8.1%±1.6 in the fourth visit compared to patients who were 
unemployed and had mean HbA1c 9.2% ±2.1 in the first visit and 8.6%±1.7 in the 
fourth visit. Other study findings showed that the level of control of  diabetes  was not 
statistically significantly  with  employment (Trief et al., 1999; Kurowska et al., 
2010).  In our study, both the employed and the unemployed had improved their mean 
HbA1c in their fourth visit. But the employed patients had better mean HbA1c 
through all visits compared to unemployed patients and this may be attributed to 
many reasons. We contribute the reason of this to the stress caused from being 
unemployed especially for men, then the financial burden caused by unemployment 
will prevent some of the patients from following up regularly in the center because of 
the cost of transportation, medication etc. Even some patients can't afford the high 
cost of living and buying whole grains, fruit, vegetables, low fat dairy products which 
are usually advised in the healthy diet. Another reason is that usually employed 
persons tend to be more active than unemployed persons. However other few studies 
showed that poor  glycemic control is also affected by work factors for employed 
diabetics. Individuals working long hours are less likely to be able to properly manage 
their diabetes due to the lack of time to check their blood glucose levels, inject 
insulin, take oral agents when necessary, or eat well-balanced meals at regular time 
intervals, all factors that may affect glucose levels. Furthermore, Job stress,  may 
influence diabetes through effects on metabolic regulations. Stress activates the 
hypothalamic pituitary adrenal axis which increases blood glucose and abdominal 
accumulation of body fat that causes insulin resistance. (Kroenke C.H et al , 2007 ; 
Kawakami N et al , 2000)  
 
Type of insurance and HbA1c 
 Patients who were with private insurance or insured with Israeli sick fund had 
significantly lower mean HbA1c than patients insured with MoH and UNRWA 
among the four visits. Between the 1st and 4th visit the mean HbA1c for patients who 
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were insured with MoH was 9.3%±2.1 in the first visit and improved to become 
8.5±1.6 compared to the mean HbA1c of the private Israeli sick fund which was 
8.5±2 in the first visit and improved to 8.1±1.7 in the fourth visit. This could be 
related to the availability of medication and the services provided to the patients and 
the costs of services and types of services covered vary widely. But it is very obvious in 
our health system that the private insurance or Israeli sick fund insurance provide a 
comprehensive care for diabetes patients by holding group educational sessions and 
individualized nutrition counseling by a registered dietitian, eye care, and provision of 
self monitoring blood sugar device to every diabetic patient with minimal charge on the 
glucosticks. On the other hand, UNRWA system and Ministry of health have recently 
included in their teams a dietitian even still not appointed in every clinic. The doctor sees 
a huge number of diabetic patients during the day which makes it impossible for him/her 
to give the patient enough time and privacy for discussion. Another problem is that 
sometimes the medication and insulin are not available in the clinics. A study in USA 
suggests that a nationwide coordinated healthcare system can implement quality 
improvement program initiatives for chronic diseases such as diabetes and that a 
nationwide system of universal access to care is a viable way to deliver care for 
patients with chronic diseases like diabetes thereby providing adequate care to all the 
citizens.( Arch G Mainous III , 2OO6)  
 
Duration of having diabetes and HbA1c 
Mean HbA1c levels increased with a longer duration of DM. Patients who had 
diabetes for ≤5 years had better mean HbA1c than patients who had diabetes for >20 
years during the four visits , but both groups have improved their HbA1c in the fourth 
visit.( as seen in page# 66 ) 
Several studies have shown significant relationship between the controlled levels of 
HbA1c with duration of illness (Hudon et al., 2008; Zhaolan Liu et al., 2010 ;Khattab 
et al., 2003;Chan et al., 2000; Bruce et al,. 2000). However, Hartz et al. (2006) and 
Ismail et al. (2011) and  Goudswaard et al (2004)  showed no significant relationship 
between the levels of control of HbA1c with duration of illness. 
The worsening of glycaemic control over time could be explained by insulin 
resistance associated with the ageing process. It is known that achieving and 
maintaining HbA1c levels < 7% is difficult in patients with a longer duration of DM 
even with the addition of medication (UKPDS, 1998). Even patients with longer 
duration of diabetes get bored from attending the clinic, having their medication and 
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even attending the educational sessions, they feel they know everything about 
diabetes from their long experience with the disease. Thus new activities and 
discussions must be held in the clinics in order to encourage those patients to attend 
regularly and abide to their management protocols.  
 
6.4 Change in HbA1c throughout visits 
In our study, the best change in HbA1c was seen between the first and fourth visit 
where 60.7% of the patients had improved their HbA1c as shown in figure 6.1. This 
shows that as our diabetic patients stay longer in the center and are undergoing the 
diabetes program they will have improvement in their HbA1c levels. In the National 
Health and Nutrition Examination Survey the mean of HbA1c levels decreased from 
7.82% in 2000 to 7.47% in 2002 and 7.18% in 2003–2004. Controlled Diabetic 
patients with HbA1c < 7.0% increased from 37.0% in 2000 to 49.7% in 2002 and 
55.7% in 2004; this indicates corresponding betterment over time (Hoerger et al, 
2007). 
 
43.60% 46.50%
49.30%
58% 58.20% 60.70%
HbA1c 3‐2 HbA1c 4‐3 HbA1c 2‐4 HbA1c 1‐2 HbA1c 1‐3 HbA1c 1‐4
Good Change
 
Figure 6.1: change in HbA1c between visits 
 
Most intervention studies on diabetic patients with similar aim like our study had a 
planned schedule for their patients, thus patients had systematic data throughout their 
visits (Adham et al., 2010; ADA, 2008; Chan, 2000). But in our study the periods 
between the various four visits included was not systematic and varied among the 
patients.  Thus we decided to focus on the 1st visit of the patient when the intervention 
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had started and the fourth visits results, which is the last one to see the impact of the 
program on the patients. 
 
Glasgow et al in his study that involved 162 patients with type 2 diabetes using a 
multidisciplinary team showed that reduction in caloric intake and percentage of 
calories from fat was significantly higher in the intervention group compared to the 
control group.  And when control group patients crossed over to the intervention 
group, their HbA1c levels decreased from 7.4% to 6.4% (Glasgow et al. 2001). In a 
prospective randomized trial, in persons newly diagnosed with or currently under 
treatment for type 2 diabetes, showed that with more intensive nutrition intervention 
programs and changes in lifestyle, HbA1c dropped by 1–2%. (Franz et al, 1995).   In 
another 24 studies that combined physical activity advice and dietary advice in their 
intervention program, both factors were associated with decreased HbA1c (−0.58% to 
−0.43%) for intervention group as compared with control participants (Umpierre, 
2011).   Several studies reviewed in this meta-analysis reported a significant reduction 
in HbA1c of 1.0% to 2.6% with lifestyle intervention corresponding to weight loss 
(Norris et al, 2004). A meta-analysis study evaluated educational interventions in adult 
outpatients with diabetes, and reported on HbA1c concentrations before and after the 
intervention and at ≥12 weeks after the intervention showed that the net glycemic 
change was 0.32% lower in the intervention group than in the control group. (Ellis et 
al, 2004). In a randomized controlled trial of medical nutrition therapy at the UK 
Prospective Diabetes Study involved 30,444 newly diagnosed diabetic patients (type 2) 
at 15 centers. All groups received nutrition counseling from dieticians for three 
months. During the study, when the nutrition counseling was the primary intervention, 
“the mean HbA1c decreased by 1.9% fasting plasma glucose was reduced by 46 mg/dl, 
and there were average weight losses of 5 kg after 3 months (Pastors et al, 2002). 
 
In our study and comparing the results of our program to other intervention programs 
(Adham et al., 2010; Wing et al., 2011, Mansour et al., 2011, Alhyas et al., 2012) we 
can say that the decline in the mean HbA1c between the 4th and 1st visit was 0.6 was  
similar to other programs in similar setups (Adham et al,. 2010; Alhyas et al , 2012; ), 
and the 60.7% of patients who had good change in their HbA1c among this period is a 
quite good percent. This finding reveals that performance on process of diabetes care 
does not essentially translate into good metabolic control. The most important is to 
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implement change and any improvement and even if not reaching the optimum control 
level means that the program had succeeded in making a good change. 
 
6.5 HbA1c change determinants between visits 1 and 4 
 
6.5.1 Association between HbA1c change and various demographic variables 
between visit 1 and 4 
 
In the multivariate model( n=746), patients’ age, period being in program, duration of 
diabetes, sex, employment, marital status, insurance and place of residence were the 
main socio-demographic factors that were included in this study model. 
Unexpectedly, age wasn’t significantly associated with good change in HbA1c among 
all age groups between the 1st and 4th visit. This non significant relationship between 
age and poor glycemic control in our study was not consistent with the findings of a 
number of studies (EL-Kebbi et al., 2003; Brenner, 2003) which reported that younger 
age was associated with poor glycemic control.  Several other studies also had shown 
that there was significant relationship between uncontrolled level of HbA1c and 
patient’s young age (Eid et al., 2003; Suhaiza et al., 2004; Ismael et al., 2011) In the 
West Bank, the MOH report for year 2010 showed that the rate of diabetes varied by 
age which was 1.6% among age group 20-59 years and 13.6% among individuals 60 
years and above (MOH report 2010).  
Unlike the main sample (n=746),  in the subsample of the 255 patients age between 
the 1st and 2nd visit had significant association with the good change in HbA1c , where 
patients at the age group 51-60 yrs had (2 folds) better to change their HbA1c 
compared to patients > 60 years ( see annex 6 table # 19) .  
A possible explanation of the association between level of HbA1c and patients age 
could be associated with physical inactivity and poor healthy lifestyle habits at older 
ages.  Karin in her analysis showed that increasing age was associated with physical 
inactivity.  (Karin et. al, 2002) Another reason is that most elderly patients with 
diabetes may suffer from other chronic disorders and consume one or more 
medications that may increase glycosylation of hemoglobin thus increase HbA1c.  
 
In our study, the period patients spent in visiting the clinic at AVH to get dietary 
consultation was a major determinant for HbA1c good change between the 1st and 4th 
visit.  In the multivariate model patients having their 4 visits within 7-12 months or 
even within one and half year significantly showed a better change in their HbA1c by 
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2 folds compared to those spending longer time (>36 months). This change became 
less if they spend longer period which is up to 36 months and had only these 4 visits 
in it.  The period being in the study for 19-24 months was not associated with good 
change in HbA1c between the 1st and 4th visit (AOR=1.29(CI=0.77-2.17)). We also 
noted this among the other visits where patients HbA1c between the 1st and 2nd visit 
and between   the 1st and 3rd visit who have their  HbA1c results within one year 
significantly showed a better change in their HbA1c by 4 and  5 times respectively 
when compared to those who spent longer times (36 months). 
 
Other studies declare that routine visits to the diabetes therapist are vital in order to 
adapt and improve the treatment, and the steps of a successful medical nutrition 
therapy include assessment, individualization and regular follow up. Sustained 
improvements in HbA1c at 12 months and longer was seen among those consulting 
with registered dietitian that provided follow-up visits ranging from monthly to three 
sessions per year. HbA1c have decreased by 1-2% in type 2 diabetes. . (Anderson et 
al., 2003; ADA, 2008; Campbell et al, 2009).  A meta analysis of 31 studies showed 
that self management education decreased HbA1c by 0.76%.  HbA1c decreased more 
with additional contact time between participant and educator; a decrease of 1% was 
noted for every additional 23.6 hour of contact. (Norris et al., 2002). 
This is an important finding and a good indicator for the success of the diabetes 
intervention program and it gives the implication that as patients being followed more 
frequently within regular times at the center, they will have better improve their 
HbA1c.  
 
Duration of Diabetes showed no significant association with HbA1c between the 1st 
and 4th visit.  Among the various visits the only association was found between 2nd 
and 4th visit where an inverse association was seen (the longer the period you had 
diabetes, the less good change in HbA1c was seen).  Franz et al showed in his study 
that the average duration of diabetes for all subjects involved in the study  was 4 years 
and the decrease in HbA1c was 0.9% (from 8.3 to 7.4%) and in the subgroup of 
subjects with duration of diabetes 1 year, the decrease in HbA1c was 1.9% (Franz et 
al, 1995). Other studies also showed that longer duration of DM was related to more 
difficulty in maintaining the glycaemic control (UKPDS,1998; Valle T et al., 1999; El 
Kebbi et al., 2003). The worsening of glycaemic control over time could be explained 
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by a reduction in pancreatic beta cell function and an increased fat mass, particularly 
visceral adiposity, leading to greater insulin resistance associated with the ageing 
process. It is known that achieving and maintaining HbA1c levels < 7% is difficult in 
patients with a longer duration of DM even with the addition of a third oral 
hypoglycaemic drug (UKPDS, 1998) 
 
In the subsample analysis on the 255 patients who had their 4 visits in 2 years period, 
duration of diabetes was also significantly strongly associated with HbA1c change 
between the 1st and 2nd visit among those patients who were diagnosed with diabetes 
for 11-15 year significantly showed a better change in their HbA1c by 4 times when 
compared to those having diabetes for >20years, AOR=4.3(CI=1.14-15.99). Also 
between the 1st and 3rd visit the duration of diabetes was associated with the good 
change in HbA1c , patients who were diagnosed for 16-20 years had 6 folds to better 
change their HbA1c compared to those who were diagnosed for >20 years (see Annex 
6) . Unlike the previous results in the main sample (n=746) that showed that duration 
of diabetes between the 2nd and 4th result are less likely for better change OR<1.   
The Jordanian study showed that shorter duration of diabetes were related to 
reductions in HbA1c between the first and 12-month visits. (Adham et al, 2010)  
Khattab et al. in her study showed that increased duration of diabetes (N7 years vs. 
≤7years) (OR=1.99, P≤.0005) was significantly associated with increased odds of 
poor glycemic control. (Khattab et al., 2011). 
 
Marital status results showed that no significant association with HbA1c good change 
between the 1st and 4th visit. Among the other visits the association was found among 
the single and divorced patients between the 3rd and 2nd visit where AOR (single) = 
4.28(CI=1.22-15.02) and AOR (divorced) =4.14(CI=1.16-14.77), both have around 4 
times to develop the good change in HbA1c than the widow.  Between the 3rd and 1st 
result also the single patient has 4 times to better change their HbA1c than the widow 
AOR= 3.96(CI=1.06-3.13). Between the 4th and 2nd visit AOR for divorced is 
5.14(CI=1.23-21.42) to develop good change than the widow. Several studies had 
indicated that, there was no significant relationship between the level of  HbA1c  for 
patients with type 2 diabetes and  marital status (Suhaiza et al., 2004; Ismail et al., 
2000 , Ismail et al., 2011).  
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We might justify this result by the fact that it is common for marriage to affect the 
lifestyle of married couples as they become less active after marriage and likely 
reinforce increased food intake—so leading to the increased body weight.   Previous 
work has suggested that widowhood increases risk of premature mortality and 
cardiovascular disease and has important implications for metabolic functioning and 
greater attention to the cardio metabolic health of this population is needed. (Cornelis 
et al., 2012) 
Other factors in the model i.e. gender, employment, education level and the various 
types of insurance and place of residence did not show any significant association 
with good change in HbA1c in any of the four visits. Even with the sub sample 
analysis on the 255 patients with more regular visit to the clinic, the multivariate 
analysis for the four HbA1c period results period in study, duration of diabetes, 
insurance, marital status, place of residence, level of education did not show any 
significant effect.   
 
 
6.5.2 Lifestyle factors associated with HbA1c change between the 1st and 4th visit  
 
6.5.2.1 Association between HbA1c and caloric intake 
 
Our study results showed that 41% of the patients were on 1000 Cal, 3.9% on 1200 
Cal, 9% on 1400 Cal, 13.9% on 1600 Cal, 13.4% on 1800 Cal, 12.5% on 2000 Cal, 
3.9% on 2200 and 2.4% on 2400 Cal among all study visits. Mean Calorie intake given 
to males was 1800 Cal. Compared to 1000 Cal mean calorie diets that were given to 
females (p=0.000).  These percentages haven’t changed during the 4 years study 
period; all patients had the same calorie intake among the four visits of the study they 
were supposed to have to change their HbA1c and BMI. This was because every 
patient was given an individualized diet according to his assessment and needs to 
control diabetes and to reduce the body weight, but as the patients in every visit hadn’t 
or had slight change in BMI thus the diet program was kept the same. 
 
No significant association was found between the calorie intake in all groups (1000, 
1200, 1400, 1600, 1800, 2000, 2200, 2400 Cal) with good change in HbA1c between 
the 1st and 4th visit.    
After controlling for the confounding variables(Age , sex, employments  , marital 
satatus and smoking ) the only association found in the multivariate analysis was in the 
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subsample sample(n=255) who followed regularly for four visits within two years and 
was between the 2nd and 4th visits for patients who were given 1000 calories and 1600 
calories. Patients who were given 1000 calories have better change in HbA1c by 15 
times compared to patients who were on diets with higher amounts of calories (2400 
calories). Also patients who were on 1600 calories had better change their HbA1c by 
21 folds compared to patients on 2400 calories. (AOR=14.9(CI=1.7-130.8), 
AOR=21.3(CI= 2.1-219.7) respectively) (See table 19 in Annex 6). 
However in other studies conducted showed that sustained improvements in HbA1c at 
12 months and longer was seen among those consulting with registered dietitian that  
provided follow-up visits ranging from monthly to three sessions per year where 
HbA1c have decreased by 1-2% in type 2 diabetes (ADA, 2008).   In a meta-analysis 
to study the efficacy of low glycemic index diets in people with type 1 and type 
2diabetes, data for six trials measuring HbA1c showed a mean reduction of 0.5% for 
patients on low glycemic index diets compared to patients with higher glycemic index 
diets (Thomas et al, 2009). In a prospective randomized trial in USA, that used two 
levels of MNT on metabolic control in persons newly diagnosed with or currently 
under treatment for type 2 diabetes patients fasting plasma glucose level decreased by 
50–100 mg/dl and the HbA1c dropped by 1–2% (Franz et al, 1995).    In a study to 
determine factors associated with poor glycemic control for patients with type 2 
diabetes showed that not following eating plan as recommended by dietitians 
(OR=2.98, P≤.0005), and increased barriers to adherence scale scores were 
significantly associated with increased odds of poor glycemic control. (Khattab et al., 
2011) 
Increased food intake is part of the socialization process and is a ritual based on large 
gatherings, where meals consisting of rice (high carbohydrates) and meat (high fat) 
are shared. 
 In our study the non-significant association between the caloric intake and the good 
change in   HbA1c may be due to several reasons: 
 The patients were not followed up regularly, the HbA1c results were taken in four 
years which make the period between the follow up visit for some patients far apart 
from other. 
 Almost every patient was given the same amount of calories during his/her visits. 
 No data documented in the patient file prove that the patient was abiding to the diet 
  
 
90
 The diet given to the patients may need some modification regarding the amount of 
calories , traditional foods etc 
 No evaluation was done on the diet program along this four years period of time. 
 
 
6.5.2.2 Association between HbA1c change and Body mass index (BMI)  
 
Our study shows that the mean body mass index (BMI) in the 1st visit was 
31.3(SD±5.3) and in the 4th visit was increased to 31.9 (SD±5.3). This may reflect the 
increase of obesity in the Palestinian population as a result of urbanization, lifestyle 
shifting toward physical inactivity and increased food consumption. 
As shown in figure 6.2, between the 1st and 4th visit only 33.4% had good change in 
their BMI. The best period where the largest number of patients had good change in 
BMI was between the 3rd and 4th visit where 46.6% of the patients had good change in 
BMI.  
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Figure 6.2: change in BMI between visits 
Unlike what was expected in our study, the results of multivariate analysis revealed 
that there was no significant association between the good changes in BMI with the 
good change in HbA1c between the 1st and 4th visit.  Even in the sub sample (n=255) 
no association was found between the change in HbA1c level and the BMI among all 
study visits. Similar results were found in other studies that showed there was no 
  
 
91
significant relationship between the levels of HbA1c with BMI. (Hartz et al., 2006; 
Ismail et al, 2011; Ghazanfari et al, 2010) 
 However other studies showed the opposite. In a study after 4 years results showed 
that the participants assigned to the Mediterranean-style diet had lost more weight and 
had more improvement in some measures of glycemic control and coronary risk than 
had participants consuming the low-fat diet.  (Esposito et al, 2009). 
 In another study in which type 2 diabetic patients were treated in a behavioral weight 
control program and followed up for one year showed that weight loss was 
significantly correlated with improvements in HbA1c. Patients who lost more than 6.9 
kg or had more than 5% reduction in body weight had significant improvements in 
HbA1c values at one year (Wing, 1987). Several studies reviewed in this meta-
analysis reported a significant reduction in HbA1c of 1.0% to 2.6% with lifestyle 
intervention corresponding to weight loss (Norris et al, 2004). In the UKPDS, the 
degree of weight loss required to normalize the fasting blood glucose was 10 kg (16% 
of initial body weight) if the initial value was 6-8mmol/L versus 22 kg (35%) if the 
initial value was 12-14 mmol/L (NHS, 2008). In a randomized control trial weight 
loss of 8.5% through an intensive education and support program decreased HbA1c 
by 0.64% (Pi-Sunyer, 2007). The United Kingdom Prospective Diabetic Study also 
showed that the level of blood glucose was greatly improved in type 2 diabetic 
patients who achieved weight reduction (UKPDS, 1998). In a study that examined the 
association between the magnitude of weight loss and changes in CVD risk factors at 
1 year showed that weight loss was strongly associated with improvements in 
glycemia, blood pressure, triglycerides, and HDL cholesterol. Also when compared 
with weight-stable participants, those who lost 5 kilograms or less than 10% of their 
body weight had increased odds of achieving a 0.5% point reduction in HbA1c (Wing 
et. al, 2011).  
A possible explanation of our study result could be as Watts et al. showed in his study 
moderate weight loss may not improve glycaemic control in all obese patients who 
have diabetes because there is a possibility that patients with longstanding disease or 
severe pancreatic β-cell dysfunction are not as responsive to weight loss as those with 
less extensive disease (Watts et al, 1990). Weight loss as an intervention is very 
challenging as there are so many factors that make it difficult to achieve. Follow up 
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with the dietitian was not upon regular basis, central obesity may be a better indicator 
to be used rather than BMI. 
 
6.5.2.3 Association between HbA1c change and Physical activity 
 
The diabetes patients following up at the Diabetes Care Center were categorized 
according to the Diabetes Center definition of the physical activity to patients who 
were with very light physical activity  and those are patients who were extremely 
inactive;  patients with light physical activity and those are patients who do the 
routine daily work with  little or no physical exercise ;and patients with  moderate  
activity and those are patients who walk or exercise 150 minute per week (3 times a 
week). 
In our study 20.8% of the patients as reported by medical files were doing physical 
exercise. In the four visits included in the study the Mean HbA1c in the 1st visit was 
8.7±2.1 and in the fourth visit decreased to 8 .0 ±1.6. In multivariate analysis physical 
activity had no significant association with the good change of HbA1c between the 1st 
and fourth visit, and among all other visits in our study population.  
Other studies showed the opposite; Castaneda et al showed in her study that sixteen 
weeks of (three times per week) resulted in reduced HbA1c levels (from 8.7 to 7.6), 
and reduced the dose of prescribed diabetes medication in 72% of exercisers 
compared with the control group, P = 0.004–0.05. Control subjects showed no change 
in HbA1c, and a 42% increase in diabetes medications (Castaneda et al 2002). 
Another Meta analysis study evaluated the effect of exercise interventions (duration ≤ 
8 weeks) in adults with type 2 diabetes (11 randomized and 3 non-randomized) using 
controlled trials. The mean HbA1c post physical exercise intervention was lower in 
the exercise groups compared with the control groups (7.65% versus 8.31) (Boule et. 
al, 2001).  
The increased availability of cars, greater use of mechanized home appliances,  
widespread use of computers, televisions and electronic gaming devices has created 
an environment that encourages sedentary lifestyles , Cultural barriers and limited 
access to sporting facilities are significant factors to low physical activity levels of the 
patients. 
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A possible explanation for our study results regarding physical activity might be due 
to:  
 The patients were reporting their activity level and not evaluated by physical 
activity trainer. 
 No physical activity level or PT trainer is available in the center to evaluate 
the accurate level of the patients 
 Physical activity program is not included within the comprehensive care 
diabetes center. 
 
6.5.3 Association between HbA1c change with MAU  
 
The % of diabetic patients who had normal levels of Micro albumin urea (MAU) was 
52% at the 1st visit and after being involved in the intervention program the % of 
patients with MAU increased to 54.3%.The highest percent of patients who developed 
good change in MAU was between the 1st and 4th visit as shown in figure 6.3. 
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Figure 6.3: change in MAU between visits 
 
There was no significant association between the good change in MAU and the good 
change in HbA1c between the 1st and 4th visit.  But we find interesting results upon 
the other visits where there was a significant inverse association between MAU with 
HbA1c change between the 1st and 2nd visit   . In the multivariate analysis for the 
subsample MAU was significantly inversely associated with HbA1c between the 1st 
and 2nd visit (AOR= 0.51(CI=0.28-0.94). 
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A study found that microalbuminuria had a highly significant correlation with  HbA1c 
(p<0.05) and an early onset of microalbuminuria could be due to poor glycaemic 
control (high HbA1c >7%). (Sheikh et al., 2009)Another cross sectional study found 
that there was no statistically significant correlation between microalbuminuria and 
glycosylated hemoglobin (HbA1c).( M. Afkhami-Ardekani et al., 2008) 
 
6.5.4 Association between HbA1c change with cholesterol level 
The mean cholesterol level at the 1st visit was 207.9 mg/dl and in the 4th visit after 
undergoing the intervention program was 194.9 mg/dl. 
As shown in figure 6.4 the highest percent of patients with good change was seen 
between the 1st and 4th visit where 54.2% of the patients developed good change in 
cholesterol.  
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Figure 6.4: change in cholesterol between visits 
 
Elevated cholesterol level is known to be one of the factors associated with 
uncontrolled type 2 diabetes mellitus. Several studies had indicated significant 
relationship between control of type 2 diabetes mellitus with high cholesterol level 
(Eid et al., 2003; Coro et al., 2004; Charumathi et al., 2009). But in our study no 
association was found between changes in HbA1c and change in cholesterol level 
between the 1st and 4th results and between the other visits (p>0.05).In a study to find 
the association between glycemic control and lipid profile HbA1c exhibited direct 
correlations with cholesterol. There was a linear relationship between HbA1c and 
dyslipidemia. The levels of serum cholesterol was significantly higher among patients 
with worse glycemic control as compared to patients with good glycemic control. The 
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findings of this study clearly indicate that HbA1c is a good predictor of lipid profile. 
(Khan HA et al.,2007) 
 
6.6 Conclusion 
 
This study described, for the first time in the diabetes center, the determinants for the 
Change in HbA1c during the intervention program within year 2005-2009. Results 
from this study are comparable with other studies elsewhere; however, there is still 
scope for further improvement.  
We found that between the 1st and 4th visit 60.7% of the patients developed good 
change in HbA1c. From socio-demographic factors, we found that change in HbA1c 
between the 1st and 4th visit was affected by period being in study. Unexpectedly and 
unlike many studies, from lifestyle factors, we found no association between the 
calorie intake, BMI and physical activity with the HbA1c change between the 1st and 
4th visit where the patients were undergoing the intervention program. Regarding 
laboratory tests, an interesting finding was found between the MAU good change and 
HbA1c change between the 2nd and 1st visit and between the 2nd and 3rd visit and 
between the 1st and 3rd visit Where  AOR was less than one. No association was found 
between the 1st and 4th visit. 
 
Since the period was long and the follow – up visits were not systematic, we took a 
subsample from the study population where the visits were regular within 2 years time 
period but the results didn’t show any much difference (Annex 6), period of study was 
the only demographic factor that determined the change in HbA1c between the 1st and 
4th visit. But interestingly in the subsample we observed strong association between 
caloric intake (1000 cal and 1600 cal) with the HbA1c change between the 2nd and 4th 
visit.  
 
Results were not as we expected due to the long period of the study without regular 
follow-up and evaluation program during this period that requires an evaluation of the 
dietary program of the diabetic patients after a particular period of intervention to 
evaluate the effectiveness of the education they received concerning dietary therapy 
and to determine the extent of the patients compliance. Detailed data about some 
aspects of patient management at baseline were not available in this study. Such as 
changes in drug management and compliance of patients with the treatment protocol, 
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could account for the improvements in HbA1c levels and likely influence glycaemic 
control 
 
But still this study demonstrates that there is encouraging progress in the diabetes care 
reflected by the overall improvement in the mean of HbA1c, MAU, cholesterol and 
even the slight increment in the number of people reaching the target of HbA1c 
control. However, the results have shown that there is scope for further improvement, 
especially for a better glycaemia control. Findings from this study can help healthcare 
professionals, policy-makers and planners in the Diabetes Care Center at AVH in 
comparing performance and planning for quality improvement initiatives within the 
program. Results showed the problems in the system of follow up and appointment of 
the patients in the center, this will help the team of the center to look up for the 
reasons of the irregular period between visits for many patients which is supposed to 
be 3 months and to communicate with patients to find better solutions. Also to 
increase the number of visits of the patients to the center to participate in individual 
and group sessions and, this was shown to be effective and caused good change in 
HbA1c levels. 
 Regarding the dietary program, there was no enough data about the adherence of 
patients to the healthy diet given by the dietitians of the center, the diet was changed 
annually for the patients and nearly all patients had the same diet and calorie content 
throughout the four years period of study, interviews with patients must be done 
regularly to assess their needs, follow up and compliance with the diet program,  this 
need new modifications and intervention strategies.    
 
6.7 Recommendations: 
 
Recommendations for the Diabetes Center team at Augusta Victoria: 
 
 Continuous monitoring and evaluating the diabetes care provided are highly 
recommended to tackle any variance in care to improve and promote the 
quality of diabetes.  
 There is a need for regular follow- up on patients treated in the center. This 
could be achieved by, using different methods of telecommunication , home 
visits, mobile clinic. 
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 Division of patients to two groups, a group of controlled patients (HbA1c≤7) 
and another group of uncontrolled groups (HbA1c>7). Uncontrolled patients 
should undergo intensive diabetes intervention program with more frequent 
visits, intensive education, frequent individual dietary counseling and 
examining for detection of early complications. 
 Use  new strategies in the dietary program that include involving of the 
patients in education through peer discussions, practical implementation such 
as cooking healthy food , carbohydrate counting and sharing healthy recipes. 
  Survey patient satisfactions on services provided, and work to improve 
quality of care accordingly. 
 Assign one of the members of the team to act as a quality officer during the 
clinic day to check the files of the patients and assure that patients have been 
examined by doctor, dietitian and specialized nurses upon the protocol of the 
center and that all needed information is documented in the file and 
appointment given for next visit. 
 Establish total quality system that continuously work to improve quality and 
safety of care provided at the center through computerized system. 
 Team discussion by the end of each clinic to discuss cases of patients and 
prepare plans for the next time visit to improve their health conditions. 
 Capacity building for the team working in the AVH Diabetes Center through 
conferences, training programs and motivation of self-learning,  skills in 
research writing and data collection , analysis and interpretation.  
  Add detailed data items collected in the patient file  about some aspects of 
patient financial issues, self-management, medication and compliance this 
would be useful in future studies. 
 Compare the current AVH nutrition program with similar other national, 
regional and international programs. 
 To modify patients' files to include more information regarding patients' 
socioeconomic status and health condition such as  complications , method of 
follow up , date of diagnosis of complications, etc…repeated up, also merge  
 Conduct analysis and encourage studies using  the huge database available in 
the  Centre.   
 Introduce attractive diabetes health education methods  such as audio-visual 
aids , leaflets , role plays  
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Recommendations for health care providers in Palestine 
 
 Link clinical practice and data with academic institutions for more evidence 
based interventions and scientific researches 
 Integrate diabetes guidelines into existing local public health and related 
programs, including emphasis on treatment and follow up the diabetes 
complications for patients with previous adverse outcomes. 
 Maximize public health surveillance and related research mechanisms to 
monitor improvements and weakness of the diabetes programs at national 
level 
 Enhance collaboration between the various health care providers to set up a 
unified national care Strategy for Type two diabetes mellitus 
 National information system to track diabetic and chronic patients   
 To have a national advocacy for applying the diabetes guidelines by all health 
care providers, in particular by those working in the private sector. 
 To have an action plan for having a well-trained specialized teams (doctors, 
nurses, dietitians etc.) in diabetes care. 
 To conduct training sessions for all health care provider staff on diabetes 
management guidelines. 
 To introduce the necessary lab tests, such as: LDL, HDL, urine for 
microalbumin and HbA1c test as the main lab tests to be done for every 
diabetic patient upon protocol. 
 To set up national monitoring and surveillance plans for the "proper" diabetes 
management. 
 To increase awareness programs amongst patients about HbA1c (value and 
utility), thereby empowering them to take appropriate action when their 
diabetes is poorly controlled. 
 To work with people with Type 2 diabetes to bridge the information gap to 
eliminate misunderstanding and improve patient outcomes. 
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Recommendations for patients with type 2 diabetes: 
 To engage with the health professionals directly, informing them of their 
status and empowering them to choose to control their diabetes and providing 
practical, realistic vehicles to achieve this. 
 To form a special society for diabetes patients, to gather, meet, cook healthy 
food, do physical activity to discuss their conditions, needs, share experiences 
 There is clearly a need for patients to have their diabetes reviewed regularly, 
and if current treatments provide inadequate control they should explore more 
effective disease management options with their healthcare professional 
 To cooperate with the health care professionals , to follow the medical advices  
adhere to healthy lifestyle 
 To share with health providers experiences and provide practical intervention 
strategies which enable them to change behavior – for example, weight loss. 
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Annex: 
Annex (1): Diabetes Care Center File 
Summary sheet 
Date B.P Wt. HbA1c MAU Choles. Hypo. Medical  Requirements 
Sig. 
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Identification Data:                               Date: ........... / ........... / ................  
- File Number: ...............................                          Interview done by:................................... 
- Hospital Number: .................................                ID. #:........................................................... 
      -     Patient Name:................................................ Preferred name:.................       Sex:.................  
- Place of birth: ...........................  Date of birth:.........................   Residency...............................    
- District:........................ Telephone number: ........................ Fax #:............................................ 
- Insurance:  (1 no  (2 yes    Type of insurance:............................. Number: ...................................... 
- Marital status:.................................................................... Age of spouse:.......................... 
===================== Subjective Data:=================== 
Patient Education: ...................................................                  Current work: 1) yes 2) no 3) retired. 
Type of work:............................................................                 Years at the last work:........................... 
Social support system: 1) live alone      2) within a family      3) others; specify.......................... 
If live within a family then:             
Total number of family members living with patient in the same house:....................................... 
Family member who mostly takes care of the patient:.............................................................. 
Patient relation to family:.............................. 
Educational background of family members: 
Husband: 1)..............................................................................2) NA 
Wife: 1).....................................................................................2) NA (mention if more than one wife). 
Sons: ..................................................................................................(mention all living with patient). 
Daughters:.........................................................................................(mention all living with patient). 
Others:..........................................................................specify:................................................................... 
Any family member has: 
- Diabetes: 1) No  2) Yes           If yes: Type of diabetes:…......………Relation to patient:...............….. 
- Hypertension:    1) No   2) Yes      Relation to patient:.................................................................. 
- Cardiovascular: 1) No   2) Yes    Relation to patient:........……………Specify the disease:……… 
- Renal failure    1) No   2) Yes        Relation to patient:……………………...…………........................ 
- Others:            1) No   2) Yes Specify:…………………......……………………………...................... 
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Patient health information: 
Type of diabetes: …………............…  Date of diagnosis: .....................   Diagnosed by:………...….. 
In your opinion, main causes of your diabetes are:……………………….....................................……. 
Treatment based on: 1) Diet only                  2) Oral preparations            3) Insulin      
4) Oral preparations and insulin together.                5) Others:................................. 
If patient on insulin, who is giving the injection:…………………….............................……..... 
Any teaching done regarding the injection of insulin:……………......................................……… 
If patient on diet: diet regime prescribed by:………………………………………….............................. 
Do you follow the prescribed diet:…………………………………………………….............................. 
Beside your normal daily activities, do you exercise regularly:……………………….......................... 
       If yes: Type of exercise:……….................………...Frequency and Duration:……............... 
Have there been changes in your weight in the past:...................……… 
       If yes: Increased…...........................…Kgs,                      or                           Decreased .......…Kgs. 
Have there been changes in your weight recently: ...................……… 
       If yes: Increased…...........................…Kgs,                      or                        Decreased …….…Kgs. 
Do you smoke: 1) Yes          2) No             3) Past smoker. 
      If yes, kind of smoking:  1) Cigarettes    2) Nargila     3) Both  
      Number of packets:……………… # of years being smoking:………............…............................ 
     If past smoker, years smoked:….............................................………………………… 
Do you have allergy to:  Food: 1) No     2) Yes if yes what types of food:………………................ 
                                        Medication: 1) No 2) Yes, Type of medications:………………........................ 
                                        Others specify.................................................................................................. 
Any kind of food not preferred: 1) No  2) Yes.    Type of food:……............................……………… 
Do you have Hypertension: ……………........…....,     Since .................................................................. 
Do you have Heart Problems: ……....…, Type:…………………………………..…..   Since:……… 
Do you ever had a Stroke: ……………, How many times:………………………...    When:…….… 
Do you have Peripheral Neuropathy:……………………………………………..… Since:………..  
Do you have Feet Problems: ………., Type:………………………………………….Since………… 
Do you have Kidney Problems:..........,  Type......................………………………… Since:……….     
Do You have Eye Problems:………., Type:………………………………………… Since………… 
Do you have increased Cholesterol: 1) Yes 2) No    3) Unknown,                   if yes,   Since:……….. 
Other Related Complications: 1) Yes 2) No  Type, and Year Diagnosed................................................ 
Other health problems: 1) Yes 2) No     Specify...................................................years........................... 
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Previous admissions to the hospital after diagnosed with diabetes........................................................ 
How many times:…………           Reasons for admission: .………................ 
Outcome of that admission: ......………..... 
Any operations done after diagnosed with diabetes ……….................................................................. 
Type of operation:……................................................…year…….......................................................…. 
For women: History of Gestational Diabetes (if any):……….......................................…………… 
venue for health education do you prefer?    
  1) Individual education                     2) Group education with other patients   
  3) Education within family context  4) Others, Specify…............................................ 
Additional comments from patients regarding his/her condition......................................................... 
........................................................................................................................................................……… 
====================Objective Data: ================================== 
Patient weight:...…........... Kgs,       Height:…........…cm,     BMI:….........….,         WHR:..............…  
Wrist Circumference:.............        Frame Size:…......…       IBW:…....….Kgs.       Kcal:................. 
Baseline vital signs: BP:……….............mmHg       Pulse:…..............bpm. 
Visual Acuity: Rt eye:…............…………… corrected:……………........... corrected by:….................. 
 Lt eye:……………............…corrected:…........…………….corrected by:….......................……. 
Last blood sugar result (F  R  PP)…................………………..mg/dl 
Dental problems:….............…………Specify:……………………….…year............................. 
Hearing problems:……..................... Specify:……………….................... year..…..................………. 
Foot inspection: Findings: Color: (Rt.........Lt................), Skin integrity (Rt..................Lt.....................) 
Ulcers: (Rt...............Lt.....................), Pulses (Rt...............Lt.....................), Others:.............................. 
 
Baseline Laboratory Investigations: 
Glucose: (F  R  PP)..............…mg/dl       HbA1c:…………%    Microalbuminuria:(Ratio)…...........… 
Total Cholesterol……………..    Triglycerides……………   LDL…...............          HDL................. 
Creatinin ................................. Urea …………………… 
U.A:  (Glucose...........................      Ketone...................        Protein................) 
Others………………………………………………......................................................…......................... 
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   Medications taken by the patient: 
 Medication Dose Route Frequency Start date Prescribed by 
1       
2       
3       
4       
5       
6       
7       
 
Follow‐up Sheet 
. 
 Date  BMI  T.Calories 
Given 
Activity 
Level 
Dilated eye 
exam 
Feet 
Exam 
Labs required and Results 
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  ﺳﻌﺮ ﺣﺮاري 0081
 وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻟﻌﺸﺎء وﺟﺒﺔ ﺧﻔﻴﻔﺔ  اﻟﻐﺬاء وﺟﺒﺔ ﺧﻔﻴﻔﺔ  اﻟﻔﻄﻮر
 رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ +    
ﻣﻠﻌﻘﺘﻴﻦ ﻟﺒﻨﺔ ﺻﻐﻴﺮة + ﻣﻠﻌﻘﺔ 
 زﻳﺖ ﺻﻐﻴﺮة+ ﺧﻀﺎر
ﺣﺒﺔ ﺧﻀﺎر  2
  ﺣﺒﺔ ﻓﻮاآﻪ+ 
ﻏﻢ ﺳﻤﻚ ﻣﺸﻮي +  021  
 2ﺻﺤﻦ ﺳﻠﻄﺔ ﺧﻀﺎر +
  2ﺣﺒﺔ ﺧﻀﺎر ﻣﺸﻮﻳﺔ +
 ﺣﺒﺔ ﺑﻄﺎﻃﺎ ﻣﺸﻮﻳﺔ
ﺣﺒﺔ ﺧﻀﺎر +ﺣﺒﺔ 
 ﻓﺎآﻬﺔ
 2+   رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ
ﻣﻠﻌﻘﺔ ﺣﻤﺺ ﺻﻐﻴﺮة + 
 ﺣﺒﺔ ﺧﻀﺎر
ﺣﺒﺔ  +ﺣﺒﺔ ﻓﻮاآﻪ 
آﺄس   + ﺧﻀﺎر
  ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ + ﺑﻴﻀﺔ 
 2ﻣﺴﻠﻮﻗﺔ +ﺣﺒﺔ ﺧﻀﺎر+ 
 ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ 
ﺣﺒﺔ ﻓﻮاآﻪ + 
 ﺣﺒﺔ ﺧﻀﺎر
آﺄس ﻣﺠﺪرة ﺑﺮﻏﻞ+ ﺳﻄﺔ 
 7آﺄس ﻟﺒﻦ +  + ½ 
 ﺣﺒﺎت زﻳﺘﻮن 
ﺣﺒﺔ ﻓﺎآﻬﺔ+ ﺣﺒﺔ  
 ﺧﻀﺎر
 2رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ +
ﻗﻠﻴﻠﺔ ﻣﻠﻌﻘﺔ ﺻﻐﻴﺮة ﻟﺒﻨﺔ 
اﻟﺪﺳﻢ+ ﻣﻠﻌﻘﺔ زﻳﺖ 
 ﺻﻐﻴﺮة+ ﺑﻨﺪورة 
ﺣﺒﺔ ﻓﺎآﻬﺔ  + آﺄس 
 ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ  
 رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ +ﻗﻄﻌﺔ 
ﺟﺒﻨﺔ ﺑﻴﻀﺎء ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ و 
ﻏﻴﺮ ﻣﺎﻟﺤﺔ + ﺧﻀﺎر + 
 آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ
ﺣﺒﺔ  2
ﺧﻀﺎر+ ﺣﺒﺔ 
 ﻓﺎآﻬﺔ
آﺄس ﻓﺮﻳﻜﺔ ﻣﻄﺒﻮخ+ آﺄس 
ﺳﻠﻄﺔ+ ﺻﺪر دﺟﺎج  ﺑﺪون 
 آﺄس ﻟﺒﻦ½ ﺟﻠﺪﻩ + 
  ﺣﺒﺔ ﻓﺎآﻬﺔ
 ﺘﻴﻦ ﻣﻜﺴﺮات+ ﻣﻠﻌﻘ
ﻣﻠﻌﻘﺘﻴﻦ ﺻﻐﻴﺮة ﺣﻤﺺ  
+ ﻣﻌﻠﻘﺔ زﻳﺖ زﻳﺘﻮن + 
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ 
 +ﺣﺒﺔ ﺧﻀﺎر 
ﺣﺒﺔ  2ﺣﺒﺔ ﻓﺎآﻬﺔ+ 
 ﺧﻀﺎر
  ﻣﻠﻌﻘﺘﻴﻦ ﺣﻤﺺ +
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ +    
  ﺧﻀﺎر
ﺧﻀﺎر +   
  ﺣﺒﺔ ﻓﻮاآﻪ+ 
آﺄس ﺧﻀﺎر ﻣﻄﺒﻮﺧﺔ + 
ﻗﻄﻌﺔ ﺻﻐﻴﺮة ﻟﺤﻤﺔ ﻋﺠﻞ 
ﺑﺪون دهﻮن + آﺄس أرز 
  ﻣﻄﺒﻮخ + ﺳﻠﻄﺔ
ﺣﺒﺔ ﻓﻮاآﻪ + ﺣﺒﺔ 
  ﻓﻮاآﻪ
 2ﺒﺰ أﺳﻤﺮ+ رﻏﻴﻒ ﺧ
  ﺧﻀﺎر + ﻟﺒﻨﺔ
آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ 
  ﺣﺒﺔ ﻓﻮاآﻪ +اﻟﺪﺳﻢ 
 
½ آﺄس ﺑﺮﻏﻞ ﻣﺴﻠﻮق، أو ½ آﺎس أرز ﻣﺴﻠﻮق، أو ½ ﺷﻄﻴﺮة هﻤﺒﺮﻏﺮ، أو ½  رﻏﻴﻒ ﺧﺒﺰ، أو :¼ ﺑﺪاﺋﻞ اﻟﺨﺒﺰ
  آﺄس آﻮرن ﻓﻠﻴﻜﺲ ﻗﻤﺢ½ آﺄس ﻣﻌﻜﺮوﻧﺔ ﻣﺴﻠﻮﻗﺔ، أو ﺣﺒﺔ ﺑﻄﺎﻃﺎ ﻣﺴﻠﻮﻗﺔ ﻣﺘﻮﺳﻄﺔ اﻟﺤﺠﻢ، ½ آﺄس ذرة، أو 
ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ، أو ﻗﻄﻌﺔ ﺟﺒﻨﺔ ﺑﻴﻀﺎء  2ﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو آﺄس ﻟﺒﻦ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو : آﺄس ﺣﻠﺑﺪاﺋﻞ اﻟﺤﻠﻴﺐ
  ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ
( ﺣﺒﺔ  2-1(ﺣﺒﺔ ﻣﺸﻤﺶ، أو ) 3-2ﺣﺒﺎت ﻋﻨﺐ، أو ) 51 – 01ﻣﻮزة آﺒﻴﺮة، أو ﺣﺒﺔ ﺗﻔﺎح، أو : ½ ﺑﺪاﺋﻞ اﻟﻔﺎآﻬﺔ
( ﺣﺒﺔ آﻴﻮي، أو ﺣﺒﺔ 2-1ﺔ، أو) ﺟﺮﻳﺐ ﻓﺮوت، أو ﺣﺒﺔ أﺟﺎص ﺻﻐﻴﺮة، ﺣﺒﺔ ﺟﻮاﻓ½ ﺗﻴﻦ، ﺣﺒﺔ ﺗﻴﻦ ﻣﺠﻔﻒ، أو 
ﺣﺒﺔ ﺻﺒﺮ ﺻﻐﻴﺮة، أو آﺄس ﺷﺮاﺋﺢ ﺑﻄﻴﺦ، آﺄس ﺷﺮاﺋﺢ  2ﺣﺒﺔ ﻣﺎﻧﻐﺎ، ½  -¼ ﺑﺮﺗﻘﺎل، أو ﺣﺒﺔ ﺧﻮخ ﺻﻐﻴﺮة، أو 
 4ﺣﺒﺔ ﺗﻤﺮ،  2ﺣﺒﺔ أﻧﺎﻧﺎس أو ﻗﻄﻌﺔ ﺻﻐﻴﺮة أﻧﺎﻧﺎس ﻣﺠﻔﻒ، آﺄس ﺗﻮت أرﺿﻲ، ¼ ﺷﻤﺎم ، أو ﺣﺒﺘﻴﻦ ﺑﺮﻗﻮق، 
  آﺄس ﻋﺼﻴﺮ ﻃﺒﻴﻌﻲ½  ﺣﺒﺔ ﺑﻮﻣﻠﺔ ﺻﻐﻴﺮة، أو ½ ﻌﻘﺔ زﺑﻴﺐ، ﺣﺒﺔ آﻠﻤﻨﺘﻴﻨﺎ، ﻣﻠ 2ﺣﺒﺔ رﻣﺎن، ½  ﺣﺒﺎت اﺳﻜﺪﻧﻴﺎ، 
آﺄس ½  أو ﺣﺒﺔ ﺧﻀﺎر) ﺣﺒﺔ ﺧﻴﺎر، ﺣﺒﺔ ﻓﻠﻔﻞ، ﺣﺒﺔ ﺑﻨﺪورة،..( ،: آﺄس ﺧﻀﺎر ﻃﺎزج )آﺄس ﺳﻠﻄﺔ(ﺑﺪاﺋﻞ اﻟﺨﻀﺎر
آﺄس ﻋﺼﻴﺮ ﺧﻀﺎر )ﻋﺼﻴﺮ ﺟﺰر، ﻋﺼﻴﺮ ½ ، أو ﺧﻀﺎر ﻣﻄﺒﻮﺧﺔ )آﻮﺳﺎ، ﺳﺒﺎﻧﺦ، ﻣﻠﻮﺧﻴﺔ، ﻣﻠﻔﻮف، ﺑﺎذﻧﺠﺎن...(
  ﺑﻨﺪورة،....(
آﺄس ﻣﻄﺒﻮخ ﻣﻦ اﻟﺒﻘﻮﻟﻴﺎت )ﺣﻤﺺ، ½  ﻏﻢ ﻣﻦ اﻟﻠﺤﻮم، دﺟﺎج، ﺳﻤﻚ، أو  09-06: ﻗﻄﻌﺔ ﺻﻐﻴﺮة ﺤﻤﺔﺑﺪاﺋﻞ اﻟﻠ
 2ﻣﻠﻌﻘﺔ ﺻﻐﻴﺮة ﻣﻦ زﺑﺪة اﻟﻔﻮل اﻟﺴﻮداﻧﻲ، أو ﺑﻴﻀﺔ واﺣﺪة،  2ﻣﻠﻌﻘﺔ آﺒﻴﺮة ﻣﻜﺴﺮات، أو  2ﻓﻮل، ﻋﺪس(، أو 
  ﻏﻢ ﻃﻦ 09-06ﻗﻄﻌﺔ ﺣﺒﺶ،  2ﻣﻠﻌﻘﺔ ﺣﻤﺺ آﺒﻴﺮة، 
ﺎد اﻟﺸﻤﺲ، زﻳﺖ ﺳﻤﺴﻢ ﺻﻐﻴﺮة(، ﻣﻠﻌﻘﺔ ﻃﺤﻴﻨﺔ ﺻﻐﻴﺮة، ﻣﻠﻌﻘﺔ : ﻣﻠﻌﻘﺔ زﻳﺖ )زﻳﺘﻮن، ذرة، ﻋﺒﺑﺪاﺋﻞ اﻟﺪهﻮن
  ﺣﺒﺎت زﻳﺘﻮن 01-5ﻣﺮﺟﺮﻳﻦ ﺻﻐﻴﺮة،
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 وﺟﺒﺔ ﺧﻔﻴﻔﺔ ﻋﺸﺎء وﺟﺒﺔ ﺧﻔﻴﻔﺔ ﻏﺬاء وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻹﻓﻄﺎر
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ +   
+ ﺧﻀﺎر + ﻟﺒﻨﺔ  و 
 زﻳﺖ زﻳﺘﻮن
  ﺣﺒﺔ ﻓﺎآﻬﺔ+ ﺧﻀﺎر+
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ ½ 
 ﻣﻊ ﻟﺒﻨﺔ 
آﺄس ﻓﺮﻳﻜﺔ ﻣﻄﺒﻮﺧﺔ ﺑﺪون  
+ آﺄس ﺳﻠﻄﺔ ﺧﻀﺎر  دهﻮن  
ﻃﺎزﺟﺔ + ﺻﺪر دﺟﺎج ﻣﺸﻮي 
 ﺑﺪون ﺟﻠﺪة
ﺣﺒﺔ ﻓﺎآﻬﺔ + ﻣﻠﻌﻘﺘﻴﻦ 
ﺣﺒﺔ  2ﻣﻜﺴﺮات + 
  ﺧﻀﺎر
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ +  
زﻳﺖ و زﻋﺘﺮ + ﺣﺒﺔ 
 ﺧﻀﺎر
آﺄس ﺣﻠﻴﺐ+ 
ﺣﺒﺔ ﻓﻮاآﻪ+ 
 ﺧﻀﺎر
آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ+ 
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ + 
 ﺧﻀﺎر + زﻳﺖ و زﻋﺘﺮ
ﺣﺒﺔ ﻓﺎآﻬﺔ + آﺄس 
رﻏﻴﻒ ½ ﺳﻠﻄﺔ + 
 ﺶﺧﺒﺰ + ﻣﺮﺗﺪﻳﻼ ﺣﺒ
آﺄس ﻟﺒﻦ ﻗﻠﻴﻞ اﻟﺪﺳﻢ +آﺄس 
ﺑﺮﻏﻞ او أرز ﺑﻨﻲ  ﻣﻄﺒﻮخ + 
آﺄس ﻳﺨﻨﻲ ﺧﻀﺎر ﻣﻄﺒﻮﺧﺔ+ 
 ﻟﺤﻤﺔ ﻋﺠﻞ ﺑﺪون دهﻮن
  رﻏﻴﻒ ﺧﺒﺰ+   ﺧﻀﺎر 2ﺣﺒﺔ ﻓﻮاآﻪ + 
ﻣﻠﻌﻘﺔ ﺣﻤﺺ  2
ﺻﻐﻴﺮة+ﺣﺒﺔ 
 ﺧﻀﺎر+ ﺣﺒﺔ ﻓﺎآﻬﺔ
آﺄس ﺣﻠﻴﺐ+ 
ﺣﺒﺔ ﻓﻮاآﻪ+ 
 ﺧﻀﺎر
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ+ 
ﻗﻄﻌﺔ ﺟﺒﻨﺔ ﺑﻴﻀﺎء ﻗﻠﻴﻠﺔ 
اﻟﺪﺳﻢ ﻏﻴﺮ ﻣﺎﻟﺤﺔ+ 
  ﺧﻀﺎر
+ ﺣﺒﺔ ﺣﺒﺔ ﺧﻀﺎر 
رﻏﻴﻒ ½ ﻓﺎآﻬﺔ + 
  ﺧﺒﺰ + ﺟﺒﻨﺔ ﺑﻴﻀﺎء
 ﻗﻄﻌﺔآﺄس ﺧﻀﺎر ﻣﻄﺒﻮﺧﺔ+ 
ﺣﺒﺔ ﺑﻄﺎﻃﺎ   2ﺳﻤﻚ ﻣﺸﻮي +
  ﻣﺸﻮﻳﺔ 
  رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ+ ﺧﻀﺎر 2ﺣﺒﺔ ﻓﺎآﻬﺔ + 
ﺑﻴﻀﺔ ﻣﺴﻠﻮﻗﺔ + ﺣﺒﺔ 
  ﺧﻀﺎر 
آﺄس ﺣﻠﻴﺐ+ 
ﺣﺒﺔ ﻓﻮاآﻪ+ 
 ﺧﻀﺎر
  
½ ﻠﻮق، أو آﺄس ﺑﺮﻏﻞ ﻣﺴ½ آﺎس أرز ﻣﺴﻠﻮق، أو ½ ﺷﻄﻴﺮة هﻤﺒﺮﻏﺮ، أو ½  رﻏﻴﻒ ﺧﺒﺰ، أو :¼ ﺑﺪاﺋﻞ اﻟﺨﺒﺰ
  آﺄس آﻮرن ﻓﻠﻴﻜﺲ ﻗﻤﺢ½ آﺄس ﻣﻌﻜﺮوﻧﺔ ﻣﺴﻠﻮﻗﺔ، أو ﺣﺒﺔ ﺑﻄﺎﻃﺎ ﻣﺴﻠﻮﻗﺔ ﻣﺘﻮﺳﻄﺔ اﻟﺤﺠﻢ، ½ آﺄس ذرة،       أو 
ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ، أو ﻗﻄﻌﺔ ﺟﺒﻨﺔ ﺑﻴﻀﺎء  2: آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو آﺄس ﻟﺒﻦ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو ﺑﺪاﺋﻞ اﻟﺤﻠﻴﺐ
  ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ
( ﺣﺒﺔ ﺗﻴﻦ،  2-1(ﺣﺒﺔ ﻣﺸﻤﺶ، أو ) 3-2ﺣﺒﺎت ﻋﻨﺐ، أو ) 01ﺒﺔ ﺗﻔﺎح، أو ﻣﻮزة آﺒﻴﺮة، أو ﺣ: ½ ﺑﺪاﺋﻞ اﻟﻔﺎآﻬﺔ
( ﺣﺒﺔ آﻴﻮي، أو ﺣﺒﺔ ﺑﺮﺗﻘﺎل، 2-1ﺟﺮﻳﺐ ﻓﺮوت، أو ﺣﺒﺔ أﺟﺎص ﺻﻐﻴﺮة، ﺣﺒﺔ ﺟﻮاﻓﺔ، أو) ½ ﺣﺒﺔ ﺗﻴﻦ ﻣﺠﻔﻒ، أو 
ﺣﺒﺔ ﺻﺒﺮ ﺻﻐﻴﺮة، أو آﺄس ﺷﺮاﺋﺢ ﺑﻄﻴﺦ، آﺄس ﺷﺮاﺋﺢ ﺷﻤﺎم ،  2ﺣﺒﺔ ﻣﺎﻧﻐﺎ،  2/1– 4/1أو ﺣﺒﺔ ﺧﻮخ ﺻﻐﻴﺮة، أو
ﺣﺒﺎت  4ﺣﺒﺔ ﺗﻤﺮ،  2ﺣﺒﺔ أﻧﺎﻧﺎس أو ﻗﻄﻌﺔ ﺻﻐﻴﺮة أﻧﺎﻧﺎس ﻣﺠﻔﻒ، آﺄس ﺗﻮت أرﺿﻲ، ¼ ﻴﻦ ﺑﺮﻗﻮق، أو ﺣﺒﺘ
آﺄس ﻋﺼﻴﺮ ½  ﺣﺒﺔ ﺑﻮﻣﻠﺔ ﺻﻐﻴﺮة، أو ½ ﺣﺒﺔ آﻠﻤﻨﺘﻴﻨﺎ، ﻣﻠﻌﻘﺔ زﺑﻴﺐ،  2ﺣﺒﺔ رﻣﺎن،  2/1ﺣﺒﺎت ﻟﻮز، 3اﺳﻜﺪﻧﻴﺎ، 
  ﻃﺒﻴﻌﻲ
آﺄس ½  ﺣﺒﺔ ﺑﻨﺪورة،..( أو ﺣﺒﺔ ﺧﻀﺎر) ﺣﺒﺔ ﺧﻴﺎر، ﺣﺒﺔ ﻓﻠﻔﻞ، ،: آﺄس ﺧﻀﺎر ﻃﺎزج )آﺄس ﺳﻠﻄﺔ(ﺑﺪاﺋﻞ اﻟﺨﻀﺎر
آﺄس ﻋﺼﻴﺮ ﺧﻀﺎر )ﻋﺼﻴﺮ ﺟﺰر، ﻋﺼﻴﺮ ½ ، أو ﺧﻀﺎر ﻣﻄﺒﻮﺧﺔ )آﻮﺳﺎ، ﺳﺒﺎﻧﺦ، ﻣﻠﻮﺧﻴﺔ، ﻣﻠﻔﻮف، ﺑﺎذﻧﺠﺎن...(
  ﺑﻨﺪورة،....(
آﺄس ﻣﻄﺒﻮخ ﻣﻦ اﻟﺒﻘﻮﻟﻴﺎت )ﺣﻤﺺ، ½  ﻗﻄﻌﺔ ﺻﻐﻴﺮة ﻏﻢ ﻣﻦ اﻟﻠﺤﻮم، دﺟﺎج، ﺳﻤﻚ، أو   09-06: ﺑﺪاﺋﻞ اﻟﻠﺤﻤﺔ
 2ﻣﻠﻌﻘﺔ ﺻﻐﻴﺮة ﻣﻦ زﺑﺪة اﻟﻔﻮل اﻟﺴﻮداﻧﻲ، أو ﺑﻴﻀﺔ واﺣﺪة،  2ﻣﻠﻌﻘﺔ آﺒﻴﺮة ﻣﻜﺴﺮات، أو  2ﻓﻮل، ﻋﺪس(، أو 
  ﻏﻢ ﻃﻦ 06ﻗﻄﻌﺔ ﺣﺒﺶ،  2ﻣﻠﻌﻘﺔ ﺣﻤﺺ آﺒﻴﺮة، 
: ﻣﻠﻌﻘﺔ زﻳﺖ )زﻳﺘﻮن، ذرة، ﻋﺒﺎد اﻟﺸﻤﺲ، زﻳﺖ ﺳﻤﺴﻢ ﺻﻐﻴﺮة(، ﻣﻠﻌﻘﺔ ﻃﺤﻴﻨﺔ ﺻﻐﻴﺮة، ﻣﻠﻌﻘﺔ ﺑﺪاﺋﻞ اﻟﺪهﻮن
  ﻣﺮﺟﺮﻳﻦ ﺻﻐﻴﺮة
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 وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻟﻌﺸﺎءوﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻟﻐﺬاء وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻟﻔﻄﻮر
آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ 
رﻏﻴﻒ +½ اﻟﺪﺳﻢ 
ﺧﺒﺰ أﺳﻤﺮ + 
ﻟﺒﻨﺔ+ ﻣﻠﻌﻘﺔ زﻳﺖ 
زﻳﺘﻮن + ﺣﺒﺔ 
 ﺧﻀﺎر
ﺣﺒﺔ ﺧﻀﺎر+ ﺣﺒﺔ  
 ﻓﺎآﻬﺔ
أرز ﻣﻄﺒﻮخ  أوآﺄس ﻓﺮﻳﻜﺔ  
ﺻﺪر ½ + ﺻﺤﻦ ﺳﻠﻄﺔ+ 
ﻟﺤﻤﺔ ﻋﺠﻞ  اودﺟﺎج ﻣﺸﻮي 
ﺑﺪون دهﻮن + آﺄس ﻳﺨﻨﻲ 
 ﺧﻀﺎر ﻣﻄﺒﻮخ
+  آﺄس ﻟﺒﻦ
  ﺣﺒﺔ ﻓﻮاآﻪ 
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ + ½  
 ﻀﺎرزﻳﺖ و زﻋﺘﺮ + ﺧ
ﺣﺒﺔ ﻓﺎآﻬﺔ + 
 ﺣﺒﺔ ﺧﻀﺎر 
آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ 
رﻏﻴﻒ +½ اﻟﺪﺳﻢ  
ﺧﺒﺰ أﺳﻤﺮ + 
ﺑﻴﻀﺔ 
 ﻣﺴﻠﻮﻗﺔ+ﺧﻀﺎر
ﺣﺒﺔ ﺧﻀﺎر + ﺣﺒﺔ 
 ﻓﺎآﻬﺔ
آﺄس ﻣﺠﺪرة ﺑﺮﻏﻞ + ﺳﻠﻄﺔ 
 ﺧﻀﺎر + آﺄس ﻟﺒﻦ
ﺣﺒﺔ ﻓﻮاآﻪ  
  +
 ﺣﺒﺔ ﺧﻀﺎر 
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ + ½  
ﻗﻄﻌﺔ ﺟﺒﻨﺔ ﺑﻴﻀﺎء ﻗﻠﻴﻠﺔ 
 اﻟﻤﻠﺢ + ﺣﺒﺔ ﺧﻀﺎر
ﺣﺒﺔ ﻓﺎآﻬﺔ + 
 ﺣﺒﺔ ﺧﻀﺎر
 رﻏﻴﻒ ﺧﺒﺰ½  
أﺳﻤﺮ + ﻟﺒﻨﺔ و 
زﻳﺖ زﻳﺘﻮن + 
 ﺧﻀﺎر
  ﺣﺒﺔ ﻓﻮاآﻪ +
  ﺣﺒﺔ ﺧﻀﺎر 2
ﺧﻀﺎر  2ﺳﻤﻚ ﻣﺸﻮي +  
ﺣﺒﺔ ﺑﻄﺎﻃﺎ  2ﻣﺸﻮﻳﺔ + 
ﺻﻌﻴﺮة ﻣﺸﻮﻳﺔ + ﺳﻠﻄﺔ 
 ﺧﻀﺎر
ﺣﺒﺔ ﻓﻮاآﻪ 
+ ﺣﺒﺔ 
  ﺧﻀﺎر
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ + ½  
 ﻣﻠﻌﻘﺔ ﺣﻤﺺ  + ﺧﻀﺎر
ﺣﺒﺔ  ﻓﻮاآﻪ + 
آﺄس ﺣﻠﻴﺐ 
 ﻗﻠﻴﻞ اﻟﺪﺳﻢ 
  ﺑﻨﻔﺲ اﻟﻜﻤﻴﺔ اﻟﺘﻲ ﺗﻌﺎدﻟﻬﺎ ﻣﻦ اﻟﺒﺪاﺋﻞ:ﻳﻤﻜﻦ اﺳﺘﺒﺪال اﻻﻏﺬﻳﺔ ﺑﺄﺧﺮى ﻣﻦ ﻧﻔﺲ اﻟﻤﺠﻤﻮﻋﺔ و 
آﺎس أرز ½ آﺄس آﻮرن ﻓﻠﻴﻜﺲ ﻗﻤﺢ أو ﻗﻄﻌﺔ ﻗﺮﺷﻠﺔ، أو ½ رﻏﻴﻒ ﺧﺒﺰ، أو ﺷﺮﺣﺔ ﺗﻮﺳﺖ، أو :¼ ﺑﺪاﺋﻞ اﻟﺨﺒﺰ
آﺄس ﻣﻌﻜﺮوﻧﺔ ﻣﺴﻠﻮﻗﺔ، أو ﺣﺒﺔ ﺑﻄﺎﻃﺎ ﻣﺴﻠﻮﻗﺔ ½ آﺄس ذرة، أو ½ آﺄس ﺑﺮﻏﻞ ﻣﺴﻠﻮق، أو ½ ﻣﺴﻠﻮق، أو 
  ﻣﺘﻮﺳﻄﺔ اﻟﺤﺠﻢ، 
ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ، أو ﻗﻄﻌﺔ ﺟﺒﻨﺔ ﺑﻴﻀﺎء  2اﻟﺪﺳﻢ، أو آﺄس ﻟﺒﻦ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو  : آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞﺑﺪاﺋﻞ اﻟﺤﻠﻴﺐ
  ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ
( ﺣﺒﺔ ﺗﻴﻦ،  2-1(ﺣﺒﺔ ﻣﺸﻤﺶ، أو ) 3-2ﺣﺒﺎت ﻋﻨﺐ، أو ) 01ﻣﻮزة آﺒﻴﺮة، أو ﺣﺒﺔ ﺗﻔﺎح، أو : ½ ﺑﺪاﺋﻞ اﻟﻔﺎآﻬﺔ
ﺣﺒﺔ آﻴﻮي، أو ﺣﺒﺔ ﺑﺮﺗﻘﺎل، ( 2-1ﺟﺮﻳﺐ ﻓﺮوت، أو ﺣﺒﺔ أﺟﺎص ﺻﻐﻴﺮة، ﺣﺒﺔ ﺟﻮاﻓﺔ، أو) ½ ﺣﺒﺔ ﺗﻴﻦ ﻣﺠﻔﻒ، أو 
ﺣﺒﺔ ﺻﺒﺮ ﺻﻐﻴﺮة، أو آﺄس ﺷﺮاﺋﺢ ﺑﻄﻴﺦ، آﺄس ﺷﺮاﺋﺢ ﺷﻤﺎم ،  2ﺣﺒﺔ ﻣﺎﻧﻐﺎ،  2/1– 4/1أو ﺣﺒﺔ ﺧﻮخ ﺻﻐﻴﺮة، أو
ﺣﺒﺎت  4ﺣﺒﺔ ﺗﻤﺮ،  2ﺣﺒﺔ أﻧﺎﻧﺎس أو ﻗﻄﻌﺔ ﺻﻐﻴﺮة أﻧﺎﻧﺎس ﻣﺠﻔﻒ، آﺄس ﺗﻮت أرﺿﻲ، ¼ أو ﺣﺒﺘﻴﻦ ﺑﺮﻗﻮق، 
آﺄس ﻋﺼﻴﺮ ½  ﺣﺒﺔ ﺑﻮﻣﻠﺔ ﺻﻐﻴﺮة، أو ½ ﻣﻠﻌﻘﺔ زﺑﻴﺐ، ﺣﺒﺔ آﻠﻤﻨﺘﻴﻨﺎ،  2ﺣﺒﺔ رﻣﺎن،  2/1ﺣﺒﺎت ﻟﻮز، 3اﺳﻜﺪﻧﻴﺎ، 
  ﻃﺒﻴﻌﻲ
آﺄس ½  أو ﺣﺒﺔ ﺧﻀﺎر) ﺣﺒﺔ ﺧﻴﺎر، ﺣﺒﺔ ﻓﻠﻔﻞ، ﺣﺒﺔ ﺑﻨﺪورة،..( ،: آﺄس ﺧﻀﺎر ﻃﺎزج )آﺄس ﺳﻠﻄﺔ(ﺑﺪاﺋﻞ اﻟﺨﻀﺎر
آﺄس ﻋﺼﻴﺮ ﺧﻀﺎر )ﻋﺼﻴﺮ ﺟﺰر، ﻋﺼﻴﺮ ½ ، أو ﺧﻀﺎر ﻣﻄﺒﻮﺧﺔ )آﻮﺳﺎ، ﺳﺒﺎﻧﺦ، ﻣﻠﻮﺧﻴﺔ، ﻣﻠﻔﻮف، ﺑﺎذﻧﺠﺎن...(
  ﺑﻨﺪورة،....(
آﺄس ﻣﻄﺒﻮخ ﻣﻦ اﻟﺒﻘﻮﻟﻴﺎت )ﺣﻤﺺ، ½  ﻏﻢ ﻣﻦ اﻟﻠﺤﻮم، دﺟﺎج، ﺳﻤﻚ، أو 09-06: ﻗﻄﻌﺔ ﺻﻐﻴﺮة ﻟﻠﺤﻤﺔﺑﺪاﺋﻞ ا
ﻣﻠﻌﻘﺔ  2ﻣﻠﻌﻘﺔ ﺻﻐﻴﺮة ﻣﻦ زﺑﺪة اﻟﻔﻮل اﻟﺴﻮداﻧﻲ، أو ﺑﻴﻀﺔ واﺣﺪة،  2ﻣﻠﻌﻘﺔ آﺒﻴﺮة ﻣﻜﺴﺮات، أو  2ﻓﻮل، ﻋﺪس(،أو 
  ﻏﻢ ﻃﻦ 06ﻗﻄﻌﺔﺣﺒﺶ،  2ﺣﻤﺺ آﺒﻴﺮة، 
ﻟﺸﻤﺲ، زﻳﺖ ﺳﻤﺴﻢ ﺻﻐﻴﺮة، ﺻﻮﻳﺎ(، ﻣﻠﻌﻘﺔ ﻃﺤﻴﻨﺔ ﺻﻐﻴﺮة، : ﻣﻠﻌﻘﺔ زﻳﺖ )زﻳﺘﻮن، ذرة، ﻋﺒﺎد اﺑﺪاﺋﻞ اﻟﺪهﻮن
  ﻣﻠﻌﻘﺔ ﻣﺮﺟﺮﻳﻦ ﺻﻐﻴﺮة
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 وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻟﻌﺸﺎء وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻟﻐﺬاء وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻟﻔﻄﻮر
رﻏﻴﻒ ﺧﺒﺰ ½ 
أﺳﻤﺮ + ﻗﻄﻌﺔ ﺟﺒﻨﺔ 
ﺑﻴﻀﺎء ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ + 
 ﺣﺒﺔ ﺧﻀﺎر
ﺣﺒﺔ ﺧﻀﺎر + 
  ﺣﺒﺔ ﻓﺎآﻬﺔ +
رﻏﻴﻒ ½  
ﺟﺒﺰ أﺳﻤﺮ ﻣﻊ 
 ﻟﺒﻨﺔ
آﺄس ﻓﺮﻳﻜﺔ ﻣﻄﺒﻮﺧﺔ 
س ﺳﻠﻄﺔ  + + آﺄ
ﺻﺪر دﺟﺎج ﻣﺸﻮي +  
 آﺄس ﺧﻀﺎر ﻣﻄﺒﻮﺧﺔ
ﺣﺒﺔ ﺧﻀﺎر + 
 ﺣﺒﺔ ﻓﺎآﻬﺔ
رﻏﻴﻒ ﺧﺒﺰ ½   
ﻣﻠﻌﻘﺔ  2أﺳﻤﺮ + 
 2 ﺻﻐﻴﺮة ﻟﺒﻨﺔ  +
 ﺣﺒﺔ ﺧﻀﺎر
ﺣﺒﺔ ﻓﺎآﻬﺔ+ ﺣﺒﺔ 
آﺄس  +ﺧﻀﺎر
 ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ
آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ 
 ½        اﻟﺪﺳﻢ +
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ + 
ﻣﻌﻠﻘﺘﻴﻦ ﻟﺒﻨﺔ + 
 ﺧﻀﺎر
ﺣﺒﺔ ﺧﻀﺎر + 
ﺣﺒﺔ ﻓﺎآﻬﺔ + 
 آﺄس ﻟﺒﻦ
ﻏﻢ ﺳﻤﻚ ﻣﺸﻮي  021 
+ ﺣﺒﺔ ﺑﻄﺎﻃﺎ ) وﺳﻂ( 
ﺧﻀﺎر  2ﻣﺸﻮﻳﺔ + 
 ﻣﺸﻮﻳﺔ
ﺣﺒﺔ ﻓﺎآﻬﺔ + 
 ﺣﺒﺔ ﺧﻀﺎر
رﻏﻴﻒ ﺧﺒﺰ ½ 
أﺳﻤﺮ+ ﻗﻄﻌﺔ ﺟﺒﻨﺔ 
 2ﺑﻴﻀﺎء ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ+
  ﺧﻀﺎر+
 ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ  2
ﺣﺒﺔ ﻓﺎآﻬﺔ+ آﺄس 
رﻏﻴﻒ ½ ﺳﻠﻄﺔ + 
 ﺧﺒﺰ أﺳﻤﺮ
رﻏﻴﻒ ﺧﺒﺰ ½ 
أﺳﻤﺮ+ زﻳﺖ زﻳﺘﻮن 
 ﻣﻊ زﻋﺘﺮ + ﺧﻀﺎر 
ﺣﺒﺔ ﺧﻀﺎر + 
  آﺄس ﻟﺒﻦ +
 رﻏﻴﻒ¼  
 ﺧﺒﺰ 
  آﺄس أرز ﻣﻄﺒﻮخ + 
آﺄس ﻳﺨﻨﻲ ﺧﻀﺎر+    
ﻗﻄﻌﺔ ﻟﺤﻤﺔ ﻋﺠﻞ ﻳﺪون 
 دهﻮن
ﺣﺒﺔ ﺧﻀﺎر+ 
 ﺣﺒﺔ ﻓﺎآﻬﺔ
رﻏﻴﻒ ﺧﺒﺰ ½   
أﺳﻤﺮ+ ﻣﻠﻌﻘﺘﻴﻦ 
ﺻﻐﻴﺮﺗﻴﻦ ﺣﻤﺺ + 
 ﺧﻀﺎر
ﺣﺒﺔ ﺧﻀﺎر + ﺣﺒﺔ 
  ﻓﻮاآﻪ +
رﻏﻴﻒ ﺧﺒﺰ ½ 
أﺳﻤﺮ + ﺑﻴﻀﺔ 
  ﺧﻀﺎر 2ﻣﺴﻠﻮﻗﺔ + 
ﺣﺒﺔ ﻓﻮاآﻪ +  
ﺣﺒﺔ ﺧﻀﺎر + 
  آﺄس ﻟﺒﻦ
آﺄس ﻣﺠﺪرة ﺑﺮﻏﻞ + 
ﺎت ﺣﺒ  5ﺳﻠﻄﺔ + 
  زﻳﺘﻮن
+ ﺣﺒﺔ ﻓﻮاآﻪ + 
ﺣﺒﺔ ﺑﻄﺎﻃﺎ 
  ﻣﺴﻠﻮﻗﺔ
  ﺷﻮرﺑﺔ ﺧﻀﺎر +
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ ½ 
  + ﺣﺒﺔ ﺧﻀﺎر
  ﺣﺒﺔ ﻓﻮاآﻪ +
آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ  
  اﻟﺪﺳﻢ
 
½ آﺄس ﺑﺮﻏﻞ ﻣﺴﻠﻮق، أو ½ آﺎس أرز ﻣﺴﻠﻮق، أو ½ ﺷﻄﻴﺮة هﻤﺒﺮﻏﺮ، أو ½  رﻏﻴﻒ ﺧﺒﺰ، أو :¼ ﺑﺪاﺋﻞ اﻟﺨﺒﺰ
  آﺄس آﻮرن ﻓﻠﻴﻜﺲ ﻗﻤﺢ½ ﺎ ﻣﺴﻠﻮﻗﺔ ﻣﺘﻮﺳﻄﺔ اﻟﺤﺠﻢ، آﺄس ﻣﻌﻜﺮوﻧﺔ ﻣﺴﻠﻮﻗﺔ، أو ﺣﺒﺔ ﺑﻄﺎﻃ½ آﺄس ذرة،       أو 
ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ، أو ﻗﻄﻌﺔ ﺟﺒﻨﺔ ﺑﻴﻀﺎء  2: آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو آﺄس ﻟﺒﻦ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو ﺑﺪاﺋﻞ اﻟﺤﻠﻴﺐ
  ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ
، ( ﺣﺒﺔ ﺗﻴﻦ 2-1(ﺣﺒﺔ ﻣﺸﻤﺶ، أو ) 3-2ﺣﺒﺎت ﻋﻨﺐ، أو ) 01ﻣﻮزة آﺒﻴﺮة، أو ﺣﺒﺔ ﺗﻔﺎح، أو : ½ ﺑﺪاﺋﻞ اﻟﻔﺎآﻬﺔ
( ﺣﺒﺔ آﻴﻮي، أو ﺣﺒﺔ ﺑﺮﺗﻘﺎل، 2-1ﺟﺮﻳﺐ ﻓﺮوت، أو ﺣﺒﺔ أﺟﺎص ﺻﻐﻴﺮة، ﺣﺒﺔ ﺟﻮاﻓﺔ، أو) ½ ﺣﺒﺔ ﺗﻴﻦ ﻣﺠﻔﻒ، أو 
ﺣﺒﺔ ﺻﺒﺮ ﺻﻐﻴﺮة، أو آﺄس ﺷﺮاﺋﺢ ﺑﻄﻴﺦ، آﺄس ﺷﺮاﺋﺢ ﺷﻤﺎم ،  2ﺣﺒﺔ ﻣﺎﻧﻐﺎ،  2/1– 4/1أو ﺣﺒﺔ ﺧﻮخ ﺻﻐﻴﺮة، أو
ﺣﺒﺎت  4ﺣﺒﺔ ﺗﻤﺮ،  2ﻲ، ﺣﺒﺔ أﻧﺎﻧﺎس أو ﻗﻄﻌﺔ ﺻﻐﻴﺮة أﻧﺎﻧﺎس ﻣﺠﻔﻒ، آﺄس ﺗﻮت أرﺿ¼ أو ﺣﺒﺘﻴﻦ ﺑﺮﻗﻮق، 
آﺄس ﻋﺼﻴﺮ ½  ﺣﺒﺔ ﺑﻮﻣﻠﺔ ﺻﻐﻴﺮة، أو ½ ﺣﺒﺔ آﻠﻤﻨﺘﻴﻨﺎ، ﻣﻠﻌﻘﺔ زﺑﻴﺐ،  2 ﺣﺒﺔ رﻣﺎن، 2/1ﺣﺒﺎت ﻟﻮز، 3اﺳﻜﺪﻧﻴﺎ، 
  ﻃﺒﻴﻌﻲ
آﺄس ½  أو ﺣﺒﺔ ﺧﻀﺎر) ﺣﺒﺔ ﺧﻴﺎر، ﺣﺒﺔ ﻓﻠﻔﻞ، ﺣﺒﺔ ﺑﻨﺪورة،..( ،: آﺄس ﺧﻀﺎر ﻃﺎزج )آﺄس ﺳﻠﻄﺔ(ﺑﺪاﺋﻞ اﻟﺨﻀﺎر
آﺄس ﻋﺼﻴﺮ ﺧﻀﺎر )ﻋﺼﻴﺮ ﺟﺰر، ﻋﺼﻴﺮ ½ ، أو ، ﺑﺎذﻧﺠﺎن...(ﺧﻀﺎر ﻣﻄﺒﻮﺧﺔ )آﻮﺳﺎ، ﺳﺒﺎﻧﺦ، ﻣﻠﻮﺧﻴﺔ، ﻣﻠﻔﻮف
  ﺑﻨﺪورة،....(
آﺄس ﻣﻄﺒﻮخ ﻣﻦ اﻟﺒﻘﻮﻟﻴﺎت )ﺣﻤﺺ، ½  ﻣﻦ اﻟﻠﺤﻮم، دﺟﺎج، ﺳﻤﻚ، أو  ﻏﻢ 09-06: ﻗﻄﻌﺔ ﺻﻐﻴﺮة ﺑﺪاﺋﻞ اﻟﻠﺤﻤﺔ
 2ﻣﻠﻌﻘﺔ ﺻﻐﻴﺮة ﻣﻦ زﺑﺪة اﻟﻔﻮل اﻟﺴﻮداﻧﻲ، أو ﺑﻴﻀﺔ واﺣﺪة،  2ﻣﻠﻌﻘﺔ آﺒﻴﺮة ﻣﻜﺴﺮات، أو  2ﻓﻮل، ﻋﺪس(، أو 
  ﻏﻢ ﻃﻦ 06ﺣﺒﺶ،  ﻗﻄﻌﺔ 2ﻤﺺ آﺒﻴﺮة، ﻣﻠﻌﻘﺔ ﺣ
  
 
031
: ﻣﻠﻌﻘﺔ زﻳﺖ )زﻳﺘﻮن، ذرة، ﻋﺒﺎد اﻟﺸﻤﺲ، زﻳﺖ ﺳﻤﺴﻢ ﺻﻐﻴﺮة(، ﻣﻠﻌﻘﺔ ﻃﺤﻴﻨﺔ ﺻﻐﻴﺮة، ﻣﻠﻌﻘﺔ ﺑﺪاﺋﻞ اﻟﺪهﻮن
  ﻣﺮﺟﺮﻳﻦ ﺻﻐﻴﺮة
  0042
 وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻟﻌﺸﺎء وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻟﻐﺬاء وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻟﻔﻄﻮر
 آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ+
 2رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ+ 
 2ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ ﺻﻐﻴﺮة +
 ﺔ ﺧﻀﺎرﺣﺒ
رﻏﻴﻒ ﺧﺒﺰ  ½ 
أﺳﻤﺮ +ﺣﺒﺔ ﻓﺎآﻬﺔ 
+ﻗﻄﻌﺔ ﺟﺒﻨﺔ ﺑﻴﻀﺎء 
 ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ
آﺄس ﻟﺒﻦ ﻗﻠﻴﻞ اﻟﺪﺳﻢ +   
 آﺄس ﻳﺨﻨﻲ ﺧﻀﺎر
ﻣﻄﺒﻮﺧﺔ +آﺄس ﻓﺮﻳﻜﺔ 
ﻣﻄﺒﻮﺧﺔ+ ﺻﺪر دﺟﺎج 
 ﺑﺪون ﺟﻠﺪة 
ﺣﺒﺔ 2 
ﺧﻀﺎر 
 +ﺣﺒﺔ ﻓﺎآﻬﺔ
  رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ+
ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ ﺻﻐﻴﺮة+  2
ﺣﺒﺔ ﺑﻨﺪورة+ ﺣﺒﺔ 
 ﺧﻀﺎر
رﻏﻴﻒ ﺧﺒﺰ ½ 
أﺳﻤﺮ + ﻣﻌﻠﻘﺔ 
ﻋﺘﺮ+ زﻳﺖ و ز
 ﺧﻴﺎرة
آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ+  
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ+ 
 2ﻗﻄﻌﺔ ﺟﺒﻨﺔ ﺑﻴﻀﺎء+   
 ﺣﺒﺔ ﺧﻀﺎر
ﺣﺒﺔ ﺧﻀﺎر+ ﻣﻠﻌﻘﺔ 
رﻏﻴﻒ ½ ﺣﻤﺺ + 
ﺧﺒﺰ أﺳﻤﺮ + ﺣﺒﺔ 
 ﻓﻮاآﻪ
ﺣﺒﺔ ﺑﻄﺎﻃﺎ ﺻﻐﻴﺮة  2
ﻏﻢ ﺳﻤﻚ  021ﻣﺸﻮﻳﺔ +
ﻣﺸﻮي + ﺳﻠﻄﺔ ﺧﻀﺎر 
 ﻃﺎزﺟﺔ
ﺣﺒﺔ 
ﺧﻀﺎر+ 
  ﺣﺒﺔ ﻓﺎآﻬﺔ
 
آﺄس ﺣﻠﻴﺐ +  رﻏﻴﻒ 
ﺧﺒﺰ أﺳﻤﺮ + ﺑﻴﻀﺔ 
 ﺎرﻣﺴﻠﻮﻗﺔ+ ﺣﺒﺔ ﺧﻀ
رﻏﻴﻒ ﺧﺒﺰ ½ 
أﺳﻤﺮ +ﻗﻄﻌﺔ 
ﺟﺒﻨﺔ ﺑﻴﻀﺎء+ 
 ﺣﺒﺔ ﺧﻀﺎر
آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ + 
رﻏﻴﻒ ﺧﺒﺰ أﺳﻤﺮ + 
ﺷﺮﺣﺔ ﻣﺮﺗﺪﻳﻼ ﺣﺒﺶ 
ﺣﺒﺔ ﺧﻀﺎر+ﺣﺒﺔ  2+
 ﻓﺎآﻬﺔ
  ﺣﺒﺔ ﺧﻀﺎر+ 
ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ  2 
ﺻﻐﻴﺮة ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ 
 +
رﻏﻴﻒ ﺧﺒﺰ ½  
 أﺳﻤﺮ
آﺄس ﺑﺮﻏﻞ ﻣﻄﺒﻮخ+ 
ﻟﺤﻤﺔ ﻋﺠﻞ ﺑﺪون دهﻮن 
ﻣﺸﻮﻳﺔ + آﺄس ﺳﻠﻄﺔ+ 
 آﺄس ﻟﺒﻦ +
 ﺼﻴﺮ ﻃﺒﻴﻌﻲآﺄس ﻋ½ 
ﺣﺒﺔ 
ﺧﻀﺎر+ 
  ﺣﺒﺔ ﻓﺎآﻬﺔ 
 
آﺄس ﺣﻠﻴﺐ+ رﻏﻴﻒ 
ﺧﺒﺰ أﺳﻤﺮ+ﺣﺒﺔ ﺧﻀﺎر 
 ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ ﺻﻐﻴﺮة 2+ 
رﻏﻴﻒ ﺧﺒﺰ ½ 
أﺳﻤﺮ + ﻣﻌﻠﻘﺔ 
زﻳﺖ و زﻋﺘﺮ+ 
 ﺣﺒﺔ ﺧﻀﺎر
  
½ آﺄس ﺑﺮﻏﻞ ﻣﺴﻠﻮق، أو ½ آﺎس أرز ﻣﺴﻠﻮق، أو ½ ﺷﻄﻴﺮة هﻤﺒﺮﻏﺮ، أو ½  رﻏﻴﻒ ﺧﺒﺰ، أو :¼ ﺑﺪاﺋﻞ اﻟﺨﺒﺰ
  آﺄس آﻮرن ﻓﻠﻴﻜﺲ ﻗﻤﺢ½ ﻣﺴﻠﻮﻗﺔ، أو ﺣﺒﺔ ﺑﻄﺎﻃﺎ ﻣﺴﻠﻮﻗﺔ ﻣﺘﻮﺳﻄﺔ اﻟﺤﺠﻢ،  آﺄس ﻣﻌﻜﺮوﻧﺔ½ آﺄس ذرة،       أو 
ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ، أو ﻗﻄﻌﺔ ﺟﺒﻨﺔ ﺑﻴﻀﺎء  2ﺑﺪاﺋﻞ اﻟﺤﻠﻴﺐ: آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو آﺄس ﻟﺒﻦ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو 
  ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ
( ﺣﺒﺔ ﺗﻴﻦ،  2-1ﺶ، أو )(ﺣﺒﺔ ﻣﺸﻤ 3-2ﺣﺒﺎت ﻋﻨﺐ، أو ) 01ﻣﻮزة آﺒﻴﺮة، أو ﺣﺒﺔ ﺗﻔﺎح، أو : ½ ﺑﺪاﺋﻞ اﻟﻔﺎآﻬﺔ
( ﺣﺒﺔ آﻴﻮي، أو ﺣﺒﺔ ﺑﺮﺗﻘﺎل، 2-1ﺟﺮﻳﺐ ﻓﺮوت، أو ﺣﺒﺔ أﺟﺎص ﺻﻐﻴﺮة، ﺣﺒﺔ ﺟﻮاﻓﺔ، أو) ½ ﺣﺒﺔ ﺗﻴﻦ ﻣﺠﻔﻒ، أو 
ﺣﺒﺔ ﺻﺒﺮ ﺻﻐﻴﺮة، أو آﺄس ﺷﺮاﺋﺢ ﺑﻄﻴﺦ، آﺄس ﺷﺮاﺋﺢ ﺷﻤﺎم ،  2ﺣﺒﺔ ﻣﺎﻧﻐﺎ،  2/1– 4/1أو ﺣﺒﺔ ﺧﻮخ ﺻﻐﻴﺮة، أو
ﺣﺒﺎت  4ﺣﺒﺔ ﺗﻤﺮ،  2ﺎس ﻣﺠﻔﻒ، آﺄس ﺗﻮت أرﺿﻲ، ﺣﺒﺔ أﻧﺎﻧﺎس أو ﻗﻄﻌﺔ ﺻﻐﻴﺮة أﻧﺎﻧ¼ أو ﺣﺒﺘﻴﻦ ﺑﺮﻗﻮق، 
½  ﺣﺒﺎت ﻟﻮز، أو  3ﺣﺒﺔ ﺑﻮﻣﻠﺔ ﺻﻐﻴﺮة، ½ ﺣﺒﺔ آﻠﻤﻨﺘﻴﻨﺎ، ﻣﻠﻌﻘﺔ زﺑﻴﺐ،  2ﺣﺒﺔ رﻣﺎن،  2/1ﺣﺒﺎت ﻟﻮز، 3اﺳﻜﺪﻧﻴﺎ، 
  آﺄس ﻋﺼﻴﺮ ﻃﺒﻴﻌﻲ
آﺄس ½  أو ﺣﺒﺔ ﺧﻀﺎر) ﺣﺒﺔ ﺧﻴﺎر، ﺣﺒﺔ ﻓﻠﻔﻞ، ﺣﺒﺔ ﺑﻨﺪورة،..( ،: آﺄس ﺧﻀﺎر ﻃﺎزج )آﺄس ﺳﻠﻄﺔ(ﺑﺪاﺋﻞ اﻟﺨﻀﺎر
آﺄس ﻋﺼﻴﺮ ﺧﻀﺎر )ﻋﺼﻴﺮ ﺟﺰر، ½ ، أو ﺒﻮﺧﺔ ) آﻮﺳﺎ، ﺳﺒﺎﻧﺦ، ﻣﻠﻮﺧﻴﺔ، ﻣﻠﻔﻮف، ﺑﺎذﻧﺠﺎن،.....(ﺧﻀﺎر ﻣﻄ
  ﻋﺼﻴﺮ ﺑﻨﺪورة،....(
آﺄس ﻣﻄﺒﻮخ ﻣﻦ اﻟﺒﻘﻮﻟﻴﺎت )ﺣﻤﺺ، ½  ﻏﻢ ﻣﻦ اﻟﻠﺤﻮم، دﺟﺎج، ﺳﻤﻚ، أو  09-06: ﻗﻄﻌﺔ ﺻﻐﻴﺮة ﺑﺪاﺋﻞ اﻟﻠﺤﻤﺔ
ﺪة اﻟﻔﻮل اﻟﺴﻮداﻧﻲ، أو ﺑﻴﻀﺔ واﺣﺪة، ﻣﻠﻌﻘﺔ ﺻﻐﻴﺮة ﻣﻦ زﺑ 2ﻣﻠﻌﻘﺔ آﺒﻴﺮة ﻣﻦ اﻟﻤﻜﺴﺮات ، أو  2ﻓﻮل، ﻋﺪس( ، أو 
  ﻗﻄﻌﺔ ﺣﺒﺶ 2ﻣﻠﻌﻘﺔ ﺣﻤﺺ آﺒﻴﺮة،  2
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  0022
 وﺟﺒﺔ ﺧﻔﻴﻔﺔ ﻋﺸﺎء وﺟﺒﺔ ﺧﻔﻴﻔﺔ ﻏﺬاء وﺟﺒﺔ ﺧﻔﻴﻔﺔ اﻹﻓﻄﺎر
ﺗﻮﺳﺖ أﺳﻤﺮ +ﺣﺒﺔ ﻓﺎآﻬﺔ  4
+ ﺣﺒﺔ ﺧﻀﺎر + ﻟﺒﻨﺔ ﻗﻠﻴﻠﺔ 
اﻟﺪﺳﻢ + آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ 
 اﻟﺪﺳﻢ
ﺣﺒﺔ ﻓﺎآﻬﺔ+ ﺣﺒﺔ  
 ﺧﻀﺎر+  
آﺄس و ﻧﺼﻒ  أرز ﻣﻄﺒﻮخ ﺑﺪون دهﻮن    
ﺻﺤﻦ ﺳﻠﻄﺔ ﺧﻀﺎر ﻃﺎزﺟﺔ + ﺻﺪر  +
دﺟﺎج ﻣﺸﻮي ﺑﺪون ﺟﻠﺪة + آﺄس ﻳﺨﻨﻲ 
 ﺧﻀﺎر ﻣﻄﺒﻮخ
ﺣﺒﺔ ﻓﺎآﻬﺔ + ﺣﺒﺔ 
   ﺧﻀﺎر
ﺗﻮﺳﺖ أﺳﻤﺮ + زﻳﺖ و  4
 زﻋﺘﺮ + ﺧﻀﺎر
ﺣﺒﺔ ﻓﻮاآﻪ + ﺣﺒﺔ 
 ﺧﻀﺎر 
 4آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ+ 
  ﺗﻮﺳﺖ  أﺳﻤﺮ + ﺧﻀﺎر + 
 ﺑﻴﺎض ﺑﻴﺾ  2
ﺣﺒﺔ ﻓﺎآﻬﺔ + 
 ﺳﻠﻄﺔ 
آﺄس ﻟﺒﻦ ﻗﻠﻴﻞ اﻟﺪﺳﻢ + آﺄس و ﻧﺼﻒ 
ﺑﺮﻏﻞ  او أرز ﺑﻨﻲ  ﻣﻄﺒﻮخ + آﺄس  ﻣﺠﺪرة
 ﻳﺨﻨﻲ ﺧﻀﺎر ﻣﻄﺒﻮﺧﺔ + ﺳﻠﻄﺔ 
  ﺗﻮﺳﺖ أﺳﻤﺮ+ 4  ﺣﺒﺔ ﻓﻮاآﻪ + ﺧﻀﺎر
ﺟﺒﻨﺔ ﺑﻴﻀﺎء ﻗﻠﻴﻠﺔ اﻟﻤﻠﺢ + 
 ﺧﻀﺎر 
ﺣﺒﺔ ﻓﻮاآﻪ +  
 ﺧﻀﺎر
آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ + 
   sekalf narbآﺄس 
 4ﺣﺒﺔ ﺧﻀﺎر + 
ﺗﻮﺳﺖ أﺳﻤﺮ + 
  ﻟﺒﻨﺔ ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ 
ﺷﻮرﺑﺔ ﺧﻀﺎر + ﺧﻀﺎر ﻣﺸﻮﻳﺔ + ﺳﻤﻚ 
  ﺳﻠﻄﺔ ﺧﻀﺎر  ﻣﺸﻮي +
ﺣﺒﺔ ﻓﺎآﻬﺔ +ﺣﺒﺔ 
 ﺧﻀﺎر
ﺗﻮﺳﺖ أﺳﻤﺮ+ ﺟﺒﻨﺔ  2
ﺑﻴﻀﺎء ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ + 
  ﺧﻀﺎر 
ﺣﺒﺔ ﻓﺎآﻬﺔ + ﺣﺒﺔ 
  ﺑﻄﺎﻃﺎ ﻣﺴﻠﻮﻗﺔ 
  
  
½ آﺄس ﺑﺮﻏﻞ ﻣﺴﻠﻮق، أو ½ آﺎس أرز ﻣﺴﻠﻮق، أو ½ ﺷﻄﻴﺮة هﻤﺒﺮﻏﺮ، أو ½  رﻏﻴﻒ ﺧﺒﺰ، أو :¼ ﺑﺪاﺋﻞ اﻟﺨﺒﺰ
  آﺄس آﻮرن ﻓﻠﻴﻜﺲ ﻗﻤﺢ½ ﻗﺔ ﻣﺘﻮﺳﻄﺔ اﻟﺤﺠﻢ، آﺄس ﻣﻌﻜﺮوﻧﺔ ﻣﺴﻠﻮﻗﺔ، أو ﺣﺒﺔ ﺑﻄﺎﻃﺎ ﻣﺴﻠﻮ½ آﺄس ذرة،       أو 
ﻣﻠﻌﻘﺔ ﻟﺒﻨﺔ ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ، أو ﻗﻄﻌﺔ ﺟﺒﻨﺔ ﺑﻴﻀﺎء  2: آﺄس ﺣﻠﻴﺐ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو آﺄس ﻟﺒﻦ ﻗﻠﻴﻞ اﻟﺪﺳﻢ، أو ﺑﺪاﺋﻞ اﻟﺤﻠﻴﺐ
  ﻗﻠﻴﻠﺔ اﻟﺪﺳﻢ
( ﺣﺒﺔ ﺗﻴﻦ،  2-1(ﺣﺒﺔ ﻣﺸﻤﺶ، أو ) 3-2ﺣﺒﺎت ﻋﻨﺐ، أو ) 01ﻣﻮزة آﺒﻴﺮة، أو ﺣﺒﺔ ﺗﻔﺎح، أو : ½ ﺑﺪاﺋﻞ اﻟﻔﺎآﻬﺔ
( ﺣﺒﺔ آﻴﻮي، أو ﺣﺒﺔ ﺑﺮﺗﻘﺎل، 2-1ﺟﺮﻳﺐ ﻓﺮوت، أو ﺣﺒﺔ أﺟﺎص ﺻﻐﻴﺮة، ﺣﺒﺔ ﺟﻮاﻓﺔ، أو) ½ ﺗﻴﻦ ﻣﺠﻔﻒ، أو ﺣﺒﺔ 
ﺣﺒﺔ ﺻﺒﺮ ﺻﻐﻴﺮة، أو آﺄس ﺷﺮاﺋﺢ ﺑﻄﻴﺦ، آﺄس ﺷﺮاﺋﺢ ﺷﻤﺎم ،  2ﺣﺒﺔ ﻣﺎﻧﻐﺎ،  2/1– 4/1أو ﺣﺒﺔ ﺧﻮخ ﺻﻐﻴﺮة، أو
ﺣﺒﺎت  4ﺒﺔ ﺗﻤﺮ، ﺣ 2ﺣﺒﺔ أﻧﺎﻧﺎس أو ﻗﻄﻌﺔ ﺻﻐﻴﺮة أﻧﺎﻧﺎس ﻣﺠﻔﻒ، آﺄس ﺗﻮت أرﺿﻲ، ¼ أو ﺣﺒﺘﻴﻦ ﺑﺮﻗﻮق، 
آﺄس ﻋﺼﻴﺮ ½  ﺣﺒﺔ ﺑﻮﻣﻠﺔ ﺻﻐﻴﺮة، أو ½ ﺣﺒﺔ آﻠﻤﻨﺘﻴﻨﺎ، ﻣﻠﻌﻘﺔ زﺑﻴﺐ،  2ﺣﺒﺔ رﻣﺎن،  2/1ﺣﺒﺎت ﻟﻮز، 3اﺳﻜﺪﻧﻴﺎ، 
  ﻃﺒﻴﻌﻲ
آﺄس ½  أو ﺣﺒﺔ ﺧﻀﺎر) ﺣﺒﺔ ﺧﻴﺎر، ﺣﺒﺔ ﻓﻠﻔﻞ، ﺣﺒﺔ ﺑﻨﺪورة،..( ،: آﺄس ﺧﻀﺎر ﻃﺎزج )آﺄس ﺳﻠﻄﺔ(ﺑﺪاﺋﻞ اﻟﺨﻀﺎر
آﺄس ﻋﺼﻴﺮ ﺧﻀﺎر )ﻋﺼﻴﺮ ﺟﺰر، ﻋﺼﻴﺮ ½ ، أو ﺠﺎن...(ﺧﻀﺎر ﻣﻄﺒﻮﺧﺔ )آﻮﺳﺎ، ﺳﺒﺎﻧﺦ، ﻣﻠﻮﺧﻴﺔ، ﻣﻠﻔﻮف، ﺑﺎذﻧ
  ﺑﻨﺪورة،....(
آﺄس ﻣﻄﺒﻮخ ﻣﻦ اﻟﺒﻘﻮﻟﻴﺎت )ﺣﻤﺺ، ½  ﻗﻄﻌﺔ ﺻﻐﻴﺮة ﻏﻢ ﻣﻦ اﻟﻠﺤﻮم، دﺟﺎج، ﺳﻤﻚ، أو   09-06: ﺑﺪاﺋﻞ اﻟﻠﺤﻤﺔ
 2ﻣﻠﻌﻘﺔ ﺻﻐﻴﺮة ﻣﻦ زﺑﺪة اﻟﻔﻮل اﻟﺴﻮداﻧﻲ، أو ﺑﻴﻀﺔ واﺣﺪة،  2ﻣﻠﻌﻘﺔ آﺒﻴﺮة ﻣﻜﺴﺮات، أو  2ﻓﻮل، ﻋﺪس(، أو 
  ﻏﻢ ﻃﻦ 06ﺣﺒﺶ،  ﻗﻄﻌﺔ 2ﻴﺮة، ﻣﻠﻌﻘﺔ ﺣﻤﺺ آﺒ
: ﻣﻠﻌﻘﺔ زﻳﺖ )زﻳﺘﻮن، ذرة، ﻋﺒﺎد اﻟﺸﻤﺲ، زﻳﺖ ﺳﻤﺴﻢ ﺻﻐﻴﺮة(، ﻣﻠﻌﻘﺔ ﻃﺤﻴﻨﺔ ﺻﻐﻴﺮة، ﻣﻠﻌﻘﺔ ﺑﺪاﺋﻞ اﻟﺪهﻮن
  ﻣﺮﺟﺮﻳﻦ ﺻﻐﻴﺮة
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Annex 3: box plots 
 
 
Distribution of  HbA1c in patients in the four visits  
 
Distribution of cholesterol in patients in the four visits  
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Distribution of  Albumin levels in patients in the four visits  
 Normal albuminuria less than 30 mg/dl 
 Microalbuminuria 30-300 mg/dl 
 Macroalbuminuria more than 300 mg/dl 
 
Data shows that mean BMI in the four visits  
 *Underweight:  BMI < 18.5, normal: 18.5-24.99, overweight: ≥ 25, pre-obese: 25-29.99, 
Obese class 1: 30 - 34.99, Obese class 2: 35.00 - 39.99, Obese class 3: ≥40.00  
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 Systolic results of the patients at the four follow up period.  
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Annex 4: 
Descriptive analysis for the four visit for HbA1c, BMI, MAU, Cholesterol, 
Systolic and Diastolic Blood Pressure 
 
 Mean Median SD SE  Min Max 
HbA1c 1st visit 9.1 8.9 2.1 0.1 4.9 17.6 
HbA1c 2nd visit 8.7 8.4 1.9 0.1 5.2 14.7 
HbA1c 3rd visit 8.6 8.3 1.8 0.1 5.2 14.8 
HbA1c 4th visit 8.5 8.2 1.7 0.1 5.5 13.7 
BMI 1st visit 31.3 30.9 5.3 0.2 17.0 55.5 
BMI 2nd visit 31.5 31.0 5.2 0.2 18.5 53.9 
BMI 3rd visit 31.8 31.4 5.2 0.2 19.6 53.8 
BMI 4th visit 31.9 31.5 5.3 0.2 18.9 53.8 
Microalbuminuria  1st visit 247.4 27.6 814 29.8 0.0 8735 
Microalbuminuria  2nd visit 223.9 29.0 775 28.4 0.0 11600 
Microalbuminuria  3rd visit 223.4 28.8 701.1 25.7 0.0 8735 
 Microalbuminuria 4th visit 302.1 25.7 1109 40.6 0.0 18723 
Cholesterol levels 1st visit 208 204 90.0 3.3 32 441 
Cholesterol levels 2nd visit 199.2 197 45.7 1.7 39 571 
Cholesterol levels 3rd visit 196.8 194 45.2 1.7 39 571 
Cholesterol levels 4th visit 195 188 88.8 3.3 44 397 
Systolic 1st visit 132 129 20.0 1.0 87 212 
Systolic 2nd visit 132 130 20.0 1.0 80 211 
Systolic 3rd visit 131 130 19.0 1.0 82 195 
Systolic 4th result 131 129 19.0 1.0 88 210 
Diastolic 1st visit 83.0 82.0 11.0 0.0 51 135 
Diastolic 2nd visit 82.0 82.0 11.0 0.0 50 125 
Diastolic 3rd visit 81.0 81.0 11.0 0.0 50 133 
Diastolic 4th visit 81.0 80.0 10.0 0.0 51 113 
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Annex 5: Univariate analysis among the various visits 
HbA1c change between Second and first visit (HbA1c 2-1): 
A-HbA1c 2-1 and demographic factors 
A significant association was found between HbA1c 2-1 with age category (50-61 
years), and  with 16 – 20 years duration of diabetes, and with period being in study 
(p<0.05) except the period (19-24 months where p >0.05). No association was found 
between HbA1c 2-1 and gender, residency and marital status  (p>0.05) (see table1). 
 
Table 1: the distribution between HbA1c 2-1 with various demographic variables 
Variable Total 
N=746 
Bad  
N= 313 
Good  
N= 433 
P 
value 
Odds ratio(CI) 
Age ≤40  35 (4.7) 13 (37) 22 (63) 0.33 1.44 (0.7 - 3.0)
41-50 143 (19.2) 69 (48.3) 74 (51.7) 0.66 0.91 (0.61- 1.37) 
51-60  296 (40) 106 (35.8) 190  (64.2) 0.01 1.52 (1.09- 2.13) 
> 60  272 (36.5) 125 (46) 147 (54)  1 
Sex Male 349 (46.8)  142 (40.7) 207 (59.3) 0.51 0.91 (0.68- 1.21) 
Female 397 (53.2) 171 (43.1) 226 (56.9) 
Period in 
study 
Months 
≤6  40 (5.3) 27 (67.5) 13 (32.5) 0.08 0.53 (0.26- 1.09) 
7-12  91 (12.2) 23 (25.3) 68 (74.7) 0.00 3.27 (1.9- 5.62) 
13- 18  50 (6.7) 15 (30) 35 (70) 0.01 2.58 (1.33- 5.0) 
19- 24 107 (14.3) 44 (41.1) 63 (58.9) 0.05 1.58 (0.99- 2.53) 
25- 30  74 (9.9) 26 (35.1) 48 (64.9) 0.01 2.04 (1.18- 3.52) 
31- 36  165 (22.1) 63 (38.2) 102 (61.8) 0.01 1.79 (1.19- 2.7) 
> 36  219 (29.4) 115 (52.5) 104 (47.5)  1 
Duration 
of 
Diabetes 
Years 
≤5  211 (28.3) 93 (44.1) 118 (55.9) 0.21 1.47 (0.81- 2.68)  
6-10  228 (30.6) 96 (42.1) 132 (57.9) 0.13 1.6 (0.88- 2.9) 
11-15 160 (21.4) 65 (40.6) 95 (59.4) 0.1 1.7 (0.91- 3.16) 
16-20  93 (12.5) 30 (32.3) 63 (67.7) 0.01 2.44 (1.22- 4.85) 
> 20  54 (7.2) 29 (53.7) 25 (46.3)  1 
Education 
level 
Illiterate 109 (14.6) 46 (42.2) 63 (57.8) 0.37 0.78 (0.46- 1.34) 
School 385 (51.6) 163 (42.3)  222 (57.7) 0.25 0.78 (0.5- 1.2) 
High school 139 (18.6) 63 (45.3) 76 (54.7) 0.15 0.69 (0.41- 1.14) 
University  113 (15.1) 41 (36.3) 72 (63.7)  1 
Profession 
Total 
N=203 
Worker 138 (68) 57 (41.3) 81 (58.7) 0.59 1.42 (0.39- 5.14) 
Highly educated 55 (27.1) 21 (38.2) 34 (61.8) 0.49 1.62 (0.42- 6.27) 
Health  sector 10 (4.9) 5 (50) 5  (50)  1 
Employed Yes 195 (26.1) 78 (40) 117 (60) 0.52 0.9 (0.64- 1.25) 
No 551 (73.9) 235 (42.6) 316 (47.4) 
Smoking Yes 119 (16) 47 (39.5) 72 (60.5) 0.59 1.15 (0.69- 1.91) 
No 501 (67.15) 212 (42.3) 289 (57.7) 0.91 1.02 (0.69- 1.52) 
Past smoker 126 (16.89) 54 (42.9) 72 (57.1)  1 
Insurance  MOH 427 (57.2) 172 (40.3) 255 (59.7) 1 1 (0.68- 1.48) 
UNRWA 175 (23.45) 81 (46.3) 94 (53.7) 0.29 0.78 (0.5- 1.23) 
Others      
Marital 
Status 
Single 14 (1.87) 4 (28.6) 10 (71.4) 0.31 1.9 (0.55- 6.5) 
Married 633 (84.85) 265 (41.9) 368 (58.1) 0.84 1.05 (0.67- 1.65) 
Divorced 13 (1.74) 7 (53.8) 6 (46.2) 0.47 0.65 (0.2- 2.09) 
Widow 86 (11.52) 37 (43) 49 (57)  1 
  
 
137
 
B-HbA1c 2-1 with various follow up criteria (MAU, cholesterol, systolic and 
diastolic blood pressure) 
HbA1c 2-1 was significantly associated with MAU 2-1 and diastolic blood pressure 
(p<0.05), while, no significant association was found between HbA1c 2-1 with 
cholesterol and with Systolic blood pressure (P >0.05, see table 2). 
 
Table 2: Associations between HbA1c 2-1 change with change in cholesterol, 
MAU, and blood pressure 
 
Variable  Total 
N=746 
Bad  
N= 313     
Good  
N= 433      
P value Odds ratio (CI) 
Good MAU* 319 (42.7) 118 (37) 201 (63) 0.02 1.43 (1.06- 1.93) 
Good cholesterol* 289 (38.7) 122 (42.2) 167 (57.8) 0.91 0.98 (0.73- 1.33) 
Good Systolic* 359 (48.12) 148 (41.2) 211 (58.8) 0.7 1.06 (0.79- 1.42) 
Good Diastolic* 381 (51.1) 138 (36.2) 243 (63.8) 0.00 1.62 (1.21- 2.17) 
*reference category bad  
 
C –HbA1c 2-1 with lifestyle behaviors 
No significant association was found between HbA1c 2-1 and BMI, Calories intake 
and activity level (P >0.05 see table 3) 
 
Table 3: Associations between HbA1c 2-1 change with BMI, caloric intake and 
physical activity  
Variable  Total 
N=746 
Bad  
N= 313 
Good  
 N= 433      
P value Odds ratio (CI) 
Good BMI* 249 (33.37) 105 (42.2) 144 (57.8) 0.93 0.99 (0.73- 1.34) 
Calories  1000 306 (41.01) 132 (43.1) 174 (56.9) 0.09 0.38 (0.12- 1.17) 
1200 29 (3.88) 11 (37.9) 18 (62.1) 0.27 0.47 (0.12- 1.79)  
1400 67 (8.98) 31 (46.3) 36 (53.7) 0.07 0.33 (0.1- 1.11) 
1600 104 (13.94) 47 (45.2) 57 (54.8) 0.08 0.35 (0.11- 1.12) 
1800 100 (13.4) 43 (43) 57 (57) 0.11 0.38 (0.12- 1.23) 
2000 93 (12.46) 34 (36.3) 59 (63.4) 0.25 0.5 (0.15- 1.62) 
2200 29 (3.88) 11 (37.9) 18 (62.1) 0.27 0.47 (0.12- 1.78) 
2400 18 (2.41) 4 (22.2) 14 (77.8)  1 
Activity level Very light 14 (1.87) 5 (35.7) 9 (64.3) 0.65 1.3 (0.41- 4.13) 
Light 613 (82.17) 258 (42.1) 355 (57.9) 0.99 0.99 (0.67- 1.48) 
Moderate 119 (15.9) 50 (42) 69 ( 58)  1 
*reference bad BMI 
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3. HbA1c change between Third and Second visit (HbA1c 3-2): 
A.  HbA1c 3-2 and demographic variables 
For the demographic factors, only significant difference was found between the 
frequency of HbA1c 3-2 with the period being in the study (P <0.05). No association 
was found between the HbA1c 3-2 change with Age, Sex, duration of diabetes, place 
of residency, education level, type of profession, employment, insurance and marital 
status  (P >0.05, see table 4 ).  
Table 4: the distribution betweenHbA1c 3-2 with demographic variables. 
 
 
 
 
Total   
 N=746 
Bad   
N= 421  
Good   
N= 325   
P  value Odds ratio (CI) 
Age ≤40  35 (4.69) 20 (57.1) 15 (42.9) 0.79 0.91 (0.45- 1.85)  
41-50 143 (19.2) 89 (62.2) 54 (37.8) 0.15 0.74 (0.49- 1.11) 
51-60  296 (40) 163 (55.1) 133 (44.9) 0.95 0.99 (0.71- 1.38) 
> 60  272 (36.46) 149 (54.8) 123 (45.2)  1 
Sex Male 349 (46.78)  195 (55.9) 154 (44.1) 0.77 0.96 (0.72- 1.28) 
Female 397 (53.2) 226 (56.9) 171 (43.1) 
Period in 
study 
≤6  40 (5.3) 40 (100) 0 (0) 0.99 0.00  (0.00) 
7-12  91 (12.19) 49 (53.8) 42 (46.2) 0.37 1.25 (0.77- 2.05) 
13- 18  50 (6.7) 29 (58) 21 (42) 0.86 1.06 (0.57- 1.97) 
19- 24 107 (14.3) 52 (48.6) 55 (51.4) 0.07 1.55 (0.97- 2.46) 
25- 30  74 (9.91) 43 (58.1) 31 (41.9) 0.85 1.05 (0.62- 1.8) 
31- 36  165 (22.1) 78 (47.3) 87 (52.7) 0.02 1.63 (1.08- 2.45) 
> 36  219 (29.35) 130 (59.4) 89 (40.6)  1 
Duration of 
Diabetes 
≤5  211 (28.28) 132 (37.4) 79 (37.4) 0.15 0.65 (0.35- 1.18) 
6-10  228 (30.56) 138 (60.5) 90 (39.5) 0.25 0.7 (0.39- 1.27) 
11-15 160 (21.4) 76 (47.5) 84 (52.5) 0.58 1.19 (0.64- 2.21) 
16-20  93 (12.46) 47 (50.5) 46 (49.5) 0.88 1.05 (0.54- 2.06) 
> 20  54 (7.23) 28 (51.9) 26 (48.1)  1 
Place of 
residency 
Middle 332 (44.5)  196 (59) 136 (41) 0.25 0.83 (0.60- 1.14) 
North 131 (17.5) 71 (54.2) 60 (45.8) 0.97 1.01 (0.67- 1.53) 
South 283 (38) 154 (54.4) 129 (45.6)  1 
Education 
level 
Illiterate 109 (14) 65 (59.6) 44 (40.4) 0.33 0.77 (0.45- 1.3) 
School 385 (51) 217 (56.4) 168 (43.6) 0.54 0.88 (0.58- 1.34) 
High school 139 (18.63) 79 (56.8) 60 (43.2) 0.55 0.86 (0.52- 1.42) 
University  113 (15.14) 60 (53.1) 53 (46.9)  1  
Profession 
Total N=203 
Worker 138 (67.98) 76 (55.1) 62 (44.9) 0.76 1.22 (0.33- 4.53) 
Highly educated 55 (27.09) 27 (49.1) 28 (50.9) 0.53 1.56 (0.4- 6.13) 
Health Sector 10 (4.92) 6 (60) 4 (40)  1 
Employed Yes 195 (26.13) 104 (53.3) 91 (46.7) 0.31 0.84 (0.61- 1.17) 
No 551 (73.85) 317 (57.5) 234 (42.5) 
Smoking 
 
Yes 119 (15.95) 66 (55.5) 53 (44.5) 0.72 0.91 (0.55- 1.51) 
No 501 (67.15) 288 (57.5) 213 (42.5) 0.38 0.84 (0.57- 1.24) 
Past smoker 126 (16.89) 67 (53.2) 59 (46.8)  1 
Insurance  MOH 427 (57.2) 239 (56.0) 188 (44.0) 0.35 1.2 (0.82- 1.76) 
UNRWA 175 (23.45) 95 (54.3) 80 (45.7) 0.271 1.29 (0.82-2.01) 
Others 144 (19.3) 87 (60.4) 57 (39.6)  1 
Marital 
Status 
Single 14 (1.87) 5 (35.7) 9 (64.3) 0.05 3.19 (0.98- 10.38) 
Married 633 (84.85) 356 (56.2) 277 (43.8) 0.18 1.38 (0.87- 2.2) 
Divorced 13 (1.74) 5 (38.5) 8 (61.5) 0.09 2.84 (0.85- 9.43) 
Widow 86 (11.52) 55 (64.0) 31 (36.0)  1 
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B- HbA1c 3-2 with various follow up criteria  
 A significant difference was found between change in HbA1c 3-2 with MAU 3-2 and 
diastolic blood pressure 3-2 (P <0.05). N o association was found between 
cholesterol, systolic blood pressure with HbA1c 3-2 (p<0.05) (see table 5). 
 
Table 5: The distribution of HbA1c 3-2 with various follow up criteria  
Variable  Total 
N=746 
Bad  
N= 421   
Good  
N= 325 
P value Odds ratio (CI) 
Good MAU*  226 (30.2) 99 (43.8) 127 (56.2) 0.00 2.09 (1.52- 2.86) 
Good cholesterol* 218 (29.2) 114 (52.3) 104 (47.7) 0.14 1.27 (0.92- 1.74) 
Good Systolic* 338 (45.3) 182 (53.8) 156 (46.2) 0.19 1.21 (0.91- 1.62) 
Good Diastolic*  340 (45.5) 162 (47.6) 178 (52.4) 0.00 1.94 (1.44- 2.6) 
*reference category bad 
 
C- HbA1c 3-2 and lifestyle behavior  
No association was found between Change in HbA1c 3-2 , BMI 3-2 and amount of 
Calories intake and activity level(see table 6). 
 
Table 6:   The distribution of HbA1c 3-2 with lifestyle behaviors 
Variable  Total 
N=746 
Bad  
N= 421  
Good  
N= 325 
P value Odds ratio (CI) 
Good BMI 231 (30.96) 119 (51.5) 112 (48.5) 0.07 1.33 (0.98- 1.82) 
Calories  1000 306 (41.01) 170 (55.6) 136 (44.4) 0.65 1.26 (0.48- 3.33) 
1200 29 (3.88) 18 (62.1) 11 (37.9) 0.95 0.96 (0.29- 3.22) 
1400 67 (8.98) 42 (62.7) 25 (37.3) 0.9 0.94 (0.32- 2.73) 
1600 104 (13.94) 53 (51) 51 (49) 0.43 1.51 (0.54- 4.21) 
1800 100 (13.4) 56 (56) 44 (44) 0.69 1.24 (0.44- 3.45) 
2000 93 (12.46) 53 (57) 40 (43) 0.75 1.19 (0.42- 3.33) 
2200 29 (3.88) 18 (62.1) 11 (37.9) 0.95 0.96 (0.29- 3.22) 
2400 18 (2.41) 11 (61.1) 7 (38.9)  1 
Activity level Very light 14 (1.87) 6 (42.9) 8 (57.1) 0.41 1.61 (0.53- 4.91) 
Light 613 (82.17) 350 (57.1) 263 (42.9) 0.62 0.9 (0.61- 1.34) 
Moderate 119 (15.9) 65 (54.6 ) 54 (45.4)  1 
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4. HbA1c change between Fourth and Third visit (HbA1c 4-3): 
A- HbA1c 4-3 and demographic factors 
Table 7 presents the association between HbA1c 4-3 with demographic variables, A 
significant association was found with age (41-50) years, period in study (31-36 months) , 
duration of diabetes ≤5 years (p<0.05), no association  was found with age category , 
Gender, place of residency and job category (p>0.05). 
 
Table 7: The distribution of HbA1c 4-3 with various demographic variables. 
 
 
Variable Total 
N=746 
Bad 
N= 399 
Good 
N= 347 
P value Odds ratio (CI) 
Age ≤40  35 (4.69) 18 (51.4) 17 (48.6) 1 1 (0.48- 2.07) 
41-50 143(19.2) 82 (57.3) 61 (42.7) 0.04 0.65 (0.43- 0.98) 
51-60  296 (40) 164(55.4) 132(44.6) 0.93 0.98 (0.7- 1.38) 
> 60  272(36.46) 135(49.6) 137(50.4)  1 
Sex Male 349(46.78)  181(51.9) 168(48.1) 0.41 0.89 (0.66- 1.18) 
Female 397 (53.2) 218(54.9) 179(45.1) 
Period in study ≤6  40 (5.3) 22 (55) 18 (45) 0.36 0.73 (0.37- 1.43) 
7-12  91 (12.19) 49 (53.8) 42 (46.2) 0.28 0.76 (0.47- 1.24) 
13- 18  50 (6.7) 26 (52) 24 (48) 0.53 0.82 (0.44- 1.52) 
19- 24 107 (14.3) 62 (57.9) 45 (42.1)  0.07 0.64 (0.4- 1.03) 
25- 30  74 (9.91) 41 (55.4) 33 (44.6) 0.21 0.72 (0.42- 1.21) 
31- 36  165 (22.1) 96 (58.2) 69 (41.8) 0.03 0.64 (0.43- 0.96) 
> 36  219(29.35) 103 (47) 116 (53)  1 
Duration of Diabetes ≤5  211(28.28) 134(63.5) 77 (36.5) 0.00 0.37 (0.2-  0.68) 
6-10  228(30.56) 113(49.6) 115(50.4) 0.16 0.65 (0.35 -  1.19) 
11-15 160 (21.4) 81 (50.6) 79 (49.4) 0.14 0.62 (0.33 - 1.16) 
16-20  93 (12.46) 50 (53.8) 43 (46.2) 0.08 0.55 (0.28- 1.08) 
> 20  54 (7.23) 21 (38.9) 33 (61.1)  1 
District Middle 332(31.09) 171(51.5) 161(48.5) 0.25 1.21 (0.88-1.66) 
North 131(17.56) 69 (52.7) 62 (47.3) 0.5 1.15 (0.76- 1.75) 
South 283(37.93) 159(56.2) 124(43.8)  1 
Education level Illiterate 109(14.61) 54 (49.5) 55 (50.5) 0.35 1.28 (0.76 - 2.18) 
School 385 (51.6) 218(56.6) 167(43.4) 0.87 0.97 (0.63 - 1.47) 
High school 139(18.63) 64 (46.0) 75 (54.0) 0.13 1.48 (0.9 - 2.43) 
University (Ref.) 113(15.14) 63 (55.8) 50 (44.2)  1 
Profession 
Total N=203 
Worker 138(67.98) 76 (55.1) 62 (44.9) 0.76 1.22 (0.33- 4.53) 
Highly educated 55 (27.09) 30 (54.5) 25 (45.5) 0.75 1.25 (0.32 - 4.93) 
Health sector 10 (4.92) 6 (60.0) 4 (40.0)  1 
Employed Yes 195(26.13) 111(56.9) 84 (43.1) 0.26 1.21 (0.87- 1.68) 
No 551(73.85) 288(52.3) 263(47.7) 
Smoking Yes 119(15.95) 62 (52.1) 57 (47.9) 0.65 0.89 (0.54-  1.47) 
No 501(67.15) 275(54.9) 226(45.1) 0.25 0.8 (0.54- 1.18) 
Past smoker 126(16.89) 62 (49.2) 64 (50.8)  1 
Insurance  MOH 427 (57.2) 221(51.8) 206(48.2) 0.95 1.01 (0.69- 1.48) 
UNRWA 17523.45 103(58.9) 72 (41.1) 0.23 0.76 (0.49- 1.18) 
Others 144 (19.3) 75 (52.1) 69 (47.9)  1 
Marital Status Single 14 (1.87) 10 (71.4) 4 (28.6) 0.13 0.38 (0.11- 1.31) 
Married 633(84.85) 341(53.9) 292(46.1) 0.38 0.82 (0.52- 1.28) 
Divorced 13 (1.74) 6 (46.2) 7 (53.8) 0.86 1.11 (0.35- 3.59) 
Widow 86 (11.52) 42 (48.8) 44 (51.2)  1 
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B-HbA1c 4-3 with various follow up criteria  
 
A significant association was found between HbA1c 4-3 and systolic blood pressure 
(p<0.05).HbA1c 4-3 was not associated with MAU 4-3 and cholesterol and diastolic 
blood pressure 4-3(P >0.05, see table 8). 
 
Table 8: The distribution of HbA1C 4-3 with various follow up criteria for 746 
diabetic patient 
Variable  Total 
N=746 
Bad 
 N= 399  
Good  
N= 347   
P 
value 
Odds ratio (CI) 
Good MAU*  339(45.44) 178 (52.5) 161 (47.5) 0.63 1.08 (0.81- 1.44) 
Good cholesterol* 328 (43.9) 165 (50.3) 163 (49.7) 0.12 1.26 (0.94- 1.68) 
Good Systolic* 354(47.4) 174 (49.2) 180 (50.8) 0.02 1.39 (1.04- 1.86) 
Good Diastolic*  372(49.8) 194 (52.2) 178 (47.8) 0.47 1.11 (0.84- 1.48) 
*reference category bad  
 
C –HbA1c 4-3 with lifestyle behaviors 
 
No association was found between the frequency of HbA1c 4-3and BMI, Calories 
intake and activity level (P >0.05 see table 9) 
 
Table 9: The distribution of Hba1c 4-3 with lifestyle behaviors 
Variable   Total 
N=746 
Bad 
N= 399 
Good 
N= 347 
P 
value 
Odds ratio (CI) 
Good BMI* 348(46.64) 174 (50) 174 (50) 0.07 1.3 (0.97- 1.74) 
Calories  1000 306(41.01) 173 (56.5) 133 (43.5) 0.59 0.77 (0.3-1.99) 
1200 29 (3.88) 15 (51.7) 14 (48.3) 0.91 0.93 (0.29- 3.03) 
1400 67 (8.98) 35 (52.2) 32 (47.8) 0.87 0.91 (0.32- 2.59) 
1600 104(13.94) 54 (51.9) 50 (48.1) 0.88 0.93 (0.34- 2.52) 
1800 100 (13.4) 54 (54) 46 (46) 0.75 0.85 (0.31- 2.33) 
2000 93 (12.46) 44 (47.3) 49 (52.7) 0.83 1.11 (0.41- 3.06) 
2200 29 (3.88) 15 (51.7) 14 (48.3) 0.91 0.93 (0.29 -3.03) 
2400 18 (2.41) 9 (50.0) 9 (50)  1 
Activity 
level 
Very light 14 (1.87) 10 (71.4) 4 (28.6) 0.1 0.36 (0.11- 1.2) 
Light 613(82.17) 333 (54.3) 280 (45.7) 0.15 0.75 (0.5- 1.11) 
Moderate 119 (15.9) 56 (47.1) 63 (52.9)  1 
*reference bad BMI 
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5  HbA1c change between fourth and second visit (HbA1c 4-2) 
A- HbA1c 4-2 and demographic factors 
A significant association was found between HbA1c 4-2 and duration of diabetes ≤ 5 
years, smoking and marital status (p<0.05). No association was found in age, sex, 
period in study , education level , type of profession , residency, employment and 
insurance ( p>0.05 )(see table 10 ). 
 
Table 10: the distribution of HbA1c 4-2 with various demographic variables. 
 
 
Variable  Total 
N=746 
Bad  
N= 378 
Good  
N= 368 
P 
value 
Odds ratio (CI) 
Age ≤40  35 (4.69) 18 (51.4) 17 (48.6) 0.66 0.85 (0.42- 1.72) 
41-50 143 (19.2) 78 (54.5 ) 65 (45.5) 0.17 0.75 (0.5-1.13) 
51-60  296 (40) 153 (51.7) 143 (48.3) 0.31 0.84 (0.61- 1.17) 
> 60  272(36.46) 129 (47.4) 143 (52.6)  1 
Sex Male 349(46.78)  173 (49.6) 176 (50.4) 0.57 0.92 (0.69- 1.23) 
Female 397 (53.2) 205 (51.6) 192 (48.4) 
Period in study ≤6  40 (5.3) 22 (55.0) 18 (45.0) 0.65 0.86 (0.44-1.69) 
7-12  91 (12.19) 48 (52.7) 43 (47.3) 0.8 0.94 (0.58- 1.53) 
13- 18  50 (6.7) 23 (46.0) 27 (54.0) 0.51 1.23 (0.66- 2.28) 
19- 24 107 (14.3) 54 (50.5) 53 (49.5) 0.91 1.03 (0.65- 1.63) 
25- 30  74 (9.91) 36 (48.6) 38 (51.4) 0.71 1.11 (0.65- 1.87) 
31- 36  165 (22.1) 83 (50.3) 82 (49.7) 0.87 1.03 (0.69- 1.55) 
> 36  219(29.35) 112 (51.1) 107 (48.9)  1 
Duration of Diabetes ≤5  211(28.28) 130 (61.6) 81 (38.4) 0.00 0.37 (0.2- 0.68) 
6-10  228(30.56) 117 (51.3) 111 (48.7) 0.06 0.56 (0.3- 1.03) 
11-15 160 (21.4) 63 (39.4) 97 (60.6) 0.76 0.91 (0.48- 1.71) 
16-20  93 (12.46) 48 (51.6) 45 (48.4) 0.09 0.55 (0.28- 1.1) 
> 20  54 (7.23) 20 (37.0) 34 (63.0)  1 
District Middle 332(31.09) 181(54.5) 151 (45.5) 0.11 0.77 (0.56-1.06) 
North 131(17.56) 61 (46.6) 70 (53.4) 0.78 1.06 (0.7-1.61) 
South 283(37.93) 136 (48.1) 147 (51.9)  1 
Education level Illiterate 109(14.61) 47 (43.1) 62 (56.9) 0.14 1.49 (0.88- 2.54) 
School 385 (51.6) 208 (54.0) 177 (46.0) 0.86 0.96 (0.63- 1.47) 
High school 139(18.63) 63 (45.3) 76 (54.7) 0.22 1.37 (0.83- 2.25) 
University  113(15.14) 60 (53.1) 53 (46.9)  1 
Profession 
Total N=203 
Worker 138(67.98) 75 (54.3) 63 (45.7) 0.73 1.26 (0.34- 4.66) 
Highly educated 55 (27.09) 24 (43.6) 31 (56.4) 0.35 1.94 (0.49- 7.65) 
Health sector 10 (4.92) 6 (60.0) 4 (40.0)  1 
Employed Yes 195(26.13) 103 (52.8) 92 (47.2) 0.49 1.12 (0.81- 1.56) 
No 551(73.85) 275 (49.9) 276 (50.1) 
Smoking 
 
Yes 119(15.95) 61 (51.3) 58 (48.7) 0.12 0.67 (0.4- 1.11) 
No 501(67.15) 265 (52.9) 236 (47.1) 0.02 0.63 (0.42-0.93) 
Past smoker 126(16.89) 52 (41.3) 74 (58.7)  1 
Insurance  MOH 427 (57.2) 208 (48.7) 219 (51.3) 0.58 1.11 (0.76- 1.62) 
UNRWA 175(23.45) 96 (54.9) 79 (45.1) 0.54 0.87 (0.56-1.35) 
Others 144(18.63) 74 (51.4) 70 (48.6)  1 
Marital Status Single 14 (1.87) 6 (42.9) 8 (57.1) 0.42 1.61 (0.51- 5.03) 
Married 633(84.85) 322 (50.9) 311 (49.1) 0.51 1.16 (0.74- 1.83) 
Divorced 13 (1.74) 3 (23.1) 10 (76.9) 0.04 4.02 (1.03- 15.62) 
Widow 86(11.52) 47 (54.7) 39 (45.3)  1 
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B-HbA1c 4-2 with various follow up criteria (MAU, cholesterol, systolic and 
diastolic blood pressure) 
 
HbA1c 4-2 was not associated with MAU 4-2 and cholesterol, systolic and diastolic 
blood pressure (P >0.05, see table 11). 
 
Table 11: The distribution of HbA1C 4-2 with various follow up criteria  
Variable  Total 
N=746 
Bad  
N= 378 
Good  
N= 368 
P 
value 
Odds ratio (CI) 
Good MAU*  333(44.6) 164 (49.2) 169 (50.8) 0.49 1.11 (0.83- 1.48) 
Good cholesterol* 360(48.25) 181 (50.3) 179 (49.7) 0.84 1.03 (0.77- 1.37) 
Good Systolic* 352 (47.18) 169 (48.0) 183 (52.0) 0.17 1.22 (0.92- 1.63) 
Good Diastolic* 397 (53.2) 193 (48.6) 204 (51.4) 0.23 1.19 (0.89- 1.59) 
*reference category bad 
 
C –HbA1c 4-2 with lifestyle behaviors 
No association was found between the frequency of HbA1c 4-2 and BMI, Calories 
intake and activity level (P >0.05, see table 12) 
 
Table 12: The distribution of HbA1c 4-2 with lifestyle behaviors 
Variable  Total 
N=746 
Bad  
N= 378 
Good  
N= 368 
P value Odds ratio (CI) 
Good BMI 284(38.06) 131(46.1) 153(53.9) 0.05 1.34 (1- 1.8) 
Calories  1000 306(41.01) 159 (52.0) 147 48.0) 0.59 0.77 (0.3- 2) 
1200 29 (3.88) 16 (55.2) 13 (44.8) 0.91 0.93 (0.3- 3.0) 
1400 67 (8.98) 42 (62.7) 25 (37.3) 0.87 0.91 (0.3- 2.6) 
1600 104 (13.94) 44 (42.3) 60 (57.7) 0.88 0.93 (0.3- 2.5) 
1800 100 (13.4) 51 (51.0) 49 (49.0) 0.75 0.85 (0.3- 2.3) 
2000 93 (12.46) 40 (43.0) 53 (57.0) 0.83 1.11 (0.4- 3.0) 
2200 29 (3.88) 14 (48.3) 15 (51.7) 0.91 0.93 (0.3- 3.0) 
2400 18 (2.41) 12 (66.7) 6 (33.3)  1 
Activity level Very light 14 (1.87) 7 (50.0) 7 (50.0) 0.1 0.36 (0.1- 1.2) 
Light 613 (82.17) 318 (51.9) 295 (48.1) 0.15 0.75 (0.5- 1.1) 
Moderate 119 (15.9) 53 (44.5) 66 (55.5)  1 
*reference category bad 
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6 HbA1c change between Third and first visit (HbA1c 3-1): 
A- HbA1c 3-1 and demographic factors 
Table 13 presents the association between HbA1c 3-1 with various demographic 
variables, a significant association was found with period in study, duration of diabetes 
(16-20years), place of residency (p<0.05). No association was found between HbA1c 3-1 
and Age, Gender, education level, employment, insurance, marital status and type of 
profession (p>0.05) 
 
Table 13:  The association between HbA1c 3-1with demographic variables. 
Variable Total 
N=746 
Bad  
N= 312  
Good  
N= 434 
P 
value 
Odds ratio (CI) 
Age ≤40  35 (4.69) 15 (42.9) 20 (57.1) 0.95 0.98 (0.48- 1.99) 
41-50 143(19.2) 66 (46.2) 77 (53.8) 0.45 0.86 (0.57- 1.28) 
51-60  296 (40) 116 (39.2) 180 (60.8) 0.45 1.14 (0.81-1.59) 
> 60  272(36.46) 115 (42.3) 157 (57.7)  1 
Sex Male 349(46.78) 137 (39.3) 212 (60.7) 0.18 0.82 (0.61- 1.1) 
Female 397 (53.2) 175 (44.1) 222 (55.9) 
Period in 
study 
≤6  40 (5.3) 27 (67.5) 13 (32.5) 0.17 0.61 (0.3- 1.24) 
7-12  91 (12.19) 23 (25.3) 68 (74.7) 0.00 3.72 (2.16- 6.4) 
13- 18  50 (6.7) 14 (28.0) 36 (72.0) 0.00 3.23 (1.65- 6.34) 
19- 24 107 (14.3) 37 (34.6) 70 (65.4) 0.00 2.38 (1.47- 3.84) 
25- 30  74 (9.91) 25 (33.8) 49 (66.2) 0.00 2.47 (1.42- 4.28) 
31- 36  165 (22.1) 64 (38.8) 101 (61.2) 0.00 1.99 (1.32- 3) 
> 36  219(29.35) 122 (55.7) 97 (44.3)  1 
Duration 
of 
Diabetes 
≤5  211(28.28) 104 (49.3) 107 (50.7) 0.7 0.89 (0.49- 1.61) 
6-10  228(30.56) 102 (44.7) 126 (55.3) 0.84 1.07 (0.59- 1.93) 
11-15 160 (21.4) 56 (35.0) 104 (65.0) 0.14 1.6 (0.86- 2.99) 
16-20  93 (12.46) 25 (26.9) 68 (73.1) 0.02 2.35 (1.16- 4.74) 
> 20  54 (7.23) 25 (46.3) 29 (53.7)  1 
Place of 
residency 
Middle 332(31.09) 154 (46.4) 178 (53.6) 0.03 0.69 (0.5- 0.96) 
North 131(17.56) 52 (39.7) 79 (60.3) 0.66 0.91 (0.6- 1.39) 
South 283(37.93) 106 (37.5) 177 (62.5)  1 
Education 
level 
Illiterate 109(14.61) 47 (43.1 ) 62 (56.9) 0.44 0.81 (0.47- 1.39) 
School 385 (51.6) 163 (42.3) 222 (57.7) 0.42 0.84 (0.54- 1.29) 
High school 139(18.63) 59 (42.4) 80 (57.6) 0.48 0.83 (0.5- 1.38) 
University (Ref.) 113(15.14) 43 (38.1) 70 (61.9)  1 
Profession 
Total 
N=203 
Worker 138(67.98) 51 (37.0) 87 (63.0) 0.16 2.56 (0.69- 9.5) 
Highly educated 55 (27.09) 21 (38.2) 34 (61.8) 0.21 2.43 (0.61- 9.63) 
Health 
background(Ref.) 
10 (4.92) 6 (60.0) 4 (40.0)  1 
Employed Yes 195(26.13) 78 (40.0) 117 (60.0) 0.55 0.9 (0.65- 1.26) 
No 551(73.85) 234 (42.5) 317 (57.5) 
Smoking 
Yes 119(15.95) 46 (38.7) 73 (61.3) 0.68 1.12 (0.67- 1.86) 
No 501(67.15) 214 (42.7) 287 (57.3) 0.77 0.94 (0.63- 1.4) 
Past smoker 126(16.89) 52 (41.3) 74 (58.7)  1 
Insurance  
MOH 427(57.2) 171 (40.0) 256 (60.0) 0.35 1.2 (0.82- 1.75) 
UNRWA 175(23.45) 77 (44.0) 98 (56.0) 0.94 1.02 (0.65- 1.59) 
Others 144(19.63) 64 (44.4) 80 (55.6)  1 
Marital 
Status 
Single 14 (1.87) 4 (28.6) 10 (71.4) 0.15 2.5 (0.73- 8.59) 
Married 633(84.85) 261 (41.2) 372 (58.8) 0.12 1.43 (0.91- 2.24) 
Divorced 13 (1.74) 4 (30.8) 9 (69.2) 0.2 2.25 (0.64- 7.86) 
Widow 86 (11.52) 43 (50.0) 43 (50.0)  1 
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B-HbA1c 3-1 with various follow up criteria  
 
HbA1c 3-1 was significantly associated with MAU 3-1(p<0.05) and diastolic blood 
pressure. While, no significant association was found between HbA1c 3-1 with 
cholesterol and diastolic pressure (P >0.05, see table 14). 
 
 Table 14: The distribution of HbA1c 3-1 with various follow up criteria  
*reference category bad 
 
C –Hba1c 3-1 with lifestyle behaviors 
Inverse association was found between HbA1c 3-1 and the Calories intake (1000, 1400 
calories) (p<0.05, OR<1).No association was found between the frequency of HbA1c 3-1 
and BMI 3-1, and activity level (P >0.05) (see table 15). 
 
Table 15: The distribution of HbA1C 3-1 with lifestyle behavior 
Variable  Total 
N=746 
Bad  
N= 312  
Good  
N= 434 
P value Odds ratio (CI) 
Good BMI 221(29.6) 96 (43.4) 125 (56.6) 0.56 0.91 (0.66- 1.25) 
Calories  1000 306(41.01) 137 (44.8) 169 (55.2) 0.03 0.25 (0.07- 0.87) 
1200 29 (3.88) 11 (37.9) 18 (62.1) 0.13 0.33 (0.08- 1.39) 
1400 67 (8.98) 33 (49.3) 34 (50.7) 0.02 0.21 (0.06- 0.78) 
1600 104(13.94) 44 (42.3) 60 (57.7) 0.05 0.27 (0.074- 1) 
1800 100 (13.4) 41 (41.0) 59 (59.0) 0.06 0.29 (0.08- 1.06) 
2000 93 (12.46) 33 (35.5) 60 (64.5) 0.13 0.36 (0.1- 1.35) 
2200 29 (3.88) 10 (34.5) 19 (65.5) 0.19 0.38 (0.09- 1.63) 
2400 18 (2.41) 3 (16.7) 15 (83.3)  1 
Activity 
level 
Very light 14 (1.87) 4 (28.6) 10 (71.4) 0.46 1.58 (0.47- 5.32) 
Light 613(82.17) 262 (42.7) 351 (57.3) 0.41 0.84 (0.57- 1.26) 
Moderate 119 (15.9) 46 (38.7) 73 (61.3)  1 
 
 
 
 
 
 
 
 
 
 
 
Variable Total 
N=746 
Bad  
N= 312  
Good  
N= 434 
P value Odds ratio (CI) 
Good MAU* 290(38.8) 108 (37.2) 182 (62.8) 0.04 1.36 (1.01- 1.84) 
Good cholesterol* 321 (43) 128 (39.9) 193 (60.1) 0.35 1.15 (0.86- 1.55) 
Good Systolic* 357(47.8) 149 (41.7) 208 (58.3) 0.96 1.01 (0.75-1.35) 
Good Diastolic*  382(51.2) 144 (37.7) 238 (62.3) 0.02 1.42 (1.06- 1.9) 
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Annex 6: Univariate and multivariate analysis of the subsample (n=255) 
HbA1c change between Second and first visit (HbA1c 2-1): 
A-HbA1c 2-1 and demographic factors 
 
 
Table 1: the association between HbA1c 2-1 with various demographic variables. 
 
 
Variable Total 
N=255 
Bad  
N= 86 
Good  
N=169  
P 
value 
Odds ratio(CI) 
Age ≤40  15(5.88) 4 (26.7) 11(73.3) 0.18 2.3(0.68-7.77) 
41-50 42(16.47) 14(33.3) 28(66.7) 0.19 1.67(0.78-3.59) 
51-60  108(42.35) 27(25) 81(75) 0.00 2.51(1.38-4.58) 
> 60  90(35.29) 41(45.6) 49(54.4)   
Sex Male 117(45.88) 36(30.8) 81(69.2) 0.36 0.78(0.46-1.32) 
Female 138(54.12) 50(36.2) 88(63.8) 
Period in 
study 
Months 
≤6  1(0.39) 0 (0) 1(100) 1 1.281E9(0.00) 
7-12  37(14.5) 7(18.9) 30(81.1) 0.02 3.4(1.27-9.13) 
13- 18  25(9.8) 8(32) 17(68) 0.31 1.69(0.62-4.59) 
19- 24 71(27.8) 26(36.6) 45(63.4) 0.4 1.37(0.66-2.85) 
25- 30  21(8.23) 5(23.8) 16(76.2) 0.11 2.54(0.81-7.96) 
31- 36  48(18.82) 17(35.4) 31(64.6) 0.37 1.45(0.65-3.24) 
> 36  52(20.39) 23(44.2) 29(55.8)  1 
Duration 
of 
Diabetes 
Years 
≤5  70(27.45) 24(34.3) 46(65.7) 0.03 3.83(1.18-12.49) 
6-10  65(25.4) 21(32.3) 44(67.7) 0.02 4.19(1.27-13.81) 
11-15 56(21.96) 14(25) 42(75) 0.00 6.00(1.75-20.57) 
16-20  49(19.22) 17(34.7) 32(65.3) 0.03 3.77(1.11-12.80) 
> 20  15(5.88) 10(66.7) 5(33.30)  1 
Regions Middle 100 (39.22) 40 (40) 60(60) 0.048 0.56(0.32-0.99) 
North 41(16.08) 15(36.6) 26(63.4) 0.26 0.65(0.3-1.38) 
South 114(44.71) 31(27.2 83(72.8)  1 
Education 
level 
Illiterate 55 (21.57) 23 (41.8) 32(58.2) 0.04 0.37(0.14- 0.96) 
School 124 (48.63) 41 (33.1) 83(66.9) 0.16 0.54 (0.23-1.28) 
High school 38 (14.9) 14(36.8) 24(63.2) 0.13 0.46(0.17-1.27) 
University  38 (14.9) 8(21.1) 30(78.9)  1 
Employed Yes 65(25.49) 20 (30.8) 45 (69.2) 0.56 0.84 (0.46-1.53) 
No 190(74.51) 66 (34.7) 124 (65.3) 
Smoking Yes 36(14.12) 11(30.6) 25(69.4) 0.28 1.66 (0.66-4.18) 
No 174(68.24) 56(32.2) 118(67.8) 0.21 1.54(0.79-3.01) 
Past smoker 45(17.65) 19(42.2) 26(57.8)  1 
Insurance  MOH 140 (54.9) 53 (37.9) 87(62.1) 0.07 0.52 (0.26- 1.06) 
UNRWA 61 (23.92) 20 (32.8) 41(67.2) 0.3 0.65(0.29-1.48) 
Others 54 (21.18) 13(24.1) 41(75.9)  1 
Marital 
Status 
Single 4 (1.57) 1 (25) 3(75) 0.46 2.43 (0.23-25.51) 
Married 209 (81.96) 66 (31.6) 143(68.4) 0.12 1.75 (0.87-3.54) 
Divorced 4 (1.57) 2 (50) 2(50) 0.84 0.81 (0.1-6.36) 
Widow 38 (14.9) 17(44.7) 21(55.3)  1 
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B-HbA1c 2-1 and lab tests   
 
Table 2: Associations between HbA1c 2-1 change with change in cholesterol, 
MAU, and blood pressure 
Variable  Total 
N=255 
Bad  
N= 86 
Good  
N=169  
P value Odds ratio (CI) 
Good MAU* 97 (38.09) 27(27.8) 70(72.2) 0.12 1.55(0.89-2.68) 
Good cholesterol* 78(30.59) 24 (30.8) 54(69.2) 0.51 1.21 (0.69-2.15) 
Good Systolic* 136 (53.3) 48(35.3) 88 (64.7) 0.57 0.86(0.51-1.45) 
Good Diastolic* 138 (54.12) 37 (26.8) 101 (73.2) 0.01 1.97(1.16-3.33) 
*reference category bad  
C –HbA1c 2-1 with lifestyle behaviors 
 
Table 3: Associations between HbA1c 2-1 change with BMI, caloric intake and 
physical activity  
Variable  Total 
N=255 
Bad  
N= 86 
Good  
N=169  
P value Odds ratio (CI) 
Good BMI* 93 (36.47) 32 (34.4) 61(65.6) 0.86 0.95 (0.56-1.63) 
Calories  1000 103 (40.39) 38 (36.9) 65(63.1) 0.15 0.21(0.03-1.78) 
1200 13 (5.1) 6 (46.2) 7 (53.8) 0.11 0.15(0.01-1.53) 
1400 19 (7.45) 7 (36.8) 12 (63.2) 0.19 0.21(0.02-2.09) 
1600 22(8.63) 9 (40.9) 13 (59.1) 0.14 0.18(0.02-1.71) 
1800 45(17.65) 16 (35.6) 29(64.4) 0.18 0.23(0.03-1.98) 
2000 32(12.55) 6 (18.8) 26 (81.3) 0.6 0.54(0.06-5.19) 
2200 12 (4.71) 3 (25) 9(75) 0.43 0.38(0.03-4.37) 
2400 9(3.53) 1 (11.1) 8 (88.9)  1 
Activity level Very light 5 (1.96) 2(40) 3 (60) 0.5 0.52 (0.08-3.56) 
Light 211 (82.75) 74(35.1) 137(64.9) 0.26 0.64(0.3-1.38) 
Moderate 39 (15.29) 10(25.6) 29(74.4)  1 
*reference bad BMI 
 
 
 
 
 
 
 
 
  
 
148
HbA1c change between third and first visit (HbA1c 3-1): 
A-HbA1c 3-1 and demographic factors 
 
Table 4: the association between HbA1c 3-1 with various demographic variables. 
 
 
 
Variable Total 
N=255 
Bad  
N= 86 
Good  
N=169  
P 
value 
Odds 
ratio(CI) 
Age ≤40  15(5.88) 8 (53.3) 7(46.7) 0.17 0.46 (0.15-
1.39) 
41-50 42(16.47) 11(26.2) 31(73.8) 0.34 1.48(0.66-3.34) 
51-60  108(42.35) 27(25) 81(75) 0.15 1.58(0.85-2.92) 
> 60  90(35.29) 31(34.4) 59(65.6)  1 
Sex Male 117(45.88) 31 (26.5) 86 (73.5) 0.24 0.72 (0.42-
1.24) Female 138(54.12) 46 (33.3) 92 (66.7) 
Period in 
study 
Months 
≤6  1(0.39) 0(0) 1(100) 1.00 1.010E9(0.00) 
7-12  37(14.5) 7(18.9) 30(81.1) 0.05 2.68 (0.99-
7.24) 
13- 18  25(9.8) 7(28) 18(72) 0.37 1.61(0.57-4.53) 
19- 24 71(27.8) 19(26.8) 52 (73.2) 0.17 1.71(0.79-3.68) 
25- 30  21(8.23) 7(33.3) 14 (66.7) 0.68 1.25(0.43- 
3.63) 
31- 36  48(18.82) 17 (35.4) 31 (64.6) 0.75 1.14(0.51-2.57) 
> 36  52(20.39) 20(38.5) 32(61.5)  1 
Duration 
of 
Diabetes 
Years 
≤5  70(27.45) 25(35.7) 45(64.3) 0.09 2.7(0.86-8.47) 
6-10  65(25.4) 20(30.8) 45(69.2) 0.04 3.38(1.06-
10.76) 
11-15 56(21.96) 12(21.4) 44(78.6) 0.01 5.5(1.63-18.52) 
16-20  49(19.22) 11(22.4) 38(77.6) 0.01 5.18(1.51-
17.76) 
> 20  15(5.88) 9(60) 6(40)  1 
Regions Middle 100 (39.22) 36(36) 64(64) 0.13 0.64(0.35-1.14) 
North 41(16.08) 11(26.8) 30(73.2) 0.95 0.97(0.44-2.18) 
South 114(44.71) 30(26.3) 84(73.7)  1 
Education 
level 
Illiterate 55 (21.57) 18(32.7) 37(67.3) 0.22 0.55(0.21-1.43) 
School 124 (48.63) 43(34.7) 81(65.3) 0.12 0.5(0.21-1.19) 
High school 38 (14.9) 8(21.1) 30(78.9) 1 1(0.33-3.01) 
University  38 (14.9) 8(21.1) 30(78.9)  1 
Employed Yes 65(25.49) 20(30.8) 45 (69.2) 0.91 1.04(0.56-1.91) 
No 190(74.51) 57(30) 133(70) 
Smoking Yes 36(14.12) 11(30.6) 25(69.4) 0.64 1.25(0.49-3.2) 
No 174(68.24) 50(28.7) 124(71.3) 0.38 1.37(0.68-2.74) 
Past smoker 45(17.65) 16(35.6) 29(64.4)  1 
Insurance  MOH 140 (54.9) 44(31.4) 96(68.6) 0.99 1(0.51- 1.97) 
UNRWA 61 (23.92) 16(26.2) 45(73.8) 0.54 1.29(0.58-2.9) 
Others 54 (21.18) 17(31.5) 37(68.5)  1 
Marital 
Status 
Single 4 (1.57) 1(25) 3(75) 0.46 2.43(0.23-
25.51) 
Married 209 (81.96) 58(27.8) 151(72.2) 0.04 2.11(1.04-4.28) 
Divorced 4 (1.57) 1(25) 3(75) 0.46 2.43(0.23-
25.51) 
Widow 38 (14.9) 17(44.7) 21(55.3)  1 
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B-HbA1c 3-1 and lab tests   
 
Table 5 :Associations between HbA1c 3-1 change with change in cholesterol, 
MAU, and blood pressure 
 
 
 
 
 
*reference category bad  
 
C –HbA1c 3-1 with lifestyle behaviors 
 
Table 6 :Associations between HbA1c 3-1 change with BMI, caloric intake and 
physical activity  
Variable  Total 
N=255 
Bad  
N= 77 
Good  
N=178  
P value Odds ratio (CI) 
Good BMI* 88 (34.51) 29(33) 59 (67) 0.49 0.82(0.47-1.43) 
Calories  1000 103 (40.39) 33(32) 70(68) 0.22 0.27(0.03-2.21) 
1200 13 (5.1) 5(38.5) 8(61.5) 0.18 0.2(.019-2.12) 
1400 19 (7.45) 6(31.6) 13(68.4) 0.26 0.27(.03-2.68) 
1600 22(8.63) 6(27.3) 16(72.7) 0.35 0.33(0.03-3.26) 
1800 45(17.65) 17(37.8) 28(62.2) 0.15 0.21(0.02-1.79) 
2000 32(12.55) 7(21.9) 25(78.1) 0.48 0.45(0.047-4.2) 
2200 12 (4.71) 2(16.7) 10(83.3) 0.72 0.63(0.048-8.2) 
2400 9(3.53) 1(11.1) 8(88.9)  1 
Activity level Very light 5 (1.96) 1(20) 4(80) 0.98 1.03 (0.1-10.56) 
Light 211 (82.75) 68(32.2) 143(67.8) 0.15 0.54 (0.24-1.24) 
Moderate 39 (15.29) 8(20.5) 31(79.5)  1 
*reference bad BMI 
 
 
 
 
 
 
 
 
 
Variable  Total 
N=255 
Bad  
N= 77 
Good  
N=178  
P value Odds ratio (CI) 
Good MAU* 85( 33.3) 19(22.4) 66(77.6) 0.5 1.8 (0.99-3.28) 
Good cholesterol* 84(32.94) 24(28.6) 60(71.4) 0.69 1.12(0.63- 1.99) 
Good Systolic* 138 (54.2) 43(31.2) 95(68.8) 0.72 0.91(0.53-1.55) 
Good Diastolic* 130 (50.98) 37 (28.5) 93(71.5) 0.54 1.18(0.69-2.02) 
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HbA1c change between third and second (HbA1c 3-2): 
A-HbA1c 3-2 and demographic factors 
  
Table 7 :  the association between HbA1c 3-2 with various demographic 
variables. 
 
 
 
 
 
 
Variable Total 
N=255 
Bad  
N= 127 
Good  
N=128  
P 
value 
Odds ratio(CI) 
Age ≤40  15(5.88) 8(53.3) 7 (46.7) 0.69 0.8(0.27-2.39) 
41-50 42(16.47) 25(59.5) 17(40.5) 0.21 0.62 (0.3-1.31) 
51-60  108(42.35) 51(47.2) 57(52.8) 0.94 1.02(0.58-1.79) 
> 60  90(35.29) 43(47.8) 47(52.2)  1 
Sex Male 117(45.88) 60 (51.3) 57(48.7) 0.66 1.12 (0.68- 1.83) 
Female 138(54.12) 67(48.6) 71(51.4) 
Period in 
study 
Months 
≤6  1(0.39) 1(100) 0(0) 1 0.00(0.00) 
7-12  37(14.5) 17(45.9) 20(54.1) 0.58 1.27(0.55-2.96) 
13- 18  25(9.8) 12(48) 13(52) 0.75 1.17(0.45-3.04) 
19- 24 71(27.8) 30(42.3) 41(57.7) 0.29 1.48(0.72-3.03) 
25- 30  21(8.23) 15(71.4) 6(28.6) 0.13 0.43(0.15-1.29) 
31- 36  48(18.82) 25(52.1) 23(47.9) 0.99 0.99(0.45-2.18) 
> 36  52(20.39) 27(51.9) 25(48.1)  1 
Duration 
of 
Diabetes 
Years 
≤5  70(27.45) 33 (47.1) 37(52.9) 0.66 1.28(0.42-3.92) 
6-10  65(25.4) 35(53.8) 30(46.2) 0.97 0.98(0.32-3.02) 
11-15 56(21.96) 29(51.8) 27(48.2) 0.92 1.06(0.34-3.33) 
16-20  49(19.22) 22(44.9) 27(55.1) 0.57 1.4(0.44-4.48) 
> 20  15(5.88) 8(53.3) 7(46.7)  1 
Regions Middle 100 (39.22) 50(50) 50(50) 1 1 (0.58- 1.71) 
North 41(16.08) 20(48.8) 21(51.2) 0.89 1.05(0.51-2.14) 
South 114(44.71) 57(50) 57(50)  1 
Education 
level 
Illiterate 55 (21.57) 27 (49.1) 28(50.9) 0.56 1.28 (0.56-2.94) 
School 124 (48.63) 62 (50) 62(50) 0.57 1.24(0.6-2.56) 
High school 38 (14.9) 17(44.7) 21(55.3) 0.36 1.53(0.62-3.77) 
University  38 (14.9) 21(55.3) 17(44.7)  1 
Employed Yes 65(25.49) 34 (52.3) 31(47.7) 0.64 1.14 (0.65- 2.01) 
No 190(74.51) 93(48.9) 97(51.1) 
Smoking Yes 36(14.12) 17 (47.2) 19 (52.8) 0.59 1.28 (0.53-3.07) 
No 174(68.24) 86 (49.4) 88 (50.6) 0.64 1.17(0.61-2.26) 
Past smoker 45(17.65) 24 (53.3) 21(46.7)  1 
Insurance  MOH 140 (54.9) 64 (45.7) 76(54.3) 0.01 2.38(1.23-4.58) 
UNRWA 61 (23.92) 27(44.3) 34(55.7) 0.02 2.52(1.18-5.38) 
Others 54 (21.18) 36(66.7) 18(33.3)  1 
Marital 
Status 
Single 4 (1.57) 1(25) 3(75) 0.32 3.33 (0.32-34.99) 
Married 209 (81.96) 104(49.8) 105(50.2) 0.75 1.12(0.56-2.24) 
Divorced 4 (1.57) 2(50) 2(50) 0.92 1.11(0.14-8.73) 
Widow 38 (14.9) 20(52.6) 18(47.4)  1 
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B-HbA1c 3-2 and lab tests   
 
Table 8: Associations between HbA1c 3-2 change with change in cholesterol, 
MAU, and blood pressure 
Variable  Total 
N=255 
Bad  
N= 127 
Good  
N=128  
P value Odds ratio (CI) 
Good MAU* 60(23.53) 22(36.7) 38 (63.3) 0.02 2.02 (1.11- 3.66) 
Good cholesterol* 36 (14.12) 17 (47.2) 19 (52.8) 0.74 1.13 (0.55-2.29) 
Good Systolic* 128(50.2) 66 (51.6) 62(48.4) 0.57 0.87 (0.53- 1.42) 
Good Diastolic* 130 (50.98) 58 (44.6) 72(55.4) 0.09 1.53 (0.93- 2.51) 
*reference category bad  
 
C –HbA1c 3-2 with lifestyle behaviors 
 
Table 9 :Associations between HbA1c 3-2 change with BMI, caloric intake and 
physical activity  
Variable  Total 
N=255 
Bad  
N= 127 
Good  
N=128  
P value Odds ratio (CI) 
Good BMI* 83 (32.5) 44 (53) 39 (47) 0.48 0.83 (0.49- 1.4) 
Calories  1000 103 (40.39) 46 (44.7) 57 (55.3) 0.22 2.48 (0.59- 10.45) 
1200 13 (5.1) 8 (61.5) 5 (38.5) 0.81 1.25 (0.21- 7.41) 
1400 19 (7.45) 10(52.6) 9 (47.4) 0.49 1.8 (0.35- 9.4) 
1600 22(8.63) 7 (31.8) 15 (68.2) 0.08 4.29 (0.82- 22.34) 
1800 45(17.65) 24(53.3) 21 (46.7) 0.47 1.75 (0.39- 7.88) 
2000 32(12.55) 20(62.5) 12 (37.5) 0.82 1.2 (0.25- 5.71) 
2200 12 (4.71) 6(50) 6 (50) 0.45 2 (0.33- 11.97) 
2400 9(3.53) 6(66.7) 3 (33.3)  1 
Activity level Very light 5 (1.96) 1 (20) 4 (80) 0.29 3.43 (0.35-33.52) 
Light 211 (82.75) 108 (51.2) 103 (48.8) 0.56 0.82 (0.41-1.62) 
Moderate 39 (15.29) 18 (46.2) 21 (53.8)  1 
*reference bad BMI 
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HbA1c change between forth and second visit (HbA1c 4-2): 
A-HbA1c 4-2   and demographic factors 
Table 10 :  the association between HbA1c 4-2 with various demographic 
variables. 
 
 
 
 
 
 
 
Variable Total 
N=255 
Bad   
N=130 
Good  
N= 125 
P 
value 
Odds ratio(CI) 
Age ≤40  15(5.88) 8 (53.3) 7 (46.7) 0.81 1.14(0.38- 3.43) 
41-50 42(16.47) 25 (59.5) 17 (40.5) 0.76 0.89 (0.42-1.87) 
51-60  108(42.35) 46 (42.6) 62 (57.4) 0.049 1.76 (1-  3.1) 
> 60  90(35.29) 51 (56.7) 39 (43.3)  1 
Sex Male 117(45.88) 65(55.6) 52 (44.4) 0.18 1.4 (0.86- 2.3) 
Female 138(54.12) 65 (47.1) 73 (52.9) 
Period in 
study 
Months 
≤6  1(0.39) 1 (100) 0 (0) 1 0.00 (0.00) 
7-12  37(14.5) 19 (51.4) 18 (48.6) 0.19 1.79 (0.76- 4.24) 
13- 18  25(9.8) 9 (36) 16(64) 0.02 3.36 (1.24-9.1) 
19- 24 71(27.8) 33 (46.5) 38 (53.5) 0.04 2.18 (1.04- 4.55) 
25- 30  21(8.23) 11(52.4) 10 (47.6) 0.3 1.72 (0.61- 4.81) 
31- 36  48(18.82) 23 (47.9) 25 (52.1) 0.08 2.05 (0.92- 4.59) 
> 36  52(20.39) 34 (65.4) 18 (34.6)  1 
Duration 
of 
Diabetes 
Years 
≤5  70(27.45) 39(55.7) 31(44.3) 0.53 0.7 (0.23-2.13) 
6-10  65(25.4) 30(46.2) 35 (53.8) 0.97 1.02 (0.33- 3.15) 
11-15 56(21.96) 27(48.2) 29 (51.8) 0.92 0.94 (0.3-2.94) 
16-20  49(19.22) 27(55.1) 22 (44.9) 0.57 0.71 (0.22-2.28) 
> 20  15(5.88) 7 (46.7) 8 (53.3)  1 
Regions Middle 100 (39.22) 57 (57) 43 (43) 0.13 0.66 (0.38-1.13) 
North 41(16.08) 20(48.8) 21(51.2) 0.8 0.91 (0.45-1.86) 
South 114(44.71) 53(46.5) 61 (53.5)  1 
Education 
level 
Illiterate 55 (21.57) 25 (45.5) 30 (54.5) 0.24 1.65 (0.72-3.8) 
School 124 (48.63) 70 (56.5) 54(43.5) 0.88 1.06 (0.51-2.21) 
High school 38 (14.9) 13 (34.2) 25(65.8) 0.04 2.64(1.04-6.7) 
University  38 (14.9) 22 (57.9) 16 (42.1)  1 
Employed Yes 65(25.49) 37 (56.9) 28 (43.1) 0.27 1.38 (0.78- 2.43) 
No 190(74.51) 93 (48.9) 97 (51.1) 
Smoking Yes 36(14.12) 17 (47.2) 19 (52.8) 0.73 1.17 (0.49-2.81) 
No 174(68.24) 90 (51.7) 84 (48.3) 0.94 0.98 (0.51- 1.88) 
Past smoker 45(17.65) 23 (51.1) 22 (48.9)  1 
Insurance  MOH 140 (54.9) 70 (50) 70(50) 0.64 1.16 (0.62- 2.18) 
UNRWA 61 (23.92) 31(50.8) 30(49.2) 0.76 1.12(0.54- 2.34) 
Others 54 (21.18) 29(53.7) 25(46.3)  1 
Marital 
Status 
Single 4 (1.57) 1 (25) 3 (75) 0.2 4.6 (0.44- 48.47) 
Married 209 (81.96) 104(49.8) 105(50.2) 0.22 1.55 (0.77- 3.13) 
Divorced 4 (1.57) 2(50) 2(50) 0.69 1.53 (0.19- 12.09) 
Widow 38 (14.9) 23(60.5) 15(39.5)  1 
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B-HbA1c 4-2 and lab tests   
 
Table 11 :Associations between HbA1c 4-2 change with change in cholesterol, 
MAU, and blood pressure 
 
Variable  Total 
N=255 
Bad  
N= 130 
Good  
N= 125 
P value Odds ratio (CI) 
Good MAU* 111 (43.52) 56 (50.5) 55 (49.5) 0.88 1.04 (0.63- 1.7) 
Good cholesterol* 101 (39.6) 55 (54.5) 46 (45.5) 0.37 0.79 (0.48- 1.31) 
Good Systolic* 125(49.02) 63 (50.4) 62 (49.6) 0.86 1.05 (0.64-1.71) 
Good Diastolic* 131(51.37) 62 (47.3) 69(52.7) 0.23 1.35 (0.83- 2.21) 
*reference category bad  
C –HbA1c 4-2 with lifestyle behaviors 
 
Table 12: Associations between HbA1c 4-2 change with BMI, caloric intake and 
physical activity  
Variable  Total 
N=255 
Bad  
N= 130 
Good  
N= 125 
P value Odds ratio (CI) 
Good BMI* 103 (40.39) 49 (47.6) 54 (52.4) 0.37 1.26 (0.76- 2.08) 
Calories  1000 103 (40.39) 41 (39.8) 62 (60.2) 0.02 12.1 (1.46- 100.38) 
1200 13 (5.1) 9 (69.2) 4 (30.8) 0.3 3.56 (0.33- 38.78) 
1400 19 (7.45) 13 (68.4) 6 (31.6) 0.26 3.69 (0.37- 36.57) 
1600 22(8.63) 9 (40.9) 13 (59.1) 0.03 11.56 (1.22- 109.19) 
1800 45(17.65) 29 (64.4) 16 (35.6) 0.18 4.41 (0.51- 38.53) 
2000 32(12.55) 16 (50) 16 (50) 0.06 8 (0.89- 71.58) 
2200 12 (4.71) 5 (41.7) 7(58.3) 0.046 11.2 (1.04- 120.36) 
2400 9(3.53) 8 (88.9) 1 (11.1)  1 
Activity level Very light 5 (1.96) 2 (40) 3 (60) 0.88 1.16 (0.17- 7.73) 
Light 211 (82.75) 111(52.6) 100 (47.4) 0.3 0.7 (0.35- 1.39) 
Moderate 39 (15.29) 17 (43.6) 22 (56.4)  1 
*reference bad BMI 
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HbA1c change between fourth and first visit (HbA1c 4-1): 
A-HbA1c 4-1   and demographic factors 
 
Table 13: the distribution between HbA1c 4-1 with various demographic 
variables. 
 
 
 
 
 
 
Variable Total 
N=255 
Bad   
N= 92 
Good  
N= 163 
P 
value 
Odds ratio(CI) 
Age ≤40  15(5.88) 7 (46.7) 8 (53.3) 0.81 1.14 (0.38- 3.43) 
41-50 42(16.47) 16 (38.1) 26 (61.9) 0.76 0.89 (0.42-1.87) 
51-60  108(42.35) 33 (30.6) 75 (69.4) 0.049 1.76 (1-3.1) 
> 60  90(35.29) 36 (40) 54 (60)  1 
Sex Male 117(45.88) 42 (35.9) 75 (64.1) 0.96 0.99 (0.59- 1.65) 
Female 138(54.12) 50 (36.2) 88 (63.8) 
Period in 
study 
Months 
≤6  1(0.39) 1(100) 0 (0) 1 0.00 (0.00) 
7-12  37(14.5) 10 (27) 27(73) 0.19 1.79 (0.76- 4.24) 
13- 18  25(9.8) 8(32) 17(68) 0.02 3.36(1.24- 9.1) 
19- 24 71(27.8) 21(29.6) 50(70.4) 0.04 2.18 (1.04- 4.55) 
25- 30  21(8.23) 9(42.9) 12(57.1) 0.3 1.72 (0.61- 4.81) 
31- 36  48(18.82) 17(35.4) 31(64.6) 0.08 2.05 (0.92- 4.59) 
> 36  52(20.39) 26(50) 26(50)  1 
Duration 
of 
Diabetes 
Years 
≤5  70(27.45) 28 (40) 42 (60) 0.53 0.7 (0.23- 2.13) 
6-10  65(25.4) 24 (36.9) 41(63.1) 0.97 1.02 (0.33- 3.15) 
11-15 56(21.96) 16 (28.6) 40 (71.4) 0.92 0.94 (0.3-2.94) 
16-20  49(19.22) 16 (32.7) 33 (67.3) 0.57 0.71 (0.22- 2.28) 
> 20  15(5.88) 8 (53.3) 7 (46.7)  1 
Regions Middle 100 (39.22) 43 (43) 57(57) 0.13 0.66 (0.38- 1.13) 
North 41(16.08) 13 (31.7) 28 (68.3) 0.8 0.91 (0.45- 1.86) 
South 114(44.71) 36 (31.6) 78 (68.4)  1 
Education 
level 
Illiterate 55 (21.57) 18 (32.7) 37 (67.3) 0.24 1.65(0.72- 3.8) 
School 124 (48.63) 49(39.5) 75 (60.5) 0.88 1.06 (0.51- 2.21) 
High school 38 (14.9) 12(31.6) 26 (68.4) 0.04 2.64 (1.04-6.7) 
University  38 (14.9) 13 (34.2) 25(65.8)  1 
Employed Yes 65(25.49) 42 (35.9) 75 (64.1) 0.96 0.99 (0.59- 1.65) 
No 190(74.51) 50 (36.2) 88 (63.8) 
Smoking Yes 36(14.12) 13 (36.1) 23 (63.9) 0.73 1.17 (0.49- 2.81) 
No 174(68.24) 61 (35.1) 113 (64.9) 0.94 0.98 (0.51- 1.88) 
Past smoker 45(17.65) 18(40) 27 (60)  1 
Insurance  MOH 140 (54.9) 51 (36.4) 89 (63.6) 0.64 1.16 (0.62- 2.18) 
UNRWA 61 (23.92) 23 (37.7) 38 (62.3) 0.76 1.12 (0.54- 2.34) 
Others 54 (21.18) 18 (33.3) 36 (66.7)  1 
Marital 
Status 
Single 4 (1.57) 1 (25) 3 (75) 0.2 4.6 (0.44- 48.47) 
Married 209 (81.96) 72 (34.4) 137 (65.6) 0.22 1.55 (0.77- 3.13) 
Divorced 4 (1.57) 2 (50) 2 (50) 0.69 1.53 (0.19- 12.09) 
Widow 38 (14.9) 17 (44.7) 21 (55.3)  1 
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B-HbA1c 4-1and lab tests   
 
Table 14: Associations between HbA1c 4-1 change with change in cholesterol, 
MAU, and blood pressure 
 
Variable  Total 
N=255 
Bad  
N= 92 
Good  
N= 163 
P value Odds ratio (CI) 
Good MAU* 111 (43.53) 35 (31.5) 76 (68.5) 0.18 1.42 (0.85- 2.4) 
Good cholesterol* 117 (45.88) 43 (36.8) 74 (63.2) 0.84 0.95 (0.57- 1.58) 
Good Systolic* 122 (47.84) 46 (37.7) 76 (62.3) 0.6 0.87(0.52- 1.46) 
Good Diastolic* 118 (46.27) 37 (31.4) 81 (68.6) 0.15 1.47 (0.88- 2.46) 
*reference category bad  
 
C –HbA1c 4-1 with lifestyle behaviors 
Table 15: Associations between HbA1c 4-1change with BMI, caloric intake and 
physical activity  
Variable  Total 
N=255 
Bad  
N= 92 
Good  
N= 163 
P value Odds ratio (CI) 
Good BMI* 100 (39.22) 40 (40) 60 (60) 0.3 0.76 (0.45-1.28) 
Calories  1000 103 (40.39) 35 (34) 68(66) 0.97 0.97 (0.23- 4.12) 
1200 13 (5.1) 6 (46.2) 7 (53.8) 0.55 0.58 (0.1-3.4) 
1400 19 (7.45) 9 (47.4) 10 (52.6) 0.49 0.56 (0.11-2.9) 
1600 22(8.63) 8 (36.4) 14 (63.6) 0.87 0.88(0.17- 4.49) 
1800 45(17.65) 18 (40) 27(60) 0.71 0.75 (0.17-3.39) 
2000 32(12.55) 11 (34.4) 21 (65.6) 0.95 0.96 (0.2-4.57) 
2200 12 (4.71) 2 (16.7) 10 (83.3) 0.38 2.5(0.32- 19.53) 
2400 9(3.53) 3 (33.3) 6 (66.7)  1 
Activity level Very light 5 (1.96) 2 (40) 3 (60) 0.77 0.75 (0.11- 5.06) 
Light 211 (82.75) 77 (36.5) 134 (63.5) 0.71 0.87 (0.42- 1.79) 
Moderate 39 (15.29) 13(33.3) 26 (66.7)  1 
*reference bad BMI 
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HbA1c change between fourth and first visit (HbA1c 4-3): 
A-HbA1c 4-3 and demographic factors 
Table 16 : the distribution between HbA1c 4-3 with various demographic 
variables. 
 
 
 
 
 
 
 
Variable Total 
N=255 
Bad   
N=143  
Good  
N=112  
P 
value 
Odds ratio(CI) 
Age ≤40  15(5.88) 8 (53.3) 7 (46.7) 0.63 0.76 (0.25- 2.29) 
41-50 42(16.47) 24 (57.1) 18 (42.9) 0.84 1.08 (0.51- 2.3) 
51-60  108(42.35) 57 (52.8) 51 (47.2) 0.17 1.52 (0.84- 2.73) 
> 60  90(35.29) 54 (60) 36 (40)  1 
Sex Male 117(45.88) 71 (60.7) 46 (39.3) 0.17 1.42 (0.86- 2.33) 
Female 138(54.12) 72 (52.2) 66 (47.8) 
Period in 
study 
Months 
≤6  1(0.39) 1 (100) 0 (0) 1.00 0.00 (0.00) 
7-12  37(14.5) 19 (51.4) 18 (48.6) 0.03 2.7(1.09- 6.69) 
13- 18  25(9.8) 13 ( 52) 12 (48) 0.14 2.13 (0.78- 5.78) 
19- 24 71(27.8) 36 (50.7) 35 (49.3) 0.02 2.38 (1.13- 5.02) 
25- 30  21(8.23) 11 (52.4) 10 (47.6) 0.58 1.33 (0.48- 3.7) 
31- 36  48(18.82) 28 (58.3) 20 (41.7) 0.14 1.82 (0.82- 4.07) 
> 36  52(20.39) 35 (67.3) 17 (32.7)  1 
Duration 
of 
Diabetes 
Years 
≤5  70(27.45) 38 (54.3) 32 (45.7) 0.35 1.71(0.56- 5.26) 
6-10  65(25.4) 34 (52.3) 31 (47.7) 0.25 1.95 (0.63- 6.06) 
11-15 56(21.96) 36 (64.3) 20 (35.7) 0.08 2.86 (0.89- 9.19) 
16-20  49(19.22) 29 (59.2) 20 (40.8) 0.15 2.36 (0.73-7.65) 
> 20  15(5.88) 6 (40)  9 (60)  1 
Regions Middle 100 (39.22) 53 (53) 47 (47) 0.09 0.61 (0.35- 1.07) 
North 41(16.08) 21 (51.2) 20 (48.8) 0.99 0.99 (0.46- 2.14) 
South 114(44.71) 69 (60.5) 45 (39.5)  1 
Education 
level 
Illiterate 55 (21.57) 30 (54.5) 25 (45.5) 0.88 1.07 (0.45- 2.57) 
School 124 (48.63) 76 (61.3) 48(38.7) 0.56 0.8 (0.37- 1.7) 
High school 38 (14.9) 17 (44.7) 21(55.3) 0.81 1.13 (0.43- 2.94) 
University  38 (14.9) 20 (52.6) 18 (47.4)  1 
Employed Yes 65(25.49) 40 (61.5) 25 (38.5) 0.3 1.35 (0.76-2.4) 
No 190(74.51) 103 (54.2) 87 (45.8) 
Smoking Yes 36(14.12) 18 (50) 18 (50) 0.72 1.18 (0.48 -2.91) 
No 174(68.24) 99 (56.9) 75 (43.1) 0.54 1.24 (0.63- 2.42) 
Past smoker 45(17.65) 26 (57.8) 19 (42.2)  1 
Insurance  MOH 140 (54.9) 81 (57.9) 59 (42.1) 0.69 0.87 (0.45- 1.69) 
UNRWA 61 (23.92) 41 (67.2) 20 (32.8) 0.63 0.83 (0.38- 1.78) 
Others 54 (21.18) 21 (38.9) 33 (61.1)  1 
Marital 
Status 
Single 4 (1.57) 3 (75) 1 (25) 0.46 2.43 (0.23- 25.51) 
Married 209 (81.96) 118 (56.5) 91 (43.5) 0.23 1.54 (0.77- 3.1) 
Divorced 4 (1.57) 1 (25) 3 (75) 0.84 0.81 (0.1-6.36) 
Widow 38 (14.9) 21 (55.3) 17 (44.7)  1 
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B-HbA1c4-3 and lab tests   
 
Table 17 : Associations between HbA1c 4-3 change with change in cholesterol, 
MAU, and blood pressure 
 
Variable  Total 
N=255 
Bad   
N=143  
Good  
N=112  
P value Odds ratio (CI) 
Good MAU* 102 (40) 62 (60.8) 40 (39.2) 0.22 0.73 (0.44- 1.21) 
Good cholesterol* 96 (37.65) 54(56.3) 42 (43.8)% 0.97 0.99 (0.59- 1.65) 
Good Systolic* 115 (45.1) 62 (53.9) 53 (46.1) 0.53 1.17 (0.71-1.93) 
Good Diastolic* 108 (42.35) 65 (60.2) 43 (39.8) 0.26 0.75 (0.45-  1.24) 
*reference category bad  
 
C –HbA1c 4-3 with lifestyle behaviors 
 
Table 18: Associations between HbA1c 4-3 change with BMI, caloric intake and 
physical activity  
Variable  Total 
N=255 
Bad   
N=143  
Good  
N=112  
P value Odds ratio (CI) 
Good BMI* 118 (46.27) 65 (55.1) 53 (44.9) 0.77 1.08 (0.66-1.77) 
Calories  1000 103 (40.39) 54 (52.4) 49 (47.6) 0.97 0.97 (0.23- 4.12) 
1200 13 (5.1) 7 (53.8) 6 (46.2) 0.55 0.58 (0.10-3.40) 
1400 19 (7.45) 13 (68.4) 6 (31.6) 0.49 0.56 (0.11- 2.90) 
1600 22(8.63) 13 (59.1) 9 (40.9) 0.87 0.88 (0.17- 4.49) 
1800 45(17.65) 27 (60) 18 (40) 0.71 0.75 (0.17-3.39) 
2000 32(12.55) 18 (56.3) 14 (43.8) 0.95 0.96 (0.20- 4.57) 
2200 12 (4.71) 5 (41.7) 7 (58.3) 0.38 2.50 (0.32-19.53) 
2400 9(3.53) 6 (66.7) 3 (33.3)  1 
Activity level Very light 5 (1.96) 4 (80) 1 (20) 0.77 0.75 (0.11- 5.06) 
Light 211 (82.75) 118 (55.9) 93 (44.1) 0.71 0.87 (0.42- 1.79) 
Moderate 39 (15.29) 21 (53.8) 18 (46.2)  1 
*reference bad BMI 
 
 
 
 158 
 
Table 19: Multivariate analysis for HbA1c change among the visits with the various variables (n=255) 
Variable  AOR (CI) 2‐1    AOR (CI) 4‐1  AOR(CI) 3‐2  AOR (CI) 4‐3  AOR(CI) 4‐2  AOR (CI) 3‐1 
Age  ≤40   2.42 (0.6‐9.8)  0.7 (0.21‐ 2.26)  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  1.34 (0.36‐ 4.98)  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
41‐50  1.54 (0.62‐ 3.8)  1.08 (0.48‐ 2.41)  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  1.02 (0.42‐ 2.46)  ‐‐‐‐‐‐‐‐‐‐‐‐ 
51‐60   2.15 (1.07‐ 4.32)  1.69 (0.89‐ 3.18)  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  2.35 (1.21‐ 4.6)  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
> 60   1  1  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  1  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
Period in 
study 
Months 
‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
7‐12   3.18 (1.06‐ 9.55)  2.54 (1.01‐ 6.43)  ‐‐‐‐‐‐‐‐‐‐‐‐‐  1.95 (0.82‐ 4.64)  2.36 (0.89‐ 6.28)  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
13‐ 18   1.83 (0.57‐ 5.92)  2.09 (0.75‐ 5.8)  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐  1.9 (0.72‐ 5.04)  5.43 (1.66‐ 17.73)  ‐‐‐‐‐‐‐‐‐‐‐‐ 
19‐ 24  1.61 (0.7‐3.73)  2.58 (1.19‐ 5.6)  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐  2(0.95‐ 4.21)  3.63 (1.55‐ 8.52)  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
25‐ 30   2.33 (0.66‐ 8.27)  1.48 (0.51‐ 4.25)  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐  1.87 (0.67‐ 5.26)  3.35 (1.02‐ 10.99)  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
31‐ 36   1.48 (0.6‐3.64)  1.78 (0.78‐ 4.06)  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐  1.47 (0.65‐ 3.32)  1.78 (0.74‐ 4.28)  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
> 36   1  1  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐  1  1  ‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐‐ 
Duration of 
Diabetes 
Years 
≤5   2.49 (0.67‐ 9.23)  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  2.59 (0.81‐ 8.35) 
6‐10   2.86 (0.76‐ 10.72)  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  3.52 (1.08‐ 
11.50) 
11‐15  4.26 (1.14‐ 15.99)  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  5.52 (1.6‐ 19.09) 
16‐20   3.38 (0.9‐12.7) ‐‐‐‐‐‐‐‐‐‐‐‐‐ ‐‐‐‐‐‐‐‐‐‐‐‐‐ ‐‐‐‐‐‐‐‐‐‐‐‐‐ ‐‐‐‐‐‐‐‐‐‐‐‐‐ 5.66 (1.6‐ 19.98) 
> 20   1  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  1 
Insurance  MOH  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
UNRWA  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐ 
Others  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
Marital 
Status 
Singe  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  3.4 (0.31‐ 37.66) 
Married  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  2.15 (1.04‐ 4.47) 
Divorced  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  4.22 (0.37‐ 48.4) 
Widow  ‐‐‐‐‐‐‐‐‐‐‐‐‐ ‐‐‐‐‐‐‐‐‐‐‐‐‐ ‐‐‐‐‐‐‐‐‐‐‐‐‐ ‐‐‐‐‐‐‐‐‐‐‐‐‐ ‐‐‐‐‐‐‐‐‐‐‐‐‐ 1
Region  Middle  0.68 (0.36‐ 1.29)  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
North  0.71 (0.29‐ 1.7)  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐ 
South  1  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
Education  
level 
Illiterate  0.58 (0.2‐1.66)  1.13 (0.44‐ 2.94)  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  1.43 (0.49‐ 4.2)  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
School  0.52(0.21‐ 1.33)  0.84 (0.38‐ 1.87)  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  0.9 (0.38‐ 2.12)  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
High school  0.45 (0.15‐ 1.38)  1.32 (0.48‐ 3.67)  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  3.28 (1.11‐ 9.71)  ‐‐‐‐‐‐‐‐‐‐‐‐ 
University   1  1  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
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*reference category bad  
 
 
 
 
 
 
 
 
 
 
 
Variable AOR (CI) 2-1  AOR (CI) 4-1 AOR(CI) 3-2 AOR (CI) 4-3 AOR(CI) 4-2 AOR (CI) 3-1 
MAU (1)*  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  0.51 (0.28- 0.94) ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
Calories intake 1000 ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  14.92 (1.7- 130.82) ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
1200 ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  3.39 (0.29- 39.06) ‐‐‐‐‐‐‐‐‐‐‐‐ 
1400 ‐‐‐‐‐‐‐‐‐‐‐‐‐ ‐‐‐‐‐‐‐‐‐‐‐‐‐ ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 4.3 (0.41- 45.23) ‐‐‐‐‐‐‐‐‐‐‐‐‐
1600 ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  21.32 (2.07-219.66) ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
1800 ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  4.17 (0.44- 39.36) ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
2000 ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐  6.9 (0.7- 67.7) ‐‐‐‐‐‐‐‐‐‐‐‐ 
2200 ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  11.63 (0.97- 139) ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
2400 ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐  ‐‐‐‐‐‐‐‐‐‐‐‐‐ 
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Annex 7: Repeated measures for patients who have four HbA1c results within two years (n=255): 
Table 1:  the mean HbA1c in each of the four visits  
                              Mean       Std. Deviation  
HbA1c 1st                 9.31     2.22      
HbA1c 2nd                 8.73       1.94  
HbA1c 3rd                 8.51             1.76  
HbA1c 4th                8.53              1.79  
Table 2: Pairwise comparison 
visit Other visits Mean Difference  Std. Error Sig. 95% Confidence Interval for Difference 
Lower Bound Upper Bound 
1 2 0.58* 0.09 0.00 0.41 0.76 
3 0.8* 0.11 0.00 0.59 1.01 
4 0.78* 0.11 0.00 0.56 1 
2 1 -0.58* 0.09 0.00 -0.76 -0.41 
3 0.22* 0.07 0.00 0.07 0.36 
4 0.19* 0.09 0.03 0.02 0.37 
3 1 -0.8* 0.11 0.00 -1.01 -0.59 
2 -0.22* 0.07 0.00 -0.36 -0.07 
4 -0.02 0.06 0.74 -0.14 0.1 
4 1 -0.78* 0.11 0.00 -1 -0.56 
2 -0.194* 0.09 0.03 -0.37 -0.02 
3 0.021 0.06 0.74 -0.1 0.14 
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دراﺳﺔ ﺗﻘﻴﻤﻴﺔ ﻟﺒﺮﻧﺎﻣﺞ رﻋﺎﻳﺔ ﻣﺮﺿﻰ اﻟﺴﻜﺮي ﻓﻲ ﻣﺮآﺰ اﻟﺴﻜﺮي اﻟﺘﺎﺑﻊ ﻟﻤﺴﺘﺸﻔﻰ اﻟﻤﻄﻠﻊ ﻓﻲ اﻟﻔﺘﺮة ﻣﺎ ﺑﻴﻦ 
  9002 – 5002
  
  اﻋﺪاد اﻟﻄﺎﻟﺒﺔ: ﺳﻤﺎح اﻟﺨﻄﻴﺐ 
  اﺷﺮاف: د. ﻧﻬﻰ اﻟﺸﺮﻳﻒ 
  
 
  اﻟﺮﺳﺎﻟﺔ ﻣﻠﺨﺺ
ﺟﻪ، دورا ﻣﺤﻮرﻳﺎ وأﺳﺎﺳﻴﺎ ﻓﻲ ادارة ﻣﺮض اﻟﺴﻜﺮي وﻋﻼ ﺑﺮﻧﺎﻣﺞ اﻟﺘﺪﺧﻞ اﻟﻐﺬاﺋﻲ ﻳﺸﻜﻞ :اﻟﺪراﺳﺔ ﺧﻠﻔﻴﺔ
ﻳﻨﺼﺢ ﻣﺮﺿﻰ اﻟﺴﻜﺮي ﺑﺘﻄﺒﻴﻖ . اﻟﻤﻀﺎﻋﻔﺎت وﻳﻬﺪف اﻟﻰ ﺗﺤﺴﻴﻦ ﻋﻤﻠﻴﺔ اﻟﺴﻴﻄﺮة ﻋﻠﻰ اﻟﺴﻜﺮي و اﻟﻮﻗﺎﻳﺔ ﻣﻦ
ﻓﻲ  ﺔﻧﻤﺎط اﻟﻐﺬاﺋﻴﺑﺮﻧﺎﻣﺞ ﻏﺬاﺋﻲ ﺻﺤﻲ، واﺣﺪاث ﺗﻐﻴﻴﺮات ﺗﻐﺬوﻳﺔ ﺗﺸﻤﻞ ﺗﻌﺪﻳﻼت ﻋﻠﻰ اﻟﻌﺎدات اﻟﻐﺬاﺋﻴﺔ واﻷ
ﻜﺮي ﻳﻌﺎﻧﻮن ﻣﻦ ﻋﺪم اﻟﺴﻴﻄﺮة ن ﻧﺴﺒﺔ آﺒﻴﺮة ﻣﻦ ﻣﺮﺿﻰ اﻟﺴﺈﺣﺒﺎﺗﻬﻢ اﻟﻴﻮﻣﻴﺔ ﻣﺪى اﻟﻌﻤﺮ. وﺑﺎﻟﺮﻏﻢ ﻣﻦ ذﻟﻚ ﻓ
  ﻋﻠﻰ اﻟﻤﺮض ﺗﺒﻘﻰ ﻋﺎﻟﻴﺔ.
 
ﺗﻘﻴﻴﻢ ﺑﺮﻧﺎﻣﺞ اﻟﺘﻐﺬﻳﺔ ﻓﻲ ﻣﺮآﺰ اﻟﺴﻜﺮي اﻟﺘﺎﺑﻊ ﻟﻤﺴﺘﺸﻔﻰ اﻟﻤﻄﻠﻊ و  إﻟﻰ اﻟﺪراﺳﺔ هﺬﻩ هﺪﻓﺖ  :اﻟﺪراﺳﺔ أهﺪاف
ﻓﻌﺎﻟﻴﺘﻪ ﻓﻲ اﻟﺴﻴﻄﺮة ﻋﻠﻰ ﻣﺮض اﻟﺴﻜﺮي و ﺗﺤﺴﻴﻦ ﻣﺴﺘﻮى ﻣﺨﺰون اﻟﺴﻜﺮ اﻟﺘﺮاآﻤﻲ و ﻣﻌﺮﻓﺔ دور ﺑﺮﻧﺎﻣﺞ 
اﻟﻐﺬاﺋﻲ ﻓﻲ اﻟﺘﺄﺛﻴﺮ ﻋﻠﻰ ﻣﺴﺘﻮى ﻣﺨﺰون اﻟﺴﻜﺮ ﻓﻲ اﻟﺪم و ﻋﻠﻰ اﻟﺼﺤﺔ اﻟﺒﺪﻧﻴﺔ و  اﻟﺴﻜﺮي و ﺑﺮﻧﺎﻣﺞ اﻟﺘﺪﺧﻞ
ﻣﺆﺷﺮ آﺘﻠﺔ اﻟﺠﺴﻢ ﻟﻠﻤﺮﺿﻰ، و ﻣﻌﺮﻓﺔ اﻟﺨﺼﺎﺋﺺ اﻟﺸﺨﺼﻴﺔ ﻟﻠﻤﺮﺿﻰ اﻟﺘﻲ ﺗﺆﺛﺮ ﻋﻠﻰ ﻣﺴﺘﻮى ﻣﺨﺰون اﻟﺴﻜﺮ 
  ﺧﻼل ﻓﺘﺮة اﻟﺪراﺳﺔ.
 
و اﻟﻤﺮاﺟﻌﻴﻦ  اﻟﺜﺎﻧﻲ اﻟﻨﻮع ﻣﻦ ﺳﻜﺮي ﻟﻤﺮﺿﻰ ﻃﺒﻲ ﻣﻠﻒ 647ﻋﻠﻰ ﺗﻘﻴﻴﻤﻴﺔ دراﺳﺔ أﺟﺮﻳﺖ :اﻟﺪراﺳﺔ ﻣﻨﻬﺠﻴﺔ
و ﻗﺪ ﺗﻢ أﺧﺬ أرﺑﻊ زﻳﺎرات ﻟﻜﻞ   9002 -5002ﻓﻲ ﻣﺮآﺰ اﻟﺴﻜﺮي ﻓﻲ ﻣﺴﺘﺸﻔﻰ اﻟﻤﻄﻠﻊ ﻓﻲ اﻟﻔﺘﺮة ﻣﺎ ﺑﻴﻦ 
  ﻣﻌﻠﻮﻣﺎت ﺟﻤﻊ ﺗﻢ ﻣﺮﻳﺾ ﺗﺸﻤﻞ اﻻوﻟﻰ و اﻻﺧﻴﺮة و آﺎﻧﺖ ﻋﻠﻰ ﻓﺘﺮات ﻏﻴﺮ ﻣﻨﺘﻈﻤﺔ ﺑﻴﻦ آﻞ زﻳﺎرة و أﺧﺮى. 
  ﻟﻤﺮﺿﻰ.اﻟﺸﺨﺼﻴﺔ، اﻟﻄﺒﻴﺔ، اﻟﺒﺪﻧﻴﺔ و ﻧﺘﺎﺋﺞ اﻟﻔﺤﻮﺻﺎت اﻟﻤﺨﺒﺮﻳﺔ ﻣﻦ ﻣﻠﻔﺎت ا
 
± )ﻣﺘﻮﺳﻂ اﻟﻤﻌﺪل 43.9± ﻋﺎم 75 هﻮ اﻟﻤﺮﺿﻰ ﻋﻤﺮ ﻣﺘﻮﺳﻂ أن اﻟﺪراﺳﺔ ﻧﺘﺎﺋﺞ أﻇﻬﺮت :اﻟﺮﺋﻴﺴﻴﺔ اﻟﻨﺘﺎﺋﺞ
 % ﻣﻦ47ﺣﻴﻦ  ﻓﻲ % ﻣﺘﺰوﺟﻴﻦ48ﺗﺒﻴﻦ أن  ﻟﻠﻤﺮﺿﻰ اﻟﻌﺎﻣﺔ اﻟﺼﻮرة ﻋﻦ ﻣﻌﻴﺎري(. وﻣﻦ ﻧﺘﺎﺋﺠﻨﺎ اﻧﺤﺮاف
 وآﺎﻧﺖ ﺳﻨﻮات 80.01 وﻣﻌﺪل ﻓﺘﺮة اﻻﺻﺎﺑﺔ ﺑﺎﻟﺴﻜﺮي  ،%51اﻻﻣﻴﻴﻦ  ﻧﺴﺒﺔ آﺎﻧﺖ ﻓﻴﻤﺎ  ﻳﻌﻤﻠﻮن ﻻ اﻟﻤﺮﺿﻰ
% ﻣﻦ اﻟﻤﺮﺿﻰ 14ﻗﺪ ﺗﻢ اﻋﻄﺎء  .ﻳﻤﻠﻜﻮن ﺗﺄﻣﻴﻦ  وزارة اﻟﺼﺤﺔ اﻟﻔﻠﺴﻄﻴﻨﻴﺔ اﻟﺼﺤﻲ  اﻟﻤﺮﺿﻰ ﻣﻦ ٪75 ﻧﺴﺒﺔ
% ﻣﻦ اﻟﻤﺮﺿﻰ 28آﺎﻟﻮري( ﺧﻼل ﻓﺘﺮة اﻟﻤﺘﺎﺑﻌﺔ. ﺗﻢ ﺗﺼﻨﻴﻒ  0001ﻧﻈﺎم ﻏﺬاﺋﻲ ﻗﻠﻴﻞ اﻟﺴﻌﺮات اﻟﺤﺮارﻳﺔ )
% ﻓﻲ اﻟﺰﻳﺎرة اﻟﺮاﺑﻌﺔ. ﻣﺘﻮﺳﻂ 67ﺒﺔ اﻟﻰ ﻋﻠﻰ أن ﻧﺸﺎﻃﻬﻢ اﻟﺒﺪﻧﻲ ﻗﻠﻴﻞ ﻓﻲ اﻟﺰﻳﺎرة اﻻوﻟﻰ  و ﺗﺤﺴﻨﺖ اﻟﻨﺴ
.  7.1± 64.8و ﻓﻲ اﻟﺰﻳﺎرة اﻷﺧﻴﺮة   1.2± 1.9ﻣﻌﺪل ﻧﺘﺎﺋﺞ ﻣﺨﺰون اﻟﺴﻜﺮ اﻟﺘﺮاآﻤﻲ ﻓﻲ اﻟﺰﻳﺎرة اﻻوﻟﻰ آﺎن 
.   3.5±9.13وﻓﻲ اﻟﺰﻳﺎرة اﻷﺧﻴﺮة   3.5± 2.13ﻣﺘﻮﺳﻂ ﻣﻌﺪل ﻣﺆﺷﺮ آﺘﻠﺔ اﻟﺠﺴﻢ ﻓﻲ اﻟﺰﻳﺎرة اﻻوﻟﻰ آﺎن 
ﻣﻦ  (ﻣﻦ ﻣﺨﺰون اﻟﺴﻜﺮ اﻟﺘﺮاآﻤﻲ %7 ﻣﻦ أﻗﻞ) ﻣﺜﺎﻟﻴًﺎ ﺿﺒﻄًﺎ ﻟﺪﻳﻬﻢ ﺬﻳﻦاﻟ ﻟﻠﻤﺮﺿﻰ اﻟﻤﺌﻮﻳﺔ اﻟﻨﺴﺒﺔ وزادت
ﻓﻲ اﻟﺰﻳﺎرة اﻷﺧﻴﺮة. ﻧﺴﺒﺔ اﻟﻤﺮﺿﻰ اﻟﺬﻳﻦ آﺎن ﻋﻨﺪهﻢ ﺗﺤﺴﻦ ﻓﻲ ﻧﺘﻴﺠﺔ  1.22 إﻟﻰ اﻷوﻟﻰ اﻟﺰﻳﺎرة % ﻓﻲ 2.91
 ﻧﻤﺎذج أﻇﻬﺮت% ﺑﻴﻦ اﻟﺰﻳﺎرة اﻷوﻟﻰ و اﻟﺮاﺑﻌﺔ )اﻷﺧﻴﺮة(.و ﻗﺪ  7.06ﻣﺨﺰون اﻟﺴﻜﺮ اﻟﺘﺮاآﻤﻲ آﺎﻧﺖ 
اﻟﻔﺘﺮة  ﺑﻴﻦ اﺣﺼﺎﺋﻴﺔ دﻻﻟﺔ ذات و اﻳﺠﺎﺑﻴﺔ ﻋﻼﻗﺔ وﺟﻮد اﻟﻤﺮﺿﻰ ﻟﺒﻴﺎﻧﺎت أن  اﻟﻤﺘﻌﺪد اﻟﻠﻮﺟﻴﺴﺘﻲ اﻻﻧﺤﺪار
اﻟﺰﻣﻨﻴﺔ اﻟﺘﻲ آﺎن اﻟﻤﺮﻳﺾ ﻳﺘﺎﺑﻊ ﻓﻴﻬﺎ ﻓﻲ اﻟﻤﺮآﺰ و ﻳﺤﺼﻞ ﻋﻠﻰ اﺳﺘﺸﺎرات ﺗﻐﺬوﻳﺔ و ﺑﻴﻦ اﻟﺘﺤﺴﻦ ﻓﻲ ﻣﺴﺘﻮى 
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اﻟﺼﺤﻲ، ﻣﺆﺷﺮ آﺘﻠﺔ  ﻣﻴﻦﻟﻠﻤﺮﺿﻰ ﻧﻈﺎم اﻟﺘﺄ اﻟﺘﻌﻠﻴﻤﻲ اﻟﻤﺴﺘﻮى ,اﻟﺠﻨﺲ ,اﻟﻌﻤﺮﻣﺨﺰون اﻟﺴﻜﺮ اﻟﺘﺮاآﻤﻲ. و أن 
ﻓﻲ اﻟﺘﻐﻴﻴﺮ و اﻟﺘﺤﺴﻦ ﻟﻤﺴﺘﻮى ﻣﺨﺰون اﻟﺴﻜﺮي اﻟﺘﺮاآﻤﻲ. وﻗﺪ  ﺗﺆﺛﺮ ﻻ  اﻟﺠﺴﻢ، ﻣﺴﺘﻮى اﻟﻜﻮﻟﻴﺴﺘﺮ ﻋﻮاﻣﻞ
ﻣﺮﻳﺾ( اﻟﺘﻲ آﺎﻧﺖ زﻳﺎراﺗﻬﻢ اﻻرﺑﻌﺔ ﻣﻨﺘﻈﻤﺔ ﺧﻼل ﻣﺪة ﺳﻨﺘﻴﻦ ﻧﻔﺲ  552أﻇﻬﺮ اﻟﺘﺤﻠﻴﻞ ﻋﻠﻰ اﻟﻌﻴﻨﺔ اﻟﺠﺰﺋﻴﺔ )
  اﻟﻨﺘﺎﺋﺞ.
  
ﻓﻲ ﻣﺮآﺰ اﻟﺴﻜﺮي ﻓﻲ ﻣﺴﺘﺸﻔﻰ اﻟﻤﻄﻠﻊ و اﻟﺬي  ﻧﻮﻋﻬﺎ ﻣﻦ اﻷوﻟﻰ أﻧﻬﺎ اﻟﺪراﺳﺔ هﺬﻩ ﻣﻴﺰات أهﻢ ﻣﻦ :اﻻﺳﺘﻨﺘﺎج
اﻟﻤﺆﺛﺮة ﻋﻠﻰ  اﻟﻌﻮاﻣﻞ ﺑﻴﻨﺖ اﻟﺘﻲ و ﻳﻌﺪ ﻣﻦ أهﻢ اﻟﻤﺮاآﺰ اﻟﻤﻮﺟﻮدة ﻓﻲ ﻓﻠﺴﻄﻴﻦ ﻟﻠﻌﻨﺎﻳﺔ ﺑﻤﺮﺿﻰ اﻟﺴﻜﺮي.
اﻟﺒﺮﻧﺎﻣﺞ و ﻋﻠﻰ اﻟﻤﺮﺿﻰ ﺣﻴﺚ ﺗﺒﻴﻦ ﻋﺪم وﺟﻮد ﻓﺘﺮات ﻣﻨﺘﻈﻤﺔ ﺑﻴﻦ اﻟﺰﻳﺎرات ﻟﺒﻌﺾ اﻟﻤﺮﺿﻰ و اﻟﺘﻲ ﺑﻴﻨﺖ 
ﺗﻌﺪﻳﻞ ﺑﺮﻧﺎﻣﺞ   ﺑﻀﺮورة وﻧﻮﺻﻲ هﺬا  .دور ﻣﻬﻢ ﻓﻲ ﺗﺤﺴﻴﻦ ﻣﺴﺘﻮى ﻣﺨﺰون اﻟﺴﻜﺮ اﻟﺘﺮاآﻤﻲ اﻟﺪراﺳﺔ أن ﻟﻬﺎ
و  اﻟﺘﻐﺬﻳﺔ ﻣﻦ ﻧﺎﺣﻴﺔ زﻳﺎدة ﻋﺪد اﻟﺰﻳﺎرات و اﻻﺳﺘﺸﺎرات اﻟﻔﺮدﻳﺔ و ﺗﻮﺛﻴﻖ ﻣﺪى اﻻﻟﺘﺰام ﺑﺘﻄﺒﻴﻖ اﻟﻨﻈﺎم اﻟﻐﺬاﺋﻲ
ﻤﺮاﺟﻌﺔ ﻣﻮاﻋﻴﺪ اﻟﻤﺮﺿﻰ ﺣﺎﺟﺔ اﻳﻀﺎ ﻟ هﻨﺎك اﻟﻤﺮﺿﻰ ﻻﺣﺘﻴﺎﺟﺎت وﻓﻘﺎ اﻟﺒﺮﻧﺎﻣﺞ اﻟﺮﻳﺎﺿﻲ و اﻻﻟﺘﺰام ﺑﺎﻻدوﻳﺔ 
 و اﻧﺘﻈﺎم اﻟﻤﺮﺿﻰ ﻓﻲ اﻟﻤﺘﺎﺑﻌﺔ ﻓﻲ اﻟﻤﺮآﺰ.
